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3Abstract
The white matter is crucial for rapid transmission of information between
different parts of the brain and spinal cord, and is damaged in diseases including the
genetic leukodystrophies, stroke, spinal cord injury and multiple sclerosis. While
damage in the grey matter of the CNS is well known to often involve over-activation
of glutamate receptors, our understanding of white matter pathology is less
advanced. The experiments in this thesis used patch-clamping and [Ca2+]i imaging to
examine the cerebellar white matter oligodendrocyte response to pathological insults
mimicking those occurring in the leukodystrophies and in the ischaemia that occurs
in stroke or after spinal cord injury.
Oligodendrocytes responded to simulated ischaemia with an inward current,
which was triggered by glutamate release mediated by reversal of glutamate
transporters, and not by exocytosis, NKCC1 or cystine/glutamate exchange.
Surprisingly, this inward current was not mediated by glutamate receptors, nor by
ASICs, gap junctional hemichannels, P2X receptors or GABAA receptors, but
reflected the closing of potassium channels. In current clamp mode this initial
closing of K+ channels produced a depolarisation of the cells, followed by
a repolarisation as other K+ channels activated. These data indicate, for the first time,
a significant role for K+ channels in the response of oligodendrocytes to ischaemia.
In Canavan and Pelizaeus-Merzbacher-like leukodystrophies, elevated levels
of N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) occur. These
compounds can activate or block neuronal NMDA receptors. Since oligodendrocytes
are reported to express NMDA receptors, I tested their response to NAAG and NAA.
NAAG, but not NAA, evoked a small inward NMDA receptor-mediated current in
oligodendrocytes, but no [Ca2+]i rise. Much of the inward current was a secondary
effect of NAAG acting on neurons. Thus, actions of NAAG and NAA on
oligodendrocyte NMDARs are unlikely to be a major contributor to white matter
damage in the leukodystrophies.
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Chapter 1: Introduction
This thesis describes experiments studying the response to pathological
situations of oligodendrocytes, the myelinating cells of the central nervous system
(CNS). In this introduction I will give the background information necessary to
understand the importance of oligodendrocytes in CNS function, the disorders they are
damaged in, and the possible role of ion channels and neurotransmitters in causing that
damage.
1.1 White matter and its role in CNS function
White matter is a crucial part of the vertebrate CNS, particularly in higher
mammals. The presence of myelin around axons (which is what makes the white matter
white) greatly speeds the propagation of the action potential, and thus confers fast
communication between distinct parts of the grey matter. For example, myelination
allows action potentials to propagate between the two hemispheres of the human
cerebral cortex (Fig. 1.1) approximately 60 times faster than would occur for
unmyelinated axons (Bakiri et al., 2009), reducing the conduction time from ~300 msec
to ~5 msec, and thus speeding up cognition considerably. Indeed, segregation of the
brain into grey matter where local processing occurs and white matter connecting tracts
has been suggested to maximize the brain’s information processing functionality (Wen
and Chklovskii, 2005).
1.2. Oligodendrocytes and their role in the white matter
The white matter is composed of myelinated axons (and a certain fraction of
unmyelinated axons in many tracts) and glial cells: astrocytes, oligodendrocytes and
microglia. Oligodendrocytes, whose name stems from the Greek words oligo (few),
dendros (branch) and cytos (cell), are highly specialized cells, the processes of which
enwrap axons (Figs. 1.2 and 1.3), forming a multilayered myelin sheath of membranes
(Fig. 1.3). The presence in series of all the myelin membranes decreases the effective
axonal membrane capacitance, while increasing its resistance. This results in less charge
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entry being needed to depolarise the cell and results in faster action potential
conduction, which becomes saltatory because Na+ ions only enter at nodes of Ranvier.
1.2.1. Oligodendrocyte development
In the experiments described in this thesis I recorded from mature myelinating
oligodendrocytes at a developmental stage of the cerebellum when there are also less
mature oligodendrocyte lineage cells present. It is therefore useful to briefly review the
development of these cells. Oligodendrocytes pass through three consecutive
developmental stages: oligodendrocyte precursor cells (OPCs), immature cells and
fully-myelinating mature cells.
Oligodendrocyte precursor cells are formed in distinct parts of the brain and
spinal cord. In the spinal cord, OPCs are derived from progenitors present in the
ventricular zone, initially from its ventral part (the first wave, at ~E12.5 of mouse
development, provides 85% of all OPCs) and later from the dorsal part (this second
wave, at ~E15 of mouse development, provides 15% of all OPCs). In the brain,
oligodendrogenesis occurs in 3 different regions: first, in the ventral medial ganglionic
eminence (MGE) at ~E12.5 of mouse development, then in the lateral ganglionic
eminence (LGE) a few days after the first wave from the MGE, and finally in the cortex
postnatally (Miller, 2002; Richardson et al., 2006; Rowitch, 2004).
From their place of origin, OPCs migrate along radial glial cells and axonal
tracts to populate different regions of the CNS. They are guided by soluble and
membrane-bound molecular clues, such as (in the optic nerve) chiasm-derived
chemorepellent signal netrin-1 (Sugimoto et al., 2001) and platelet-derived growth
factor (PDGF) (Armstrong et al., 1990), produced by astrocytes and neurons. It is not
clear what the ‘stop signals’ are that terminate the cells’ migration: the most likely
candidates are extracellular matrix molecules (such as tenascin-C and chemokine
CXC1), but the involvement of yet uncharacterized axonal signals cannot be excluded
(Miller et al., 2002).
The precursor cells proliferate during migration and this proliferation is highly
regulated by environmental factors provided by astrocytes and neurons, such as PDGF,
fibroblast growth factor (FGF) and neuregulin (Barres and Raff, 1994; Barres and Raff,
1999; Miller, 2002). The axonal action potential also plays an important role in
controlling OPC proliferation, since either axotomy or the application of TTX to the
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optic nerve cause a significant decrease in the number of mitotic OPCs (Barres and
Raff, 1993; Barres and Raff, 1999; Ueda et al., 1999)
After arrival at their final destination, OPCs exit their cell cycle and differentiate
into myelin-forming, mature oligodendrocytes. This process seems to be intrinsic to the
cells’ development, with a fixed number of cell divisions occurring before
differentiation occurs (Raff et al., 1985). However, oligodendrocyte differentiation is
also influenced by axonal signalling molecules, such as the EGF-like growth factor
neuregulin 1 (NRG1) and the Notch receptor ligand Jagged 1 (Wang et al., 1998;
Miller, 2002; Simons and Trajkovic, 2006). Neuronal activity also seems to play an
important role in the process, since myelination can be inhibited by tetrodoxin
(Demerens et al., 1996; but see also: Colello et al., 1995), and this influence of activity
might be linked to axonal release of promyelinating factors, such as adenosine and
glutamate (Káradóttir and Attwell, 2007). Glutamate is a good candidate for an axon-
derived differentiation-controlling molecule, because it has been shown that OPCs
receive glutamatergic synapses from unmyelinated axons (Kukley et al., 2007; Ziskin et
al., 2007), prompting the idea that synaptic transmission from unmyelinated axons to
OPCs is a “myelinate me” signal.
In order to distinguish the three main phases of oligodendrocyte development,
the cells can be characterized based on their morphology and the expression of specific
antigenic markers (Fig. 1.4). OPCs are identified as bipolar (when migrating) or stellate
(after migration) cells that express the proteoglycan NG2, a surface glycoside
recognised by the antibody A2B5, GD3 ganglioside and PDGFRα (Kettenmann and
Ransom, 2005). When differentiation occurs and the expression levels of NG2 and
PDGFRα are downregulated, the change is accompanied by the cell becoming 
immunoreactive for the surface antigen O4 (expressed by late stage precursor cells,
immature and early mature oligodendrocytes: Girolamo et al., 2010) and GalC
(Jackman et al., 2009). This expression pattern is characteristic for immature, early
myelinating oligodendrocytes that possess a small number of myelinating processes
aligned parallel to axons, with the majority of the processes protruding in different
directions, presumably because they are actively ‘searching’ for axons to myelinate.
Differentiation is completed by the cell acquiring the fully mature phenotype, with the
multiple processes aligned in parallel and myelinating up to 30 different axons. Mature
cells express myelin basic protein (MBP), proteolipid protein (PLP) and myelin
associated glycoprotein (MAG), which are localised in the myelin. In this thesis I used
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both morphological criteria and immunostaining against MBP to distinguish mature
oligodendrocytes from the population of precursors and immature cells (Trapp et al.,
1997; Kettenmann and Ransom, 2005), as described in later chapters.
Although most OPCs turn into myelinating oligodendrocytes (Zhu et al., 2008)
some OPCs, after arriving at their destination, remain as undifferentiated “adult OPCs”
and preserve their proliferative capabilities (Dawson et al., 2000; Miller, 2002). These
cells stain positively for the OPC markers PDGFR and proteoglycan NG2, and are
found distributed throughout the grey and white matter of the adult brain (Dawson et al.,
2000). They represent approximately 5% of all the cells in the brain (~8% of cells in
white matter and 3% in the grey matter; Dawson et al., 2003) and are the main
proliferative cell population (Dawson et al., 2003). Their proliferation and migration
rates are slower than for OPCs early in development, but these rates increase in
response to injury and demyelination (Levine and Reynolds, 1999; Dawson et al., 2000)
probably to promote remyelination (Levine and Reynolds, 1999; Dawson et al., 2000).
A small proportion of OPCs has been reported to generate cells other than
oligodendrocytes, i.e. astrocytes (Zhu et al., 2008) and neurons (Rivers et al., 2008),
although this is controversial (Kang et al., 2010).
1.2.2 Neuron-glia interaction at the node of Ranvier
The complex interplay between oligodendrocytes and axons leads, at the final
stage of oligodendrocyte development, to the formation of myelin. Oligodendrocytes
enwrap axons, dividing their structure into 4 different domains: the node, the paranode,
the juxtaparanode and the internode itself (Fig. 1.5).
At the node of Ranvier, which is formed by the gap between two segments of
myelin at regularly spaced intervals along the axon, the sodium channels that are
initially continuously distributed along unmyelinated axons become clustered and
anchored. The clustering depends on axon action potential activity, and can be promoted
by either oligodendrocyte-conditioned medium (Kaplan et al., 2001) or direct physical
contact with oligodendrocyte processes (Kaplan et al., 1997), underlining the necessity
of the interaction between glia and axons in the process.
The paranode is the region of the axon-glial junction per se, with the myelin
being directly anchored to the axonal membrane. This depends crucially on a complex
interaction between oligodendrocyte-expressed (neurofascin-155) and axon-expressed
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(contactin, Caspr and 4.1B) membrane proteins (Simons and Trajkovic, 2006; Jackman
et al., 2009). The anchoring is essential for the axonal action potential to propagate
normally. Its disruption has been reported in various pathological conditions (Wolswijk
and Balesar, 2003; Howell et al., 2006; Fu et al., 2009), and might occur during the
experiments described in this thesis.
The juxtaparanode domain, which is slightly further away from the node than
the paranodal region, is the final specialised region before the main part of the
internode. Voltage-gated potassium channels on the axonal membrane, which may
contribute to repolarization of the action potential, are located in the juxtaparanode
(Wang et al., 1993).
The main internode region consists of myelin wrapped around and tightly
apposed to the axonal membrane. It is necessary that a highly restricted space exists
between the myelin and axonal membrane in order to restrict extracellular current flow
outside the axon and thus avoid short-circuiting of the capacitance-reducing effect of the
myelin (because such short-circuiting would oppose rapid action potential propagation).
1.2.3 The classification of mature oligodendrocytes
A single mature oligodendrocyte can myelinate up to 30 different axons, with
each cell process extending to form one internode (Fig. 1.2). The internodal processes
are usually parallel to each other, and form myelin segments of a thickness and length
that depends on the brain area and the diameter of the axon myelinated (Butt and
Ransom, 1989). The properties of oligodendrocytes have been classified both
morphologically and electrically.
Del Rio-Hortega first classified oligodendrocytes into four morphological types
(denoted I-IV), depending on the shape and size of their soma, the number and size of
the axons they myelinate, and their distribution within the CNS (Rio-Hortega, 1928)
(Fig. 1.6). This classification was confirmed later with the use of immunohistochemistry
assays (Butt and Ransom, 1989). Type I and II oligodendrocytes have a similar
morphology, with small cell bodies and 4 or more primary processes that branch
repeatedly to myelinate 10-30 axons of less than 2 µm in diameter. Type I
oligodendrocytes, the most abundant of all types, have multiple branching processes
supporting numerous myelin sheaths that need not to be parallel and are primarily found
in the forebrain, cerebellum and spinal cord, while type II oligodendrocytes are
distinguished by their processes forming parallel myelin sheaths and are present only in
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the white matter, including the area that I studied in this thesis – the white matter of
cerebellum. Type III oligodendrocytes have large cell bodies, myelinate up to five thick
axons (4-15 µm), and are localized in the cerebral and cerebellar peduncles, the medulla
oblongata and the spinal cord. Finally, type IV oligodendrocytes form a single long (up
to 1000 µm) myelin sheath around large diameter fibres and are located exclusively near
the entrance of the nerve roots into the CNS (Wood and Bundge, 1984; Kettenmann and
Ransom, 2005).
Morphologically classified oligodendrocytes may differ functionally. For
example, the properties of type II oligodendroglia differ depending on the region of the
white matter they populate. Bakiri et al. (2011) reported that in the developing corpus
callosum oligodendrocytes myelinate ~10 axons, whereas in the cerebellar white matter
at the same age the average number of internodes formed by a single cell was ~7. In
addition, oligodendrocytes in the corpus callosum formed shorter internodes than those
in the cerebellar white matter. As a result of these differences, and the different diameter
of the underlying axons, a computational model predicted the conduction speed for
cerebellar axons to be twice that for corpus callosum axons. It was suggested that this
difference may reflect a higher conduction speed being needed for axons conveying
information to and from the cerebellum (in order to rapidly control motor output) than is
needed for less time-critical movement of information between the cerebral cortices.
Thus, differences in oligodendrocyte morphology and electrical properties may
stem from different functions that these cells perform in distinct parts of the brain,
instead of being simply the result of their intrinsic developmental program. This notion
is supported by a study showing that oligodendrocyte precursors purified from rodent
optic nerve (which contains uniformly small-diameter axons) when transplanted into the
spinal cord (containing both large- and small-diameter axons) myelinated both large and
small axons in the host, rather than preferentially myelinating small axons (Fanarraga et
al.. 1998).
1.2.4 The structure and role of the cerebellum
All the experiments that I performed for this thesis were carried out on cells in
the rat cerebellum (Fig. 1.7). This brain region was chosen as it is well described in the
literature, its microcircuits have been examined in depth, and it had been used
previously to study oligodendrocyte properties by other workers in our lab, so my
results could be directly compared with those previously obtained by the other members
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of the lab. In this section I will give the background information on the cerebellum that
is needed to understand the experiments that I performed. The anatomy and function of
the cerebellar cortex can be summarised as follows (Kandel et al., 2000).
The main function of the cerebellum is to store motor programmes and use them
to provide fine motor control. The cerebellum does not initiate the movement per se, but
it is important for the regulation of precise motor output to confer proper balance,
posture and smooth motor movements. The cerebellum is located behind the cerebral
cortex and has a highly organized and uniform structure. It can be divided into three
lobes, denoted flocculonodular, anterior and posterior, of which the last two can be
further divided into the central vermis and the two lateral cerebellar hemispheres. My
experiments were carried out on cells in the vermis, which is composed of multiple
folia, each of them characterized by the same layered structure (Fig. 1.7). Each folium
comprises white and grey matter, with the grey matter surrounding centrally located
white matter. The grey matter can be divided into three different layers: the granule cell,
Purkinje cell and molecular layers.
The innermost granule cell layer is composed of a high number of densely
packed granule cells and a smaller number of interneurons (Golgi cells), astrocytes and
NG2 positive oligodendrocyte precursor cells. Granule cells are distinguished by their
small cell body and 4-5 dendrites which receive excitatory synaptic input from the
mossy fibers and inhibitory input from the Golgi cells (which also receive input from
the mossy fibers). The mossy fibres are myelinated axons which provide information to
the cerebellar cortex on the sensory environment (information derived from peripheral
receptors) and on the desired motor output (information from the cortex and other brain
areas). In the granule cell layer this input information is recoded into the firing of the
granule cells. Each granule cell projects its axon (which is unmyelinated in rodents)
vertically through the molecular layer where it splits into two branches which travel
horizontally in opposite directions to form a so-called parallel fibre, which is
approximately 4 mm long in the adult rat. The parallel fibre sends excitatory synapses
onto the dendritic tree of ~130 Purkinje cells as well as onto the dendrites of
interneurons, the basket and stellate cells, which inhibit the Purkinje cells. The Purkinje
cells have their somata arranged in a thin layer – the Purkinje cell layer, which also
contains the somata of radial glial cells (the Bergmann glia) which send long processes
through the molecular layer. The elaborate Purkinje cell dendritic tree is flattened in a
plane perpendicular to the cerebellar folds, so that the molecular layer mainly comprises
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an array of these dendritic trees, with the parallel fibres running perpendicular to them,
like telephone wires on poles. In addition to receiving excitatory synaptic input from the
parallel fibres, the Purkinje cell also receives excitation from (myelinated) climbing
fibres which arise in the inferior olive. This input may provide a teaching input to
induce plasticity at the parallel fibre synapses and thus correct erroneous motor outputs.
After integration of the information arriving on the approximately 100,000 synapses
impinging on the Purkinje cell dendritic tree, the final output from the cerebellar passes
via the Purkinje cell output axon (which is also myelinated) through the white matter to
the deep cerebellar nuclei, whose cells are inhibited by the Purkinje cells. The deep
cerebellar nuclear neurons then send axons to the premotor cortex, primary motor area
and red nucleus to modulate the motor output of the body.
For the cerebellar cortex to process motor information rapidly, information has
to arrive on the mossy and climbing fibres and leave on the Purkinje cell axons at high
speed. This is achieved by these axons in the white matter of the cerebellum being
myelinated. In addition to the myelinated axons, the white matter consists of
oligodendrocytes, astrocytes, microglia and blood vessels. My experiments were
performed mostly on mature oligodendrocytes in the white matter of the P12 rat vermis,
at which age the cerebellum is to a large extent developed and it is easy to find mature
myelinating oligodendrocytes. However not all axons are myelinated at this stage, and
since myelin scatters light intensely, this makes it easier to see the cells’ somata for
whole-cell patch-clamp experiments.
1.3 Channel and receptor expression by oligodendrocytes
In the experiments described in this thesis I test the involvement of various
receptors and ion channels in contributing to the membrane current response of
oligodendrocytes to ischaemia and to agents like glutamate, N-acetyl-aspartate and N-
acetyl-aspartyl-glutamate. This section provides background information on the
receptors and ion channels that oligodendrocyte lineage cells express. The expression
level of these proteins depends greatly on the cells’ developmental stage, in part because
many of them regulate important developmental processes such as cell migration,
proliferation and maturation. However, overactivation of some of these receptors or
channels in pathological conditions (e.g. in ischaemia as I investigate in Chapters 3 and
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4), may lead to cell depolarization, a deleterious calcium or sodium influx and
eventually cell death. In the following sections I focus in particular on the ion channels
and receptors which I investigate the role of in this thesis.
1.3.1 Ion channels
1.3.1.1 Voltage-gated ion sodium channels
Voltage-dependent sodium channels are expressed by OPCs and may have an
important role in axon-glia communication. Their characteristics are similar to those of
neuronal sodium channels (i.e. they have rapid kinetics of activation, deactivation and
inactivation, and a high sensitivity to TTX), but their density is much lower (Lin and
Bergles, 2002). There is a progressive loss of these channels during cell maturation,
which has been reported both at the mRNA (Cahoy et al., 2008) and the functional level
(Paez et al., 2009a; De Biase et al., 2010). It is possible, therefore, that sodium currents
are involved in the mechanism through which OPCs sense electrically active axons in
the environment (amplifying the depolarization produced by synaptic input, as
suggested by Káradóttir et al. (2008)), a feature that is not required at later stages of
development. Interestingly, sodium-channel-expressing OPCs are more vulnerable to
dying in response to ischaemic insults, in comparison to NG2-expressing OPCs not
expressing the sodium channels (Káradóttir et al., 2008).
1.3.1.2 Voltage-gated calcium channels
The existence of voltage-dependent calcium channels (VDCCs) in
oligodendrocytes was for a long time controversial. Sontheimer et al. (1989) and Barres
et al. (1990) declared that these channels were absent from OPCs and oligodendrocytes
in culture, but more recent studies reported the expression of these channels, specifically
R-type and L-type VDCCs, in oligodendrocyte precursors and immature
oligodendrocytes in brain slices (Chen et al., 2000; Paez et al., 2007; Paez et al.,
2009b). Their expression may be downregulated during developmental progression
(Berger et al., 1992a; Takeda et al., 1995), although Agrawal et al. (2000) reported L-
and N-type calcium channel expression by mature oligodendrocytes in spinal cord white
matter.
The physiological function of oligodendrocyte VDCCs remains elusive. It was
suggested that they might be preferentially localized to the cell processes and participate
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in axon-glia signalling (Chen et al., 2000), but others reported a possible role in the
precursor cell migration and process extension (Paez et al., 2009a). Additionally, and of
potential relevance to my experiments, Agrawal et al. (2000) suggested that
overactivated oligodendrocyte calcium channels might mediate deleterious calcium
influx and damage to oligodendrocytes in a model of spinal cord injury.
1.3.1.3 Potassium channels
Oligodendrocytes express a wide range of potassium channels and their
expression pattern depends strongly on the developmental stage of the cell. I will show
in later chapters that K+ channels play a key role in the cells’ response to ischaemia, so
this section reviews the properties of these channels in some detail.
OPCs express mainly voltage- and time-dependent potassium channels. Delayed
rectifying channels (i.e. channels which are activated by depolarization and thus show
an outward current at positive potentials after the channels have activated) in these cells
have consistently been reported both in culture (Sontheimer et al., 1989) and in brain
slices (Berger et al., 1991; Chvátal et al., 1997), while A-type channels generating a
transient outward current were initially claimed to be absent (Berger et al., 1991), but
subsequently found to be present (Chvátal et al., 1997) in OPCs in CNS slices. In
cultured cells some of the outward rectifying potassium channels are activated by
calcium (Sontheimer et al., 1989). Also, a transcriptome analysis by Cahoy et al. (2008)
reported that OPCs express high levels of TASK-1, TREK-1 and TWIK-1, i.e. members
of a newly-identified two-pore domain (K2P) family of K+ channels. Additionally,
OPCs express inwardly rectifying potassium channels, including Kir4.1 (Olsen and
Sontheimer, 2008) and ATP-sensitive channels (Butt and Kalsi, 2006). The primary
function of the K+ channels in the cell is to set a negative resting membrane potential
but, possibly because of this, they may also be important for regulating cell proliferation
and differentiation (Sontheimer et al., 1989; Gallo et al., 1996; Olsen and Sontheimer,
2008; Fogal et al., 2010). For the full list of K+ channels expressed by OPCs and mature
oligodendrocytes, see Tables 1.1-3.
Mature oligodendrocytes express mainly “passive” potassium channels (also
known as ‘background’ channels), with little apparent voltage- and time-dependence to
their conductance, together with some voltage-activated outward rectifying channels
(Gipson and Bordey, 2002). The passive conductance is partly mediated by weakly
inwardly rectifying channels, mainly Kir4.1, the level of which increases during cell
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development (Neusch et al., 2001; Kalsi et al., 2004; for a full list of inwardly rectifying
K+ channels in oligodendrocytes, see Table 1.2). However, an additional role could be
played by THIK-1 channels (belonging to the K2P family), the mRNA levels of which
are also elevated in mature oligodendrocytes (Cahoy et al., 2008). In another type of
glial cell, astrocytes, whose membrane properties are also heavily dominated by passive
potassium currents, a recent paper also suggests the involvement of the K2P channels
TWIK-1 (a weak inward rectifier) and TREK-1 (a weak outward rectifier) (Zhou et al.,
2009). These channels could also contribute to the passive potassium currents in
oligodendrocytes, as their mRNAs are expressed by mature oligodendrocytes (though to
a lower level than in OPCs; Cahoy et al., 2008; for a full list of K2P channels expressed
by oligodendrocytes, see Table 1.3). The large permeability of the mature
oligodendrocyte membrane mediated by passive potassium channels has been suggested
to be important for spatial buffering of potassium by the oligodendrocyte (Berger et al.,
1991), just as Kir4.1 is important for spatial buffering of potassium in Müller glia
(Kofuji et al., 2002). In addition, or possibly because of this function, expression of
Kir4.1 (possibly in OPCs: Olsen and Sontheimer, 2008) is necessary for myelination to
occur in vivo (Neusch et al., 2001).
No specific diseases have been assigned directly to potassium channel
dysfunction in oligodendrocyte lineage cells, but many pathological conditions are
associated with a downregulation of Kir4.1 channel expression, at least in astrocytes
(Olsen and Sontheimer, 2008), suggesting that changes in the expression of these
channels may occur in response to changes in the cells’ environment and might thus
contribute to pathology.
1.3.1.4 Acid-sensing ion channel (ASIC)
Acid-sensing ion channels are tetrameric cation channels activated by a decrease
in extracellular pH (Waldmann et al., 1999), which are predominantly permeable to
Na+, but can also be permeable to K+ and Ca2+, depending on the subunits they are
composed of (Baron et al., 2002; Xiong et al., 2004). They are widely expressed by
neurons, in which cells they may be important in normal synaptic transmission, and
contribute to pain sensation, mechanosensation, learning and memory, and the
pathological response to ischaemia (Allen and Attwell, 2002; Xiong et al., 2004;
Feldman et al., 2008).
It was shown recently that oligodendrocytes in culture and in brain slices express
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transcripts for ASICs, including the calcium-permeable ASIC1a subunit, and that their
level of expression decreases with cell development (Feldman et al., 2008).
Electrophysiological and calcium imaging studies confirmed the functionality of these
channels (Feldman et al., 2008). Their role in oligodendrocyte physiology remains
unknown, but it is possible that they contribute to oligodendrocyte pathology. In a
mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis, EAE;
Friese et al., 2007), inflammatory lesions in the spinal cord were associated with an
acidic shift of extracellular pH, and knock-out or blockade of ASIC channels were
neuroprotective, suggesting that opening of ASIC channels, possibly in
oligodendrocytes, contributes to cell damage. Since oligodendrocytes are highly
vulnerable to ischaemic insult, and ischaemia is associated with an acid pH shift by ~1
unit as a result of an initial switch to anaerobic respiration (Kraig et al., 1983; Silver and
Erecińska, 1992), it is possible that Ca2+ entry caused by activation of ASICs
contributes to a damaging rise in the intracellular calcium concentration ([Ca2+]i) in
these cells (in addition to that produced by AMPA and NMDA receptors: see section
1.3.2.1 below).
In Chapter 4 of this thesis I examine the contribution of ASIC channels to the
response of oligodendrocytes to ischaemia.
1.3.1.5 Transient receptor potential (TRP) channels
Transient receptor potential channels are a large family of cation channels that
are expressed in a variety of CNS regions. TRP channels are permeable to sodium and
calcium (to varying degrees) and play an important role in sensory physiology, such as
vision, taste, olfaction, hearing, nociception and thermo- and mechanosensation, and
also in growth cone guidance, neurite outgrowth and synaptic activity (Venkatachalam
and Montell, 2007). Broadly speaking, on the cellular level, they allow the individual
cells to sense changes in their surrounding.
The expression of two particular calcium-permeable TRP channels – TRPC3 and
TRPM3 - has been reported in oligodendrocytes using immunohistochemistry (Fusco et
al., 2004; Hoffmann et al., 2010). TRPM3 expression in oligodendrocytes was found to
start with the onset of myelination (Hoffmann et al., 2010), so it is possible that its
activation may contribute to triggering the differentiation process. TRPM3 is known to
be activated by the lipid component sphingosine, which is a major component of myelin
lipids, and Hoffmann et al. (2010) demonstrated a sphingosine-evoked Ca2+ influx into
32
oligodendrocytes, but the functional significance of this is uncertain. In neurons, it was
shown that the opening of TRPs, specifically TRPM7, is involved in the acute response
to ischaemia in culture (Aarts et al., 2003), in slices (Lipski et al., 2006) and in vivo
(Sun et al., 2009), however their role in pathologies affecting oligodendrocytes is
unknown.
In Chapter 4 of this thesis I examine the contribution of TRP channels to the
response of oligodendrocytes to ischaemia.
1.3.1.6 Gap junctions and hemichannels
Gap junctions are channels expressed on the membranes of two coupled cells
that allow direct cytoplasm-cytoplasm communication through the exchange of
intracellular metabolites and ions (e.g. ATP, NAD+ and glutamate) up to 1 kDa in size
(Sáez et al., 2005). In vertebrates they were originally thought to be formed of two
families of proteins, the connexins and the pannexins, although now it is believed that
only connexins form gap junctions between cells (Sosinsky et al., 2011), while
pannexins form so-called hemi-channels connecting the cytoplasm with the extracellular
space (see below). In gap junctions, each cell contributes to the junction one connexon,
which is made up of six connexin subunits. Connexons which are not coupled to a
connexon on an apposed cell usually change conformation so that their intrinsic channel
is closed, but under certain circumstances (e.g. low extracellular [Ca2+]), this may open
(as also occurs for the pannexons), allowing an efflux of molecules like ATP and
glutamate from the cytoplasm to the extracellular space (Sáez et al., 2005).
Oligodendrocytes express 3 types of connexins (Cx29, Cx32 and Cx47) which
are localized to the cell plasma membrane, and may form functional gap junctions
between different oligodendrocytes, between oligodendrocytes and astrocytes, or
between different lamellae of the myelin sheath within each oligodendrocyte (Pastor et
al., 1998; Orthmann-Murphy et al., 2008; Maglione et al., 2010; Wasseff and Scherer,
2011). There is controversy about the importance of gap junctions between
oligodendrocytes and other cells. It was initially agreed that, unlike astrocytes,
oligodendrocytes form gap junctions only occasionally, mostly with astrocytes and
rarely with other oligodendrocytes (Pastor et al., 1998; Orthmann-Murphy et al., 2008),
but two recent reports found extensive coupling between oligodendrocytes in the white
matter (Maglione et al., 2010; Wasseff and Scherer, 2011). In my experiments,
however, gap junctions between oligodendrocytes and other cells were never detected
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(i.e. dye entering the patch-clamped cell never passed to other oligodendrocytes) and a
similar low incidence of coupling (3% and 9% of cells coupled in the corpus callosum
and cerebellum, respectively) was reported by Bakiri et al. (2011). The reason for these
differences is uncertain. Although the use of an intracellular medium with a more
alkaline pH (7.4) would tend to promote the opening of gap junctions (Sáez et al.,
2005), the pH of my internal solution (7.3) was only slightly more acidic than that used
in the other studies.
There are at least two examples of mutations in oligodendrocyte connexin genes
leading to severe debilitating conditions (Kleopa et al., 2010). Disruption of Cx32
expression leads to X-linked Charcot-Marie Tooth disease that mostly affects Schwann
cells in PNS (causing peripheral neuropathy), but also affects oligodendrocytes, leading
to cognitive dysfunctions. Mutation of another oligodendrocyte connexin, Cx47, was
reported in some of the cases (~8%; Henneke et al., 2008) of Pelizaeus-Merzbacher-like
disease which causes severe mental disability and premature death of the affected
individuals (see section 1.4.3.1 below). Furthermore, double knock-out of Cx32 in
oligodendrocytes and Cx43 in astrocytes leads to white matter vacuolation, astrocyte
loss and early mortality (Magnotti et al., 2011).
Pannexins are structurally and functionally (though not evolutionarily) similar to
connexins (MacVicar and Thompson, 2010). Pannexins are also expressed on the
plasma membrane but, unlike connexins, they cannot form functional gap junctions with
other pannexins (Sosinsky et al., 2011; formation of gap junctions was found only when
pannexins were overexpressed in oocyte: Bruzzone et al., 2003, but this finding was
criticised by: MacVicar and Thompson, 2010) and instead they serve as large-pore non-
selective hemichannels. Like connexins, they are permeable to large molecules, such as
ATP, glucose and glutamate, and it has been suggested that their main function is to
allow the release of these metabolites, and to mediate an ion influx across the membrane
upon NMDA receptor activation (Thompson et al., 2006). Pannexins were found on
astrocytes and neurons (Thompson and MacVicar, 2008), but their expression by
oligodendrocytes is controversial. The transcriptome analysis by Cahoy et al. (2008) did
not detect mRNA for pannexins in oligodendrocytes, however, another group found
pannexin expression in mature oligodendrocytes, both at the mRNA and the protein
level (Domercq et al., 2010).
In neurons, hemichannel opening as a result of NMDA receptor overactivation
was linked to such pathological conditions as epilepsy and ischaemia (Thompson et al.,
34
2006). Hemichannels were suggested to be activated by ischaemia, leading to a large
inward current that evokes depolarization, but this has been criticised by Madry et al.,
2010. In oligodendrocytes it has been suggested that hemichannel opening in ischaemia
leads to a release of ATP and a subsequent activation of P2X7 receptors (Domercq et
al., 2010).
In Chapter 4 of this thesis I examine the contribution of hemichannels to the
response of oligodendrocytes to ischaemia.
1.3.2 Receptors expressed by oligodendrocytes
In this section I will describe the three types of oligodendrocyte receptor that I
studied during my PhD: ATP, GABA and glutamate receptors. Oligodendrocytes also
express a variety of other receptors (such as serotonin, acetylcholine and glycine
receptors), which I will not cover in this introduction as I did not examine their
properties during my experiments.
1.3.2.1 Glutamate receptors
1.3.2.1.1 AMPA/KA receptors
AMPA receptors are formed from subunits GluR1-GluR4 (also known as
GluA1-4; Collingridge et al., 2009), while kainate receptors are made from GluR5,
GluR6, GluR7, KA1 and KA2 (also known as GluK1-5, respectively; Collingridge et
al., 2009). AMPA/KA receptors are mostly permeable to sodium and potassium, with
the permeability of AMPA receptors towards calcium being determined by the presence
of GluR2 (which, when edited at the mRNA level, as normally occurs, suppresses the
calcium permeability; Dingledine et al., 1999).
Oligodendrocyte express GluR2-4, 6, 7, and KA1 and KA2, which permits them
to form functional AMPA and KA receptors (Patneau et al., 1994; Matute et al., 1997;
Itoh et al., 2002). Indeed, a glutamate-evoked inward current in oligodendrocytes,
mediated by AMPA/KA receptors, has been demonstrated both in culture (Barres et al.,
1990; Patneau et al., 1994; Gallo et al., 1996) and in brain slices (Berger et al., 1992b).
Although some studies reported a lack of GluR2 in functional AMPA/KA receptors in
oligodendrocytes (Matute et al., 1997), which would allow calcium to pass through the
channel, others have suggested that the expression of this subunit varies with
developmental stage, with GluR2 being present in mature oligodendrocyte and absent in
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precursor and immature cells (Itoh et al., 2002). This would explain the increased
susceptibility of cells at these developmental stages to excitotoxic death (Back et al.,
2002; Deng et al., 2003). Apart from subunit composition, it is not clear whether the
overall expression level of AMPA/KA receptors changes during oligodendrocyte
development. A transcriptome study found a downregulation of AMPA receptor
expression with development (Cahoy et al., 2008), but functional studies have given
more varied results. While some researchers have reported that, in culture and in brain
slices, the AMPA/KA-receptor mediated response to glutamate is larger in precursor
and immature cells than in mature oligodendrocytes (Itoh et al., 2002; Deng et al.,
2003), some studies in brain slices found a comparable size of response at different
stages of development (Berger et al., 1992b), and other researchers have reported that,
both in culture and in slices, mature oligodendrocytes respond more to the application of
AMPA than do OPCs (Patneau et al., 1994; Káradóttir et al., 2005).
AMPA/KA receptors have been proposed to play an important role in
oligodendrocyte development, although the main function of these receptors remains to
be resolved. Gallo et al. (1996) found that Na+ influx through AMPA receptors causes a
rise of intracellular sodium concentration ([Na+]i) which blocks delayed rectifier
potassium channels, and this leads to a block of cell proliferation and differentiation,
while having no impact on cell migration. On the other hand, Wang et al. (1996) and
Gudz et al. (2006) reported increased cell migration upon AMPA receptor activation,
which correlated with calcium transients evoked in the cells and involved activation of
Gi-coupled proteins (an effect that was not mediated by mGluRs).
AMPA/KA receptors are expressed on OPCs at the synapses these cells receive
from axons in the grey (Bergles et al., 2000) and the white matter (Kukley et al., 2007;
Ziskin et al., 2007). These synapses are lost as the cells differentiate into mature
myelinating oligodendrocytes (De Biase et al., 2010; Kukley et al., 2010), which further
suggests a role for AMPA/KA receptors in cell maturation. In mature myelinating
oligodendrocytes, the low number of AMPA/KA receptors present seems to be localized
to their soma, with their functional role still unknown (Salter and Fern, 2005; Káradóttir
and Attwell, 2007).
Oligodendrocyte AMPA/KA receptors are activated in pathological conditions,
such as multiple sclerosis (MS) and ischaemia, as described in detail in later sections. In
a mouse model of MS, glutamate (possibly released by activated immune cells) acts on
mature oligodendrocyte AMPA/KA receptors causing cell damage and subsequent
36
damage to the underlying axon (Pitt et al., 2000; Smith et al., 2000). Similarly, during
ischaemia, overactivation of AMPA/KA receptors leads to substantial oligodendrocyte
death (McDonald et al., 1998; Tekkök and Goldberg, 2001). It was suggested that the
increased OPC vulnerability towards hypoxic/ischaemic insult (compared to mature
cells) is caused by the calcium influx that results from their AMPA/KA receptor subunit
composition, i.e. the lack of GluR2 described above (Fern and Möller, 2000; Deng et
al., 2003). However, the developmental change in the contribution of AMPA/KA
receptors to ischaemia-evoked damage of axons is different to that for the overlying
oligodendrocytes: McCarran and Goldberg (2007) reported that at early ages the
AMPA/KA blocker NBQX protected oligodendrocyte lineage cells but not axons, while
at later ages the axons were protected by AMPA/KA receptor block. More details on the
role of AMPA/KA receptors in the response to ischaemic insult, both in the white and
the grey matter, will be given below in section 1.4.2.
In Chapter 4 of this thesis I examine the contribution of AMPA/KA receptors to
the response of oligodendrocytes to ischaemia.
1.3.2.1.2 NMDA receptors
NMDA receptors are composed of the following subunits: NR1 (also known as
GluN1; Collingridge et al., 2009), which binds glycine, NR2 (NR2A, NR2B, NR2C or
NR2D, also known as GluN2A, 2B, 2C and 2D, respectively; Collingridge et al., 2009),
which binds glutamate and NR3 (NR3A and NR3B, also known as GluN3A and 3B;
respectively; Collingridge et al., 2009), which binds glycine. The receptors are
composed of 4 subunits, thought usually to be two glycine-binding NR1 subunits and
two glutamate binding subunits (i.e. NR2A-D), but it has also been shown that glycine-
binding NR3A or NR3B can assemble with NR1 to form excitatory glycine receptors
which are unaffected by glutamate (reviewed by Cull-Candy and Leszkiewicz, 2004),
and heterotrimeric receptors containing NR1, NR2 and NR3 subunits are also formed
and may be important in oligodendrocytes as described below.
NMDA receptors are permeable to sodium, potassium and calcium. For them to
pass ions, in addition to the binding of extracellular glutamate and the co-agonist
glycine (or D-serine), a depolarization of the cell membrane is required to release
magnesium from the channel pore (Dingledine et al., 1999; Wollmuth and Sobolevsky,
2004). The receptor sensitivity to magnesium depends on the NR2 and NR3 subunits
involved in its structure, with a sensitivity ranging from the highest to the lowest in the
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order: NR2A > NR2B > NR2C >NR2D; Kuner and Schoepfer, 1996), with the NR3
subunits conferring only a weak magnesium block (Sasaki et al., 2002).
Even though mRNA for NMDA receptors was detected in oligodendrocyte
cultures (Yoshioka et al., 1996; Matute et al., 1997), their functional expression in these
cells was long denied based on a lack of current evoked by NMDA application, both in
culture (Barres et al., 1990; Patneau et al., 1994) and in brain slices (Berger et al.,
1992b). Recently, however, many labs reported, based on immunocytochemistry,
electron microscopy, electrophysiological and calcium-imaging studies, the presence of
functional NMDA receptors at all three oligodendrocyte developmental stages, in brain
slices and in the optic nerve (Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al.,
2006) (Fig. 1.8).
Oligodendrocyte NMDA receptors were found to have a very weak magnesium
block, with 2 mM extracellular magnesium concentration (twice the normal
extracellular level) reducing the current only 3 to 5-fold relative to that seen in a
magnesium-free solution (in contrast, for neuronal receptors comprised of NR1 with
either NR2A or 2B, or NR2C or 2D, expressed in oocytes, the reduction would be 70 to
20 fold respectively; Kuner and Schoepfer, 1996). This weak magnesium sensitivity,
together with antibody labelling, suggested that the white matter oligodendrocyte
NMDA receptors might be composed of NR1, NR2C and NR3 subunits (Káradóttir et
al., 2005; Salter and Fern, 2005; Micu et al., 2006). Indeed, the co-assembly of
NR1/NR2C/NR3A subunits in HEK cells leads to the formation of NMDA receptors
with a magnesium block that closely resembles that seen in cerebellar oligodendrocytes
(Burzomato et al., 2010), consistent with this constitution being the one for
oligodendrocyte NMDA receptors.
The physiological role of NMDA receptors in oligodendrocyte lineage cells still
waits to be discovered: notably they do not seem to be activated by glutamate release at
the synapses made from axons onto OPCs (Kukley et al., 2007; Ziskin et al., 2007),
suggesting an extrasynaptic location in the OPCs (analogous to the extrasynaptic
NMDA receptors found on neurons). Their preferential location on myelinating
processes (detected by immunolabelling at both the light microscopy level, and also the
EM level which showed expression of NR1 in the myelin: Káradóttir et al., 2005; Salter
and Fern, 2005; Micu et al., 2006) suggests a possible role of these receptors in axon-
glia signalling, probably during the myelination process (Káradóttir and Attwell, 2007).
In pathological conditions, such as ischaemia, oligodendrocyte NMDA receptors were
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shown to become overactivated, which has a detrimental effect on the cell, presumably
by allowing calcium influx into the processes, resulting in myelin disruption and even a
loss of the myelinating processes (Salter and Fern, 2005; Micu et al., 2006), as
described in more detail below in section 1.4.2.
In Chapter 4 of this thesis I describe experiments to investigate the role of
NMDA receptors in the oligodendrocyte response to ischaemia.
1.3.2.1.3 Metabotropic glutamate receptors
Metabotropic glutamate receptors (mGluRs) can be divided into 3 groups, of
which group I comprises mGluR1 and mGluR5, group II comprises mGluR2 and
mGluR3, and group III comprises mGluR4 and mGluR6-8. Group I are Gq-coupled
receptors, the activation of which stimulates phospholipase C (PLC) to generate IP3 and
diacylglycerol, and thus leads to the opening of endoplasmic reticulum calcium
channels (raising [Ca2+]i) and protein kinase C activation. Group II and III receptors are
Gi-coupled proteins whose activation causes adenylyl cyclase inhibition and so
decreases the intracellular cyclic AMP concentration (for a review see Conn and Pin,
1997).
OPCs in culture express a range of mGluRs, with mGluR3 and mGluR5 being
the most commonly found, both at the mRNA and the protein level (Luyt et al., 2003;
Deng et al., 2004; Luyt et al., 2006; Cahoy et al., 2008). The expression of mGluRs,
apart from mGluR3 (Deng et al., 2004; Cahoy et al., 2008), seems to decrease with
oligodendrocyte maturation, suggesting they may have a role in oligodendrocyte
development (Luyt et al., 2006). Activation of mGluR5 causes calcium oscillations in
OPCs (Luyt et al., 2003; Luyt et al., 2006) and mGluR3 reduces intracellular cAMP
concentration (Luyt et al., 2006), both processes thought to enhance OPC migration
(Othman et al., 2003; Gudz et al., 2006). Surprisingly, however, activation of these
receptors alone failed to exert any effect on OPC motility (Luyt et al., 2006). Activation
of mGluR5 may decrease the cells’ vulnerability to excitotoxic insults and apoptosis
(Kelland and Toms, 2001; Deng et al., 2004; Luyt et al., 2006). Additionally,
stimulation of group I mGluRs on oligodendrocytes has been recently found to cause a
release of BDNF, an effect that may influence cell survival and development (Bagayogo
and Dreyfus, 2009). However, to date, although mGluRs have been detected on OPCs in
brain slices (Luyt et al., 2003) there is no definite study proving a functional role for
oligodendrocyte mGluRs in situ.
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In Chapter 4 of this thesis I examine the contribution of mGluRs to the response
of oligodendrocytes to ischaemia.
1.3.2.2 GABA receptors
GABA receptors are widely expressed in the CNS and can be divided into 3
subclasses: GABAA, GABAB and GABAA-ρ (formerly GABAC).
GABAA receptors are ionotropic chloride-permeable receptors, the activation of
which evokes a hyperpolarization in cells where the intracellular chloride concentration
([Cl-]i) is low (so the chloride reversal potential is more negative than their resting
membrane potential), and a depolarization in cells with a high [Cl-]i (so the chloride
reversal potential is above their resting membrane potential). They are formed of 5
subunits: 2 α, 2 β and an auxiliary one (most commonly γ).  
OPCs have been reported to express mRNA for 4 α (α2-5) and 2 γ (γ2, γ3)
subunits, while β subunits were not tested for (Williamson et al., 1998). These cells are
found to have a high [Cl-]i that is maintained by NKCC1 co-transporter activity (Wang
et al., 2003) and so their reversal potential for chloride is shifted to a potential more
positive than the resting potential (~-43 mV; Lin and Bergles, 2004). Consequently,
opening of GABAA receptors causes an efflux of chloride, depolarizing the cell
membrane, and GABA acts as an excitatory neurotransmitter at the synapses which
OPCs receive from interneurons in the grey matter (Lin and Bergles, 2004; Vélez-Fort
et al., 2010).
The physiological role of GABAA receptors in OPCs is uncertain. Lin and
Bergles (2004) showed that activation of these receptors causes a transient inhibition of
AMPA receptor currents in the OPCs, so it was suggested that GABAA receptors may
regulate cell development by modulating the efficacy of glutamate signalling (and hence
presumably modulating glutamate’s effects on OPC proliferation or migration). In the
Attwell lab, Nicola Hamilton (unpublished) has shown that blocking GABAA receptors
in cultured cortical slices leads to a doubling of the number of oligodendrocyte lineage
cells formed, but it is uncertain if this action of endogenous GABA is mediated via
receptors on OPCs or on neurons..
The expression and importance of GABAA receptors in mature oligodendrocytes
is unclear: Vélez-Fort et al. (2010) reported decreasing GABAergic synaptic activity in
OPCs during cell differentiation which implies either a loss of GABA release onto
OPCs or a downregulation of their GABAA receptors. However, Butt and Tutton (1992)
recorded a small membrane depolarization (2-3 mV) evoked by GABA in optic nerve
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mature oligodendrocytes, and similarly Pastor et al. (1995) reported a small inward
current upon GABA application in spinal cord oligodendrocytes.
GABAB receptors are Gi-protein coupled metabotropic receptors. In OPCs they
are expressed both in culture and in the white matter of brain slices, and inhibition of
these receptors increases OPC migration and differentiation (Luyt et al., 2007). In
mature oligodendrocytes, GABAB receptors have only been found under culture
condition (Charles et al., 2003; Luyt et al., 2007).
To date, GABAA-ρ receptor expression has not been detected in oligodendrocyte 
lineage cells.
In Chapter 4 of this thesis I examine the contribution of GABA receptors to the
response of oligodendrocytes to ischaemia.
1.3.2.3 Purinergic receptors
Purinergic receptors can be divided into two families: P1 (adenosine-activated)
and P2 (ATP/ADP-activated) receptors. P2 receptors further subdivide into P2Y
(metabotropic) and P2X (ionotropic) receptors (Burnstock, 2006). All of these types are
expressed by oligodendrocytes.
All four subtypes of adenosine-activated P1 receptor (A1, A2a, A2b and A3)
were found to be expressed in OPCs and in immature oligodendrocytes (defined by O4
expression, which does not allow for a rigid distinction between late precursors,
immature and early mature oligodendrocytes, see Fig. 1.4) (Stevens et al., 2002). They
were found to be important for axon-glia communication, inhibiting cell proliferation
and stimulating differentiation and myelination (Stevens et al., 2002). Later studies
showed that the A1a receptor (high-affinity A1 receptor variant; Ralevic and Burnstock,
1998) has a positive effect on migration, without exerting an influence on cell
proliferation and differentiation (Othman et al., 2003), suggesting that the effects
observed by Stevens et al. (2002) on proliferation and myelination may have been
mediated by adenosine receptors other than A1a receptors.
Although the role of adenosine receptors in mature oligodendrocyte physiology
remains to be uncovered, Melani et al. (2009) have shown that blocking A2a receptors
in ischaemia results in less damage occurring to myelin and a reduced death of OPCs
and oligodendrocytes.
P2X receptors are classical cationic ligand-operated channels, permeable to
sodium, potassium and calcium (Abbracchio et al., 2009), of which oligodendrocytes
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express many subtypes (such as P2X1-4,7: Agresti et al., 2005), with a most prominent
role for P2X7 receptors. P2X7 receptors are reported to be responsible for producing an
increase in intracellular calcium concentration upon ATP application, both in OPCs and
in mature oligodendrocytes (Domercq et al., 2010; Hamilton et al., 2010). The
physiological role of these receptors is unknown, but their overactivation leads to
excitotoxic damage and death of oligodendrocytes during ischaemia and spinal cord
injury (Wang et al., 2004; Domercq et al., 2010). Furthermore, blocking P2X7 receptors
in a mouse model of MS (EAE) reduced demyelination and ameliorated the EAE
symptoms (Matute et al., 2007).
P2Y receptors are classical G-protein coupled metabotropic receptors
(Abbracchio et al., 2009), of which subtypes 1, 2 and 4 are expressed by OPCs. Their
activation leads to increased OPC migration and differentiation, and inhibits
proliferation (Agresti et al., 2005). Their expression by mature oligodendrocyte has not
been yet investigated.
In Chapter 4 of this thesis I examine the contribution of P2X7 receptors to the
response of oligodendrocytes to ischaemia.
1.4 Pathologies of the white matter and the role of oligodendrocytes
As described in section 1.1, myelination of axons in the white matter greatly
enhances the speed of signal transmission between distant parts of the CNS and so is
crucial for the proper functioning of the nervous system. In many diseases affecting the
white matter, the myelin sheath gets damaged (Levine et al., 2001), causing a decrease
of the conduction speed because of an increase in axon capacitance, and possibly also
because of disruption of the protein organisation at the node of Ranvier (Howell et al.,
2006). Such processes eventually lead to axon atrophy (Papadopoulos et al., 2006),
probably because oligodendrocytes provide axons with trophic or energetic factors
(Nave, 2010). If a significant fraction of axons in a tract are affected, this will inevitably
lead to severe mental or physical disability. Such an outcome is seen in diseases such as
multiple sclerosis, ischaemia (which occurs in stroke, spinal cord injury and in some
cases of periventricular leukomalacia leading to cerebral palsy) and the genetic
leukodystrophies. Prevention of myelin sheath damage and oligodendrocyte death, as
well as restoration of destroyed myelin, is therefore a crucial aim of therapies for
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pathological conditions affecting white matter.
In this section I will give an overview of oligodendrocyte pathologies, and their
underlying mechanisms, some of which may also be involved in the particular
pathologies that I am concerned with (ischaemia and the leukodystrophies).
1.4.1 Multiple sclerosis
Multiple sclerosis (MS; also known as disseminated sclerosis or
encephalomyelitis disseminata) is an autoimmune demyelinating disease that affects
young adults. It is characterized by the presence of large lesions in white matter that
appear as a result of primary demyelination (Fig. 1.9A), and subsequent axonal
dystrophy and loss of axonal function. In most cases, the early stages of multiple
sclerosis have remission periods that are associated with remyelination of the primary
lesions. Gradually, however, remyelination becomes less effective and a progressive
loss of function of the affected tracts leads to a progressive deterioration of motor and
cognitive functions, leading to permanent disability.
The origin of MS is unknown, but there are numerous hypotheses for possible
causative agents, including genetic predisposition, and environmental and infectious
factors (Hemmer et al., 2002). At the cellular level, the primary demyelination is
thought to be an autoimmune response mediated by T cells entering the CNS and failing
to recognize myelin as being a normal part of the body, and subsequently attacking it,
leading to inflammation, activation of microglia and macrophages, and release of
cytokines and reactive oxygen species, all of which damage the myelin (Hemmer et al.,
2002). Afterwards the myelin debris is cleared. In the last 10 years it has been suggested
that three ion channels on oligodendrocytes play a role in the pathological events of MS:
glutamate receptors, ASIC channels and P2X7 receptors. I will review these actions here
since, in Chapter 4, I will investigate whether they also play a role in the
oligodendrocyte response to ischaemia.
Glutamate release plays a role in multiple sclerosis. In the EAE mouse model of
MS, activated immune cells were suggested to release glutamate that could act on
oligodendrocyte AMPA/KA receptors, damaging the oligodendrocytes, and
subsequently the underlying axons (Pitt et al., 2000; Smith et al., 2000). The evidence
for this was that blocking AMPA/KA receptors resulted in a significant amelioration of
the disease symptoms, increased oligodendrocyte survival and reduced
dephosphorylation of neurofilament H, an indicator of axonal damage, without altering
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immune system function or the amount of inflammation occurring (Pitt et al., 2000).
ASIC1 channels also contribute to cell damage in EAE. In the ASIC knock out
mouse there was a significant reduction in the clinical deficits and axonal degeneration
evoked by EAE, when compared to the effects of EAE in control mice (Friese et al.,
2007). Further investigation, performed both on the EAE mice and on tissue samples
from MS patients, showed an upregulation of ASIC1 channel expression on axons and
oligodendrocytes and a co-localization of the axonal ASIC1 channel expression with the
axonal injury marker beta amyloid precursor protein (Vergo et al., 2011). Blocking
ASICs with amiloride proved to be neuroprotective in nerve explants and protected both
myelin and neurons from damage in EAE, an effect that was independent of activation
of the immune system (Friese et al., 2007; Vergo et al., 2011). It is currently uncertain
whether the main damaging action of ASICs is mediated by the ASICs on
oligodendrocytes, or those on axons, or whether both are involved.
The purinergic P2X7 receptor has similarly been proposed to play a role in MS,
as prolonged activation of this receptor causes myelin damage and lesions similar to
those found in MS, and its expression is elevated in MS patients (Matute et al., 2007).
Consistent with this, blocking P2X7 receptors in mice with EAE proved to be beneficial,
reducing the demyelination and restoring normal axon conduction velocity (Matute et
al., 2007).
It was reported that mature oligodendrocytes cannot form new myelin sheaths
when transplanted into areas of demyelination (Targett et al., 1996; Crang et al., 2004)
and that postmitotic oligodendrocytes that survive demyelination do not contribute to
remyelination (Keirstead and Blakemore, 1997). This strongly suggests that mature
oligodendrocytes are not involved in the restoration of myelin. The cells that are the
most probable source of new myelin are adult NG2 cells (adult OPCs: Polito and
Reynolds, 2005), which, in the absence of pathology, mostly differentiate into
oligodendrocytes (Rivers et al., 2008). It was found that, following lysolecithin-induced
demyelination, OPCs that were labeled with BAG retrovirus (i.e. labeled by retrovirally-
delivered beta-galactosidase, the activity of which leads to the emergence of
intracellular blue staining) eventually transformed into BAG-labeled remyelinating
oligodendrocytes (Gensert and Goldman, 1997), and that adult NG2 cells isolated from
healthy white matter, when injected into a demyelinated area, can remyelinate it (Zhang
et al., 1999).
There are two main phases to the remyelination process: a recruitment phase
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(which involves cell activation, proliferation and migration to the demyelinated area)
and a differentiation phase (which is characterised by cells maturing into myelin-
forming oligodendrocytes) (Franklin, 2002; Franklin and Ffrench-Constant, 2008) (Fig.
1.9B). Different growth factors play a role in both of these phases. PDGF and FGF were
found to be involved in OPC recruitment, as they increase cell migration and
proliferation (see section 1.2), while IGF and TGFβ1 were reported to be involved in 
the differentiation phase by regulating cell maturation (for a full review see: Franklin,
2002; Franklin and Ffrench-Constant, 2008; Fancy et al., 2010).
It was also suggested that axons might play an active role in the remyelination
process (as they do in primary myelination) both because their activity will release
factors that regulate myelination, and because axonally expressed PSA-NCAM was
found in demyelinating but not remyelinating areas, suggesting that this molecule
prevents myelination (Charles et al., 2002).
With time (and with increasing age of the affected individuals: Sim et al., 2002)
the remyelination process gradually becomes less efficient and its inadequacy results in
the appearance of sustained lesions. The reason for this is unclear. It is supposed that
either OPC recruitment or, more probably, their differentiation phase is disturbed
(Fancy et al., 2010).
The available therapies for MS involve mostly suppresion of inflammation
which decreases the speed of the demyelination. Remyelination treatments, which
potentially include transplantation of adult OPCs, are still being developed (Windrem et
al., 2008).
1.4.2 The pathology of white matter ischaemia
Brain ischaemia is a critical reduction in cerebral blood flow that leads to
irreversible brain damage in conditions such as stroke (one of the leading causes of
death and disability in developed countries), traumatic brain injury, spinal cord injury
and some cases of periventricular leukomalacia leading to cerebral palsy (Khwaja and
Volpe, 2008; Taoufik and Probert, 2008). Neuronal cell death in the grey matter has a
pivotal role in the loss of proper brain function, but the white matter also suffers greatly
during ischaemia. Oligodendrocytes have been shown to be especially vulnerable to
anoxic conditions and their damage has a deleterious effect on axonal action potential
propagation, ultimately affecting proper communication between different brain areas.
A comprehensive understanding of oligodendrocyte responses to the ischaemic insult
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may therefore allow the occurrence of oligodendrocyte damage to be minimised. Since
many of the experiments in this thesis investigate the electrical response of
oligodendrocytes to simulated ischaemia, in the following sections I will review our
current knowledge of ischaemia’s effects, first on the grey matter (which is better
studied) and then on the white matter.
1.4.2.1 An overview of the grey matter response to ischaemia
In the grey matter the greatly reduced supply of oxygen and glucose occurring in
ischaemia results in various extracellular and intracellular changes that finally lead to an
impairment of neuronal function and to cell death. In this overview I will highlight the
main changes in cellular physiology affected by ischaemia in the grey matter, while a
more detailed description of the effects of ischaemia on the white matter and on
oligodendrocytes, a major focus of my PhD, will be given in section 1.4.2.2.
1.4.2.1.1 Energy failure
One of the most profound features of ischaemia is the energy failure due to the
inhibition of oxidative phosphorylation. The lack of oxygen supply initially results in
glycolysis becoming the major source of ATP production, but as this process is much
less efficient than oxidative phosphorylation (producing 2 as opposed to 28 ATP
molecules per molecule of glucose), and because local stores of glycolytic intermediates
(and of astrocyte glycogen) are no longer being replenished by glucose arriving in the
blood, the cell is soon deprived of sufficient energy levels (Lipton, 1999). That leads to
an inhibition of cellular kinases and ATP-dependent pumps, notably the Na+/K+-
ATPase, on which 75% of brain energy is used (Attwell and Laughlin, 2001). This
causes a severe ionic imbalance which results in membrane depolarization.
1.4.2.1.2 Ionic imbalance
Failure of the energy supply is the direct cause of the ion homeostasis disruption
occurring in ischaemia. As mentioned above, the Na+/K+-ATPase fails during ischaemia
or anoxia due to ATP depletion. The block of the Na+/K+ pump results in the potassium
efflux that occurs normally into the extracellular space (because cell resting potentials
are more positive than the Nernst potential for K+ so K+ exits through the cells’ resting
K+ conductance) not being pumped back, so the extracellular potassium concentration
([K+]o) rises. This depolarizes neurons and glia, leading initially to action potential
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firing and also to excessive synaptic vesicle release that is action potential independent
(Katchman and Hershkowitz, 1993). After several minutes a regenerative increase of
[K+]o occurs, resulting in [K+]o rising to 40 mM in anoxia and ~55 mM in ischaemia
(Hansen, 1985) and a fall of extracellular sodium concentration ([Na+]o) by a similar
amount due to a sodium flux into the cell. These changes depolarize cells to about -
20 mV, an event termed the anoxic depolarization.
1.4.2.1.3 Glutamate release and excitotoxicity
As mentioned above, the initial depolarization evoked by ischaemia, and the rise
of [Ca2+]i produced by this and by the inhibition of Ca2+ extrusion mechanisms
occurring when ATP levels and ion gradients fall, causes excessive synaptic release of
different neurotransmitters, among them glutamate. Nevertheless, the main mode of
glutamate release in ischaemia is calcium-independent and mediated by glutamate
transporters (Rossi et al., 2000; Hamann et al., 2005).
Under physiological conditions, glutamate transporters transport glutamate into
the cell, removing it from the extracellular space (and, most importantly, from the
synaptic cleft). The transport is Na+-dependent and electrogenic: for each glutamate
anion entering the cell, three Na+ ions and one proton enter, and one K+ ion moves out
of the cell (Fig. 1.10A). However, in ischaemia, the increase in [Na+]i, fall of [Na+]o,
and rise of [K+]o (and associated depolarization) cause the transporter to reverse and
pump glutamate out of the cell (Rossi et al., 2000) (Fig. 1.10B). This process generates
a massive increase in the extracellular glutamate concentration, reaching up to ~100 µM
(Globus et al., 1991; Phillis et al., 1996), and leads to the overactivation of glutamate
receptors, of which NMDA receptor opening is the most detrimental to the cell as it
permits an excessive calcium influx, the effect of which is described below.
1.4.2.1.4 Calcium influx
A massive calcium influx from the extracellular space during ischaemia is
triggered by multiple factors (Fig. 1.11). Predominantly, as mentioned above, it is
caused by the activation of AMPA and NMDA receptors when the extracellular
glutamate level increases (Rossi et al., 2000; Hamann et al., 2005; for a review see:
Siesjö, 1988, and Lipton, 1999). However, activation of other channels and receptors
may also contribute to the Ca2+ influx: ASICs (Xiong et al., 2004), TRPs (Aarts et al.,
2003; Lipski et al., 2006) and P2X7 receptors (Domercq et al., 2010) are all Ca2+-
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permeable and open during ischaemia. In addition, depolarization opens voltage-gated
calcium channels, and the rise of [Na+]i produced by glutamate-gated Na+ entry reverses
the action of the Na+/Ca2+ exchanger, both of which result in a further increase in the
intracellular calcium concentration (Hertz, 2008). At the same time, calcium extrusion
from the cell by the ATP-dependent calcium pump is blocked because of ATP depletion
(Nestler et al., 2008).
The calcium concentration rise in the cell cytoplasm can also have an
intracellular source (Fig. 1.11). In the ER, a process known as calcium-dependent
calcium release (CIRC) occurs, where an increase in [Ca2+]i activates (ryanodine
receptor) channels on the ER, causing a calcium efflux into the cytoplasm (Lipton,
1999; Nestler et al., 2008). Additionally, the action of inositol trisphosphate
(a downstream product of group I mGluR activation) on its ER receptors causes opening
of IP3 receptor calcium channels in the ER membrane and a release of calcium (Nestler
et al., 2008). In addition the fall of ATP level in the cell inhibits the Ca2+-ATPase that
normally pumps Ca2+ into the endoplasmic reticulum, and the fall of energy supply to
mitochondria will run down their membrane potential and reduce Ca2+ buffering by
these organelles.
The intracellular calcium concentration is around 100 nM under normal
conditions but during ischaemia rises to ~2.5 µM (Lipton, 1999), causing an
overstimulation of normally well-controlled Ca2+-dependent processes. The increased
activation of proteases, such as calpain, causes the irreversible activation of signalling
pathways and may ultimately result in the break-down of the cytoskeleton and induction
of apoptotic pathways. Elevated [Ca2+]i leads also to the increased activation of lipases,
such as phospholipase A (PLA) and C (PLC) (Raichle, 1983), whose action causes a
breakdown of membrane phospholipids and may result in decreased membrane
integrity. Activation of lipases also leads to the production of free fatty acids, including
arachidonic acid, that in turn stimulate the production of eicosanoids, such as
prostaglandins, thromboxanes and leukotrienes. Prostaglandin production may result in
the formation of reactive oxygen species (described in the next section) and an increase
in membrane permeability. Eicosanoids can additionally exacerbate the ischaemic insult
by promoting vasoconstriction and platelet aggregation and in this way further block the
supply of oxygen and glucose to the affected area (Raichle, 1983).
The promotion of reactive radical formation by Ca2+ is not restricted to the
production of eicosanoids. Binding of nitric oxide (NO) synthase to the Ca2+-calmodulin
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complex initiates the production of NO from arginine (Lipton, 1999), which may result
in the formation of the highly increased levels of reactive nitrogen species, described
below.
1.4.2.1.5 Formation of reactive radicals
Excitotoxicity is frequently associated with the formation of reactive radicals
(also known as free radicals or reactive oxygen and nitrogen species). Free radicals are
molecules with an unpaired electron in an outer shell; this unpaired electron causes the
molecule to be unstable and highly reactive, targeting membrane fatty acids with double
bonds and protein sulphydryl groups, which greatly destabilizes their structures and
leads to changes in their properties (Nestler et al., 2008).
The production of reactive oxygen and nitrogen species (ROS and RNS,
respectively) requires the presence of some oxygen, and greatly increases (i) in the
penumbra of an ischaemic area where some oxygen is still provided by unblocked
vessels nearby, and (ii) when blood flow is restored after ischaemia if an occluding clot
is removed either spontaneously or by medical intervention with tissue plasminogen
activator. Due to their high activity, free radicals (which may normally serve as second
messengers in various signalling pathways) become detrimental to the cell, causing
DNA damage, lipid peroxidation and severe protein oxidation, which lead to cell death
(Raichle, 1983; Siesjö, 1988; Lipton, 1999).
The most damaging free radical, hydroxyl radical (·OH) can be formed through
different pathways (Fig. 1.12). The formation of superoxide anion, which may be
initiated by phospholipase activation, is a prerequisite for the formation of other ROS,
and it is also involved in the RNS pathway. Superoxide anion is transformed by
superoxide dismutase (SOD) into hydrogen peroxide (H2O2), which may serve as a
precursor for ·OH.
Excessive NO synthesis induced by the [Ca2+]i rise occurring in ischaemia leads
to the formation of RNS. Upon reaction of NO with superoxide anion, peroxynitrate is
formed and that, together with H2O2, may result in ·OH and nitrogen dioxide formation.
Peroxynitrate is also a precursor of other RNS radicals (e.g. nitrosoperoxycarbonate;
Fig. 1.12).
In ischaemia, therefore, the greatly increased Ca2+ flux into the cell may lead to
excessive ROS formation (through the activation of phospholipases; Raichle, 1983) and
RNS formation (by NO synthase stimulation; Lipton, 1999).
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Most of the free radicals, however, are formed during reperfusion after
ischaemia. Upon a sudden increase in oxygen level, mitochondria drastically raise their
level of superoxide production due to side reactions of electron carriers along the
respiratory chain (mostly complexes I and III: Sugawara and Chan, 2003; Sugawara et
al., 2004). Additionally, radicals are formed during the autooxidation of many
compounds (e.g. catecholamines) and in the xanthine oxidase reaction (Lipton, 1999).
The process of ROS and RNS formation leads to an increased membrane
permeability, a prolonged inhibition of protein synthesis and promotion of DNA
cleavage, including cleavage via the activation of pro-apoptotic signalling systems such
as mitogen-activated protein kinases (MAPKs; Matsuzawa and Ichijo, 2005) which
eventually cause extensive apoptotic cell death.
1.4.2.1.6 Acidotoxicity
Glycolysis, which is the main source of ATP in ischaemia (until the exhaustion,
after a few minutes, of glucose and glycogen stores), produces large amount of pyruvate
which is then transformed into lactate, because there is no oxidative phosphorylation to
drive its consumption by the citric acid cycle. Lactate formation (and probably also the
cessation of CO2 clearance by the blood) greatly decreases the intra- and extracellular
pH (to 6.0-6.5: Nedergaard et al., 1991). The resulting fall of extracellular pH leads to
the opening of ASICs (see section 1.3.1.4) and a further detrimental influx of Na+ and
Ca2+ (Xiong et al., 2004) which add to the ionic imbalance and to Ca2+-induced cell
damage during ischaemia. Moreover, the intracellular pH change is suggested to
interfere with many cellular processes, leading to an increase in protein degradation, a
decrease in its synthesis and a loss of cell volume control (Rehncrona, 1985).
1.4.2.2 The white matter mature oligodendrocyte response to ischaemia
The white matter is vulnerable to anoxia and ischaemia. Oligodendrocytes, and
especially their precursors at an early stage of development, suffer greatly from
ischaemic insult, which may result in their death causing concomitant mental and
physical impairment in stroke, spinal cord injury and periventricular leukomalacia
leading to cerebral palsy (Park et al., 2004; Stys, 2004; Khwaja and Volpe, 2008). The
vulnerability of action potential propagation to anoxic disruption becomes greater as
white matter tracts mature (Hamner et al., 2011), but the response of mature
oligodendrocytes to ischaemia is less studied than that of developing oligodendrocytes
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and, in the adult when myelination is essentially complete, it is their damage that leads
to axon dysfunction and the eventual loss of connectivity between different brain areas.
Just as for neurons, oligodendrocyte lineage cells are damaged by the glutamate
that is released in anoxia and ischaemia. The following sections review the role of
glutamate in damaging oligodendrocytes, its origin in the white matter and its actions on
white matter ionotropic and metabotropic receptors, as well as additional factors and
receptors that may add to the deleterious effect of ischaemia on mature
oligodendrocytes.
1.4.2.2.1 The mechanism of ischaemic glutamate release in the white matter
In grey matter ischaemia, glutamate, which is the main trigger of neuronal
damage, is mainly released via the reversal of glutamate transporters following a brief
initial phase of increased vesicular release (see above). In the white matter, however, the
origin of glutamate is still controversial.
Li et al. (1999) suggested that, as in the grey matter, the reversal of glutamate
transporters is the main source of extracellular glutamate in white matter anoxia (Fig.
1.13). By immunolabelling glutamate, they showed it was predominantly released from
axons and oligodendrocytes, but not from astrocytes (a result confirmed later by Li and
Stys, 2001). Later, Fern and Möller (2000) also reported that cultured immature
oligodendrocytes release glutamate in simulated ischaemia via reversal of glutamate
transporters.
Immunostaining for glutamate transporters showed expression of EAAC1 on
axons, GLAST on oligodendrocytes and astrocytes, and GLT1 on astrocytes (Li et al.,
1999), suggesting that EAAC1 and GLAST release the glutamate. However, the identity
of the transporter primarily involved in glutamate release in white matter ischaemia is
unclear, since Li et al. (1999) and Deng et al. (2003) found that dihydrokainate (DHK),
a blocker that preferably inhibits GLT1, was neuroprotective in anoxia and OGD
(oxygen-glucose deprivation) to a similar extent as the broad-spectrum glutamate
transporter inhibitor, PDC. This result suggests a major involvement of GLT1 in
glutamate release, and is surprising considering that GLT1 expression was confined to
the astrocytes which apparently did not contribute to glutamate release (Li et al., 1999;
Stys, 2004). In comparison, in grey matter ischaemia, GLT1 and GLAST on Bergmann
glia did not significantly contribute to the glutamate release, and the release was
tentatively attributed to reversal of EAAC1 in neurons (Hamann et al., 2005).
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Another possible source of glutamate in white matter ischaemia is release of
synaptic vesicles, at the synapses from axons to OPCs, which are described above
(section 1.2.1). It was shown in grey matter that anoxia/ischaemia results in excessive
vesicular release of neurotransmitters such as glutamate (Katchman and Hershkowitz,
1993) and GABA (Allen et al., 2004) into the extracellular space. This release is
independent of action potentials and probably reflects a rise of [Ca2+]i occurring in the
synaptic terminal when [K+]o rises and depolarizes cells at the same time as Ca2+
extrusion is slowed. The increased vesicular release lasts several minutes until the
anoxic depolarization occurs (Allen et al., 2004). After the anoxic depolarization, Rossi
et al. (2000) reported that glutamate release in grey matter ischaemia is predominantly
by reversed uptake, but the role of exocytotic release in white matter ischaemia is
unknown.
An additional potential mechanism for glutamate release in the white matter in
response to ischaemic insult could be an overactivity of astrocyte NKCC1 co-
transporters. NKCC1 co-transporters mediate the electroneutral transport of Na+, K+ and
2Cl- into the cell under physiological conditions and are expressed throughout the brain
by neurons, astrocytes and oligodendrocytes (Chen and Sun, 2005). Their proposed role
is to generate intracellular Cl- accumulation, which results in GABA depolarizing
(rather than hyperpolarizing) neurons especially early in development (Alvarez-
Leefmans et al., 1988; Sun and Murali, 1999). NKCC1 also plays a role in K+ uptake
and cell volume regulation in astrocytes (Mongin et al., 1994). Under ischaemic
condition, when [K+]o rises (see above), the resulting increase of white matter astroglial
NKCC1 activity (Su et al., 2000) brings excessive K+, Na+, and Cl- into the cell,
followed by water, which causes cell swelling, membrane rupture and glutamate release
(Su et al., 2002). This leads to a sudden increase in extracellular glutamate
concentration which directly damages oligodendrocytes (Wilke et al., 2004).
Finally, another source of glutamate release in white matter has been suggested.
Domercq et al. (2007) have shown that microglia activated by lipopolysaccharide (LPS,
a constituent of bacterial walls) release glutamate through cystine/glutamate antiporters
(system Xc-). System Xc-, which is especially abundant in macrophages and microglia,
imports extracellular cystine in exchange for intracellular glutamate. Activated
microglia produce and release large amounts of ROS, and in order to protect themselves
from these molecules, they maintain high levels of ROS scavengers, such as glutathione
(Watanabe and Bannai, 1987). Cystine is necessary for glutathione production and so
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upon microglial activation there is an increase in cystine uptake and, consequently,
more glutamate release through system Xc-. This mechanism could occur during
ischaemia, as microglia get activated under this condition (Yenari et al., 2010), although
Cavelier and Attwell (2005) have argued that the extracellular cystine concentration in
the CNS is not high enough to allow significant glutamate efflux by this mechanism.
1.4.2.2.2 Oligodendrocyte glutamate receptor activation in ischaemia
Glutamate release in ischaemia has a detrimental effect on the white matter,
especially on oligodendrocytes, which for a long time was attributed solely to the
activation of their AMPA/KA receptors.
Fern and Möller (2000) found that the death of immature oligodendrocytes that
occurs in culture during simulated ischaemia was mediated by a calcium influx through
AMPA/KA receptors (and not due to the activation of voltage-gated calcium channels
or NMDA receptors). Similarly, Tekkök and Goldberg (2001) concluded that hypoxic-
ischemic white matter injury in adult mouse brain was due to AMPA/KA receptor
activation, and McCarran and Goldberg (2007) found that blocking AMPA/KA
receptors in ischaemia (applied to mimic one cause of periventricular leukomalacia)
reduced axonal degeneration and oligodendrocyte loss (with oligodendrocytes being
protected across a broader range of ages than axons were) while blocking NMDA
receptors was not protective.
It is not clear which developmental stage of the oligodendrocyte lineage is more
affected by AMPA/KA-mediated injury during ischaemia. Deng et al. (2003) reported
that OPCs were more vulnerable to simulated ischaemia than were mature
oligodendrocytes, while McCarran and Goldberg (2007) found that oligodendrocytes at
postnatal days 10 and 21 (i.e. when a larger fraction are immature and mature
oligodendrocytes) suffer more from AMPA/KA-receptor-mediated damage than cells at
earlier ages (i.e. mostly OPCs). Considering that AMPA/KA receptors become
downregulated with oligodendrocyte development (Cahoy et al., 2008; De Biase et al.,
2010; Kukley et al., 2010), it seems probable that OPCs and early immature
oligodendrocytes are indeed more vulnerable than are the mature oligodendrocytes to
the effects of hypoxic-ischaemic insult that are mediated by these receptors.
Although most of the studies performed so far on oligodendrocyte or white
matter ischaemia did not show a beneficial effect of NMDA receptor blockers (Li and
Stys, 2000; Fern and Möller, 2000; Tekkök and Goldberg, 2001; Tekkök et al., 2007;
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McCarran and Goldberg, 2007; Baltan et al., 2008) recently Káradóttir et al. (2005)
reported that NMDA receptors on white matter OPCs and mature oligodendrocytes are
activated during ischaemic exposure (Fig. 1.14). Additionally, Salter and Fern (2005)
and Micu et al. (2006) found that in the optic nerve during ischaemia there is an
NMDA-receptor-mediated increase in intracellular calcium concentration in the
myelinating processes of oligodendrocytes (but not in their somata), and that the
myelinating processes are damaged in an NMDA-receptor-dependent manner.
Consistent with this, Bakiri et al. (2008) found that NMDA receptor blockers reduced
loss of the optic nerve compound action potential during ischaemia, while AMPA/KA
receptor block was not protective. It is unclear why this study gave different results to
that of the studies described above (e.g. Tekkök et al., 2007; Baltan et al., 2008),
although the fact that Bakiri et al. (2008) studied rat optic nerve while the other two
papers studied mouse optic nerve may account for the difference.
Salter and Fern (2005) and Micu et al. (2006) also found that in the optic nerve
during ischaemia there is an AMPA/KA-receptor-mediated increase in intracellular
calcium concentration in the somata of oligodendrocytes (but not in their myelinating
processes), and AMPA/KA receptor blockers prevented soma damage (Salter and Fern,
2005), suggesting a preferential localization of AMPA/KA receptors on oligodendrocyte
cell bodies, with NMDA receptors mainly located to the processes (as described above).
The lack of protective effect of NMDA receptor antagonists in some studies
could be explained by the different models employed. For example, NMDA receptors
may be downregulated in culture due to the lack of interaction with axons.
Alternatively, the difference in developmental stage may play an important role, as
Cahoy et al. (2008) have shown that the level of NMDA receptor mRNA decreases with
cell maturation. Also, there might be regional and developmental variations of
expression of NMDA receptors – for instance, oligodendrocytes in cerebellum were
shown to respond with a larger current to NMDA application than those in corpus
callosum (Káradóttir et al., 2005).
1.4.2.2.3 Ischaemia-induced calcium influx in oligodendrocytes
A significant fraction of the damage occurring to oligodendrocytes in ischaemia
is dependent on calcium entry from the extracellular space. Using a Ca2+-sensitive dye
Micu et al. (2006) showed that [Ca2+]i rises both in the cell soma and the myelinating
processes. Furthermore, calcium removal greatly reduces oligodendrocyte death and
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somewhat reduces loss of their myelinating processes (Salter and Fern, 2005). It is thus
important to assess the route by which Ca2+ enters oligodendrocytes in ischaemia.
AMPA/KA receptors were long considered solely responsible for the Ca2+ influx
occurring in ischaemia (Fern and Möller, 2000; Tekkök and Goldberg, 2001; Deng et
al., 2003; Wilke et al., 2004). However, most of these studies were conducted in culture
(where the cells might change the proteins they express) and on immature cells, and it
was found that the Ca2+-permeability of oligodendrocyte AMPA/KA receptors depends
strongly on the developmental stage of the cell. As noted above (section 1.3.2.1.1),
OPCs and immature oligodendrocytes do not express the GluR2 subunit that is
responsible for suppressing the Ca2+ permeability of AMPA/KA receptors, while this
subunit is expressed by mature oligodendrocytes (Itoh et al., 2002). What is more, as
mentioned above, AMPA/KA receptors become downregulated with oligodendrocyte
maturation (Cahoy et al., 2008), which implies that the calcium influx into mature
oligodendrocytes, which is evoked by ischaemia (Micu et al., 2006), may be performed
by other receptors or channels in addition to AMPA/KA receptors.
Recently, oligodendrocyte NMDA receptors were shown to mediate a Ca2+
influx into the cells’ processes in ischaemia (Micu et al., 2006). The presumed
NR1/NR2C/NR3 subunit composition of these receptors should theoretically allow for
some Ca2+-permeability (although the presence of the NR3 subunit decreases the Ca2+
permeability, at least in neuronal receptors: Tong et al., 2008). However, no direct
studies were performed to prove this assumption and so it cannot be excluded that the
depolarization or Na+ influx evoked by these receptors’ activation results in the opening
of other channels that allow a Ca2+ influx, or reverses Na+/Ca2+ exchange to raise
[Ca2+]i. In addition to NMDA and AMPA/KA receptors and voltage-gated calcium
channels (which were suggested to cause calcium influx into oligodendrocytes in a
model of spinal cord injury; Agrawal et al., 2000), other receptors and channels that
might contribute to the Ca2+ influx into mature oligodendrocytes include P2X7
receptors, and TRP and ASIC channels.
Oligodendrocyte P2X7 receptors are Ca2+-permeable (as described in section
1.3.2.3) and their overactivation during ischaemia results in the induction of an inward
current (Fig. 1.15), intracellular Ca2+ overload, ROS formation and a drop in
mitochondrial potential, which together lead to the death of the cells (Matute et al.,
2007; Domercq et al., 2010). During ischaemia there is a remarkable increase in the
extracellular level of ATP (Domercq et al., 2010), which may be caused by
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hemichannel opening (as described previously in neurons by Thompson et al., 2006).
Accordingly, blocking oligodendrocyte hemichannels and P2X7 receptors remarkably
increased cell survival (Domercq et al., 2010). Consequently, the activation of P2X7
receptors by ATP released from hemichannels was proposed to be responsible for a
substantial part of the Ca2+-induced damage to oligodendrocytes occurring in ischaemia.
TRP or ASIC channel opening is another possible cause of the [Ca2+]i increase
in oligodendrocytes during ischaemia. As described in sections 1.3.1.4 and 1.3.1.5,
ASIC and TRP channels are expressed in oligodendrocytes, and in neurons their
activation in ischaemia leads to a damaging Ca2+ influx. It is possible therefore that, as
in neurons, ischaemia-evoked opening of these channels in oligodendrocytes leads to a
detrimental Ca2+ influx into the cell.
Experiments described in Chapter 4 assess the contribution of AMPA/KA,
NMDA, TRP and ASIC channels to the response of oligodendrocytes to ischaemia.
1.4.2.2.4 Additional factors that may influence the oligodendrocyte response to
ischaemia
In the grey matter, during the first few minutes of ischaemia (as described in
section 1.4.2.1.2), there is a massive increase in the spontaneous synaptic release of
neurotransmitters into the extracellular space, and this includes a substantial rise in
GABA release (Allen et al., 2004). As a result, in neurons, ischaemic insult causes
overactivation of GABAA receptors which results in an excessive Cl- entry and cell
swelling (Allen et al., 2004). GABA is also released into the white matter (in tracts
including axons of inhibitory cells) during ischaemia (Shimada et al., 1993), and so
could activate the GABAA receptors which are present on oligodendrocyte lineage cells
(Gilbert et al., 1984; Berger et al., 1992a; Kirchhoff and Kettenmann, 1992; Pastor et
al., 1995). Although GABAA receptor expression seems to be downregulated with
oligodendrocyte development (Vélez-Fort et al. 2010), applying GABA to mature cells
still evokes a response (Butt and Tutton, 1992; Pastor et al., 1995), and so it is possible
that GABA exerts an additional effect on mature oligodendrocytes during ischaemia.
Finally, a depolarizing membrane current may enter oligodendrocytes via
potassium channels as a result of the ischaemia-evoked rise in extracellular potassium
concentration: the extracellular potassium concentration ([K+]o) in white matter
ischaemia can rise to 14 mM (Ransom et al., 1992). Additionally, Ca2+-activated
potassium channels could be activated in ischaemia when [Ca2+]i rises. We will see in
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Chapter 3 that ischaemia does indeed evoke a change of oligodendrocyte membrane K+
currents.
1.4.3 Leukodystrophies
Leukodystrophies (from the Greek: leuko, white, dys, lack of, and troph, growth)
are a group of rare genetic disorders that are characterized by the lack of properly
formed myelin (dysmyelination) or loss of once-formed myelin (demyelination), that
lead to the white matter degeneration. Patients are mostly young children that exhibit
normal early development, but then lose their previously acquired motor skills and
regress as myelin deteriorates, with typical clinical symptoms of nystagmus, ataxia,
spasticity and delayed mental development (although the severity of these symptoms
and their onset depend greatly on the type of the leukodystrophy).
Although the specific genes whose mutation leads to leukodystrophy
development are mostly identified, the reason for the myelin deterioration and
oligodendrocyte death is still not well established. In some of the disorders (such as
adrenoleukodystrophy, metachromatic leukodystrophy and Krabbe disease), the
mutations cause a lack or decreased efficiency of the enzymes involved in the
breakdown of long chain fatty acids (adrenoleukodystrophy), sulfatide lipids
(metachromatic leukodystrophy) or terminal -galactose-containing sphingolipids
(Krabbe disease). This leads to the accumulation of unmetabolised lipids, which cannot
be used for normal myelin formation, and ultimately causes the loss of
oligodendrocytes. In many other types of leukodystrophy, however, the reason for the
demyelination remains elusive. In this thesis I will focus on two leukodystrophies,
Canavan disease and Pelizaeus-Merzbacher-like disease, in which there is a rise in the
concentration of agents which might activate glutamate receptors on oligodendrocyte
lineage cells.
The treatment for leukodystrophies is currently symptomatic, although new
therapies, such as bone marrow and hematopoietic stem cell transplantation, are under
investigation.
1.4.3.1 Canavan and Pelizaeus-Merzbacher-like diseases
Canavan disease (CD) and Pelizaeus-Merzbacher-like disease (PMLD) are two
types of leukodystrophies where the reason for defects in myelin formation and
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maintenance is not fully understood.
CD is an autosomal recessive disorder caused by a mutation in gene coding for
the enzyme aspartoacylase (ASPA; Fig. 1.16), expressed solely by oligodendrocytes
(Luyt et al., 2007). ASPA breaks down N-acetylaspartylacetate (NAA), a molecule
found in a high concentration in CNS (see section 1.4.3.2.5), into aspartate and acetate
(Baslow, 2003). The resulting lack of acetate (which could disturb myelination: Fig.
1.17 and Chakraborty et al., 2001), and high level of NAA (the elevated extrusion of
which from oligodendrocytes in CD could result in damage to the cells due to excessive
water efflux: Baslow, 2003) are proposed to be the reasons for the spongy degeneration
of the white matter observed in CD.
Pelizaeus-Merzbacher disease (PMD) is caused by a mutation (duplication,
missense or null mutation) in the gene for PLP protein, which is one of the main myelin
proteins. However, around 20% of patients with symptoms indistinguishable from PMD
do not have a mutation in PLP gene, and the aetiology of this disorder, named
Pelizaeus-Merzbacher-like disease (PMLD), is unknown. In a minority of PMLD cases
(around 8%: Henneke et al., 2008), there is a mutation in the GJA12 gene that codes for
oligodendrocyte connexin Cx47, which may mediate metabolic trafficking between
different lamellae of the myelin sheath or between oligodendrocytes and astrocytes (see
section 1.3.1.6). The majority of PMLD patients, however, do not carry this mutated
allele and so the cause of the white matter deterioration in these cases is still obscure.
PMLD is frequently associated with high levels (up to 200 µM: Wolf et al., 2004) of N-
acetylaspartylglutamate (NAAG), formed from NAA and glutamate, the reason for
which is unknown.
1.4.3.2 The role of NAA and NAAG in CNS physiology and pathology
N-acetylaspartate (NAA) and its derivative, N-acetylaspartylglutamate, are
highly abundant in the vertebrate CNS. NAA is the second most abundant metabolite in
the brain after glutamate. Its concentration in neurons can be up to 20 mM (Wiame et
al., 2009), while it is present in the extracellular space at ~100 µM (Sager et al., 1997;
Chakraborty et al., 2001). NAAG is the next most concentrated peptide in the brain with
a concentration in neurons of up to 10 mM (Chakraborty et al., 2001; Hanaya et al.,
2008) and in the extracellular space 5-8 µM (Faull et al., 1999).
Although highly concentrated in the brain, the role of NAA and NAAG in
various physiological and pathological conditions – including CD and PMLD
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leukodystrophies - is still obscure.
1.4.3.2.1 The NAA and NAAG cycle in the brain
The formation and interconversion of NAA and NAAG in the brain is a complex
process which involves three types of cells: neurons, oligodendrocytes and astrocytes
(Fig. 1.16).
NAA is synthesized in neurons from aspartate and acetyl-CoA by aspartate N-
acetyltransferase, NAT8L (Wiame et al., 2009; Ariyannur et al., 2010). There is a
controversy over where NAT8L is localized in the cell, with the proposed compartments
being either mitochondria (Madhavarao et al., 2003; Ariyannur et al., 2010),
microsomes (Lu et al., 2004) or endoplasmic reticulum (Wiame et al., 2009). Once
formed, NAA can then be transported to oligodendrocytes (Figs. 1.16, 1.17) via sodium-
dependent dicarboxylate transporter 3, NaDC3 (Huang et al., 2000) or transformed into
N-acetylaspartylglutamate (NAAG). NAA which reaches oligodendrocytes is, at least in
part, incorporated into myelin (Chakraborty et al., 2001; Figs. 1.16, 1.17; see below)
NAAG is generated from NAA and glutamate by the cytosolic enzyme, NAAG
synthetase (NAAGS; Becker et al., 2010), and then released from neurons in synaptic
vesicles in a calcium-dependent manner (Williamson and Neale, 1988a; 1988b;
Williamson et al., 1991). Once in the extracellular space, NAAG can be broken down to
NAA and glutamate by glutamate-carboxypeptidases II (GCP II, also know as
NAALADase; Bzdega et al., 1997) and GCP III (Bzdega et al., 2004), located on the
extracellular membrane of astrocytes (Berger et al., 1999). NAA is then transported to
oligodendrocytes (Huang et al., 2000), where it is broken down by ASPA into acetate
and aspartate (Baslow, 2003).
Interestingly, astrocytes may also play an active role in NAA transport.
Astrocytes do not express ASPA (Madhavarao et al., 2003) and therefore are unable to
catabolise NAA. However, these cells were found to express functional NaDC3
transporters (Fujita et al., 2005) and, as they form a significant portion of the blood-
brain barrier, they may be involved in NAA clearance from the brain (NAA is found
normally in urine, perhaps indicating that there is a continuous NAA efflux from the
brain: Kelley and Stamas, 1992). Another possibility is that NAA taken up from the
extracellular space by astrocytes is transferred to oligodendrocytes via heterologous gap
junctions (see section 1.3.1.6) composed of connexins Cx43 (expressed by astrocytes)
and Cx47 (expressed by oligodendrocytes; Orthmann-Murphy et al., 2008). It is
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interesting that a mutation in the gene coding for Cx47 was linked to some of the cases
of PMLD (see section 1.4.3.1).
1.4.3.2.2 Receptors for NAA and NAAG
Although the majority of NAA seems to be transported directly to
oligodendrocytes and astrocytes by NaDC3 transporters (Huang et al., 2000; Yodoya et
al., 2006), NAA also activates metabotropic glutamate receptors, causing neuronal
depolarization (Yan et al., 2003; Hanaya et al., 2008), and NMDA receptors, evoking a
rise in intracellular calcium concentration (Rubin et al., 1995). The physiological role of
these responses is unknown.
NAAG was also shown to bind to NMDA receptors (Westbrook et al., 1986:
Fig. 1.18), with a 25-fold lower affinity than glutamate (Valivullah et al., 1994). Low
levels of NAAG were suggested to antagonise NMDA-receptor mediated currents,
decreasing the influx of calcium (Burlina et al., 1994; Yourick et al., 2003; Bergeron et
al., 2005; 2007; but see: Losi et al., 2004), while at high levels NAAG seems to act as
NMDA receptor agonist, increasing intracellular calcium levels (Yourick et al., 2003).
Another receptor proposed for NAAG is mGluR3 (Wroblewska et al., 1997; Gafurov et
al., 2001; Losi et al., 2004). By acting on mGluR3, NAAG was shown to block
adenylate cyclase and decrease forskolin-stimulated cAMP levels (Wroblewska et al.,
1993; 1997).
1.4.3.2.3 The physiological role of NAA
NAA is thought to be involved in myelin formation, serving as a form of acetate
‘storage’ in the CNS and possibly being transported to oligodendrocytes when they
experience increased demand for fatty acid production during myelination (Fig. 1.16).
This hypothesis has been supported by the study of Chakraborty et al. (2001) which
demonstrated that radiolabeled NAA was eventually transformed into lipids in the
myelin sheath (Fig. 1.17). Also, Bhakoo et al. (2001), followed by Kirmani et al.
(2003), showed that in the white matter ASPA activity strongly increases during the
period of active myelination, and ASPA has been reported to be expressed solely in
myelinating oligodendrocytes (Baslow et al., 1999). However, the proposed role of
NAA in myelination has been criticised on the grounds that in hypoacetylaspartia
(caused by a mutation in NAT8L; Wiame et al., 2009; Fig. 1.16), when NAA is
deficient in the brain, there is only a moderate decrease in myelination efficiency
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(Burlina et al., 2006).
Another role that NAA could play in the CNS is serving as an osmolyte to act as
a molecular water pump (Baslow, 2003), which allows the cotransport of water across a
membrane against its gradient as NAA is transported down its own inter-compartmental
gradient. NAA was calculated to transport 120 molecules of water per one molecule of
NAA (Baslow, 2002). A different theory for NAA’s role in the brain suggests its
involvement in dopaminergic transmission, as the activity of the NAA synthetase,
NAT8L (also called ‘shati’), was found to be upregulated after D1 and D2 dopamine
receptor activation by metamphetamine (Niwa et al., 2007).
Finally, NAA plays a crucial role in NAAG formation.
1.4.3.2.4 The physiological role of NAAG
NAAG has been found to be a co-transmitter with several small
neurotransmitters, including glutamate, GABA and acetylcholine, and is released from
synaptic terminals in a calcium-dependent manner (Williamson and Neale, 1988a,
1988b; Williamson et al., 1998). It has been suggested that upon NAAG binding to
NMDA receptors, it antagonises the action of glutamate, reducing NMDA receptor
mediated currents (Fig. 1.19) and blocking the induction of long-term potentiation.
(Bergeron et al., 2005; 2007). However, Yourick et al. (2003) reported that, with
increasing concentration, NAAG becomes an NMDA receptor agonist. NAAG might
therefore be better viewed as a modulator of glutamate’s action on NMDA receptors,
but whether it ever reaches extracellular concentrations high enough to significantly
affect NMDA receptors is debatable.
NAAG was frequently found to be neuroprotective and this effect was mostly
assigned to its activation of mGluR3 receptors. In ischaemia, application of low doses
of NAAG increased cell survival (Thomas et al., 2001; Cai et al., 2002), while in a
model of diabetic neuropathy, NAAG was found to protect neurons against glucose-
induced programmed cell death and neurite degeneration (Berent-Spillson et al., 2004).
Also, inhibition of the peptidase GCP-II (which prevents NAAG from being cleaved
into NAA and glutamate and so should increase the NAAG concentration in the CNS)
was found to have an analgesic effect in animal models of pain (Zhang et al., 2006;
Yamamoto et al., 2007), to delay the onset of symptoms and motor neuron loss in
amyotrophic lateral sclerosis (Ghadge et al., 2003), and to reduce the symptoms of
schizophrenia (Olszewski et al., 2004).
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1.4.3.2.5 The possible role of NAA and NAAG in the leukodystrophies
As mentioned above, in CD and PMLD the concentrations of NAA and NAAG
rise considerably. In CD, due to the lack of ASPA activity, the extracellular NAA levels
can increase 10-fold, reaching up to 0.9 mM (Burlina et al., 1999), and the extracellular
concentration of NAAG rises as well (as a by-product of NAA) up to 20 µM (Burlina et
al., 1999). In PMLD, the NAAG concentration was reported to be 50 µM (Sartori et al.,
2008) and 200 µM (Wolf et al., 2004), and so greatly exceeds its normal levels in the
CNS.
The reason for the heavy damage to myelin observed in both these
leukodystrophies has not been determined yet. It is possible that both NAA and NAAG,
acting on the recently discovered oligodendrocyte NMDA receptors, cause
overactivation of these receptors and thus a detrimental calcium influx (similar to that
observed for high, but not low, NAAG concentration in neurons: Yourick et al., 2003).
As oligodendrocyte NMDA receptors are most probably located on the cell processes
(Salter and Fern, 2005; Micu et al., 2006), the action of NAA and NAAG might cause
preferential damage to newly formed myelin (a protective effect of NAAG acting on
mGluR3 is highly unlikely as these receptors have not been described in
oligodendrocytes in vivo yet).
The hypothesis that NAA and NAAG directly activate oligodendrocyte NMDA
receptors and thus cause myelin loss in CD and PMLD is assessed in Chapters 5 and 6
of this thesis.
1.5 The aims of the thesis
The experiments performed in this thesis had four aims as follows:
The experiments in Chapter 3 investigated the electrical response of mature
oligodendrocytes to ischaemia. They aimed to define the typical current time course and
changes in cell membrane properties that occur in ischaemic condition, and the cause of
the observed changes. Surprisingly, although ischaemia evokes an inward current in
oligodendrocytes, as also occurs in neurons, the main component of this response turns
out to be a decrease of membrane K+ conductance rather than an opening of glutamate-
gated channels as in neurons.
The experiments in Chapter 4 tested the idea that ischaemia-evoked glutamate
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release was the main trigger of the electrical response described in Chapter 3, and the
source of the glutamate released into the white matter was investigated. The idea of
performing this work was to provide basic information which might help with
developing therapies that increase oligodendrocyte survival during white matter
ischaemia.
The experiments in Chapter 5 tested the hypothesis that two substances found at
a high concentration in human brain, NAA and NAAG, exert a direct effect on
oligodendrocyte NMDA receptors. The electrophysiological responses to NAA and
NAAG were recorded and compared to neuronal ones in order to assess the possibility
of NAA and NAAG affecting oligodendrocytes selectively, for example because of the
unusual subunit composition of oligodendrocyte NMDA receptors.
The experiments in Chapter 6 explored the possibility of a Ca2+ influx being
produced in mature oligodendrocytes by NAA- and NAAG-evoked NMDA receptor
activation. Together, the experiments in Chapters 5 and 6 investigated the possible role
that NAA and NAAG may play in myelin damage and oligodendrocyte loss in the two
types of leukodystrophies, Canavan Disease and Pelizaeus Merzbacher-Like Disease,
where the concentrations of these substances rise substantially.
In Chapter 7, a global summary of the experiments is provided and future
directions for carrying the work forward are suggested.
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Gene Protein Effect of
hypoxia
Cs+
perme-
ability
Level of
expression
References
Kcna1 Kv1.1,
fast delayed voltage-
gated potassium
channel
No Very high
expression level
in mature
oligodendrocytes
and in myelin;
much lower in
OPCs
Hille, 2001;
Cahoy et al.,
2008;
Ishii et al., 2009
Kcna2 Kv1.2,
fast delayed voltage-
gated potassium
channel
No Duprat et al.,
1995;
Hille, 2001;
Ishii et al., 2009
Kcna6 Kv1.6,
fast delayed voltage-
gated potassium
channel
No Similar
expression in
mature
oligodendrocytes
and OPCs
Hille, 2001;
Cahoy et al., 2008
Kcnc1 Kv3.1,
fast delayed voltage-
gated potassium
channel
No No expression in
myelin; 4 x higher
expression in
OPCs than in
mature
oligodendrocytes
Hille, 2001;
Cahoy et al.,
2008;
Doyle et al., 2008
Kcnd2 Kv4.2,
transiently activated
voltage-gated
potassium channel
Yes High expression
in mature
oligodendrocytes,
but even
higher in OPCs
Hille, 2001;
Cahoy et al.,
2008;
Wagner et al.,
2010
Kcnd3 Kv4.3, transiently
activated voltage-
gated potassium
channel
Yes High expression
in mature
oligodendrocytes,
but even
higher in OPCs
Hille, 2001;
Cahoy et al., 2008
Kcnma3 K(Ca)5.1, potassium
large conductance
calcium-activated
pH-sensitive channel
Yes Hille, 2001;
Doyle et al., 2008
Kcnmb4 BK channel,
potassium large
conductance
calcium-activated
channel
Conductance
decreases after
hypoxia,
activation
decreases
neuronal
damage in
ischaemia
Yes High expression
in mature
oligodendrocytes,
but even higher in
OPCs
Hille, 2001;
Gao and Fung,
2002;
Cahoy et al.,
2008;
Zhang et al., 2008
Kcnq1 KCNQ1,
slow delayed
voltage-gated
potassium channel
Block by low
pH
No Small expression
in mature
oligodendrocytes,
myelin and OPCs
Hille, 2001;
Peretz et al.,
2002;
Cahoy et al., 2008
Table 1.1
List of outwardly-rectifying potassium channels expressed by oligodendrocytes and
oligodendrocyte precursor cells (OPCs).
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Gene Protein Effect of
hypoxia
Cs+
perme-
ability
Level of expression References
Kcnh8 Kv11.1 (hERG),
rapid delayed
voltage-gated
potassium channel
No Expressed by
cerebellar
oligodendrocytes
Smith et al.,
1996;
Hille, 2001;
Doyle et al.,
2008
Kcnj10 Kir4.1,
potassium inwardly-
rectifying channel
Decrease in
channel
conductance,
loss of the
channel
expression
No Very high expression
in mature
oligodendrocytes
and in myelin,
lower in OPCs
Hille, 2001;
Pannicke et al.,
2004;
Iandiev et al.,
2005;
Cahoy et al.,
2008
Kcnj11 Kir6.2,
ATP-dependent
inwardly-rectifying
potassium channel
Activation
protective in
hypoxia/
ischaemia
No Moderate expression
in mature
oligodendrocytes,
myelin and OPCs,
mainly in white
matter
Hille, 2001;
Zhou et al.,
2002;
Sun et al.,
2007;
Cahoy et al.,
2008
Table 1.2
List of inwardly-rectifying potassium channels expressed by oligodendrocytes and
oligodendrocyte precursor cells (OPCs).
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Gene Protein Effect of
hypoxia
Cs+
perme-
ability
I-V
relation
Level of expression References
Kcnk1 TWIK-1,
two-pore
domain
potassium
channel
Acid-
sensitive
Yes,
but
very
low
Weak
inward
rectifier
Moderate
expression in
mature
oligodendrocytes,
higher in OPCs
Cahoy et al.,
2008;
Zhou et al.,
2009
Kcnk2 TREK-1,
two-pore
domain
potassium
channel
Mechano-
sensitive,
acid-
sensitive
Yes,
but low
Passive/
outward
rectifier
Low expression in
mature
oligodendrocytes,
higher in OPCs
Maingret et
al., 1999;
Cahoy et al.,
2008;
Zhou et al.,
2009
Kcnk3 TASK-1,
two-pore
domain
potassium
channel,
Blocked by
low pH
and
hypoxia
Outward
rectifier
Moderate
expression only in
OPCs
Duprat et al.,
1997;
Cahoy et al.,
2008;
Meuth et al.,
2009
Kcnk13 THIK-1,
two-pore
domain
potassium
channel
Reversibly
inhibited
by hypoxia
Yes Inward/
moderately
outward
rectifier
Low expression
only in myelin
Rajan et al.,
2001
Bushell et al.,
2002;
Campanucci
et al., 2003;
Cahoy et al.,
2008;
Doyle et al.,
2008
Table 1.3
List of two-pore domain potassium channels expressed by oligodendrocytes and
oligodendrocyte precursor cells (OPCs).
grey matter
white matter
corpus callosum
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Figure 1.1
Coronal section of the human cerebral cortex. The white matter, which comprises over
half of the human brain (Fields, 2008), underlies the grey matter and is largely
composed of the myelinated neuronal axons. The corpus callosum is a large white
matter tract, allowing fast signal transmission between the two cerebral hemispheres.
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Figure 1.2
Confocal image of a mature Lucifer yellow-filled oligodendrocyte in the white matter
of the cerebellum of a P12 rat. The cell has a characteristic oval soma and multiple
parallel processes. Each process forms one internode on a different axon. Scale bar,
10 µm.
Myelin
Multiple
layers of
myelin
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Figure 1.3
An electron micrograph showing myelinated axons in the optic nerve. The axons are
surrounded by multiple layers of myelin. Adapted from Simons and Trajkovic (2006),
scale not provided.
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Figure 1.4
Changes in morphology and expression of different antigenic markers at different
developmental stages of oligodendrocytes. Adapted from Arai and Lo (2009).
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Figure 1.5
Oligodendrocyte interaction with axons at the node of Ranvier with the
oligodendrocyte shown in blue and the axon in yellow. A An electron micrograph of a
node of Ranvier and the adjacent oligodendrocyte domains: the paranode, the
juxtaparanode and the internode (section from rat spinal dorsal root nerve). B Protein
interactions and channel distribution at the node of Ranvier, with the oligodendrocyte
shown in blue and the axon in yellow. The sodium channel (NaCh)-enriched node of
Ranvier is adjacent to the paranode where the loops of myelin adhere to the axon
through cell-adhesion molecules linked to the axon cytoskeleton: axonal contactin
(Cont) and contactin-associated protein (Caspr), and oligodendroglial neurofascin-155
(NF). The juxtaparanodal domain contains clusters of potassium channels (KCh), and
is followed by the internode, where compacted layers of myelin membrane restrict
transmembrane ion currents to the nodal region. Adapted from Fields (2008), scale not
provided.
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Figure 1.6
Drawing of white matter oligodendrocytes after staining with silver carbonate, by del
Rio Hortega (1928) (see section 1.2.3). Three types out of the 4 classified by del Rio
Hortega are found in the picture. Adapted from Wood and Bundge (1984), scale not
provided.
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Figure 1.7
Synaptic organization of the cerebellar cortex. The diagram shows the cytoarchitecture
of a single folium of the cerebellar vermis with each folium composed of 4 layers: the
molecular layer (ml), the Purkinje cell layer (pcl), the granule cell layer (gcl) and the
white matter (WM). The cerebellar cortex receives two types of excitatory afferents:
mossy fibres originate from the neocortex, thalamus, vestibular system, brain stem
nuclei and the spinal cord, and contact granule cells, deep cerebellar nuclear cells,
OPCs (NG2 cells) and Golgi cells, while climbing fibres from the inferior olive
directly synapse onto the Purkinje cells and NG2 cells (not shown), and also send
collaterals to the deep cerebellar nuclei and the Golgi cells. The granule cells, through
the parallel fibres, excite the Purkinje cells which send inhibitory axons to cells in the
deep cerebellar nuclei. The deep cerebellar nuclei send excitatory axons via the
thalamus and red nucleus to the spinal cord and multiple cortical areas (among them
the premotor cortex). Adapted from Sillitoe and Joyner (2007).
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Figure 1.8
NMDA receptor subunits are expressed in the myelinating processes of cerebellar
oligodendrocytes. A-C The myelinating processes of oligodendrocytes in the
cerebellar white matter are labelled with an antibody against NR1 (A), NR2C (B; note
that granule cells in the grey matter also strongly express NR2C) and NR3 (C; this
antibody recognizes both NR3A and NR3B). The arrows indicate oligodendrocyte
processes while the arrowheads indicate glial somata. WM: white matter; GL: granule
cell layer. D NR1 subunits are present in the myelin of oligodendrocyte processes in
the adult cerebellum, as indicated by immunogold staining with antibody recognizing
NR1 subunit. Black dots (indicated with arrowheads) represent gold particles that
antibodies were attached to. Scale bars, 20 µm (A-C), 0.25 µm (D). From Káradóttir et
al. (2005).
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Figure 1.9
Demyelination and remyelination in multiple sclerosis. A Structural magnetic
resonance image of the head of a patient with multiple sclerosis. Red arrows point at
demyelinated lesions. B The main phases of the remyelination process. After
demyelination, which results from an acute inflammatory episode, the myelin-forming
oligodendrocytes are damaged and lost, leaving naked axons (green) (a). This is
followed by the recruitment of OPCs (brown) from the neighbouring area: they
proliferate and migrate to the affected brain region (b), where OPCs differentiate into
mature oligodendrocytes (c). When the process is completed, the former lesion is fully
remyelinated (d). Note that the newly-formed myelin sheath is thinner than the one
that was originally destroyed. Adapted from Franklin (2002).
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Figure 1.10
The reversal of sodium-dependent glutamate transporters in ischaemia. A Under
normal conditions, glutamate is transported into the cell by sodium-dependent,
electrogenic glutamate transporters, which co-transport 3 Na+ and an H+ into the cell
with each glutamate anion, while counter-transporting a K+ anion. B In ischaemia, the
rundown in ionic gradients and depolarization evoked by the fall of ATP level
occurring results in the sodium-dependent glutamate transporters running backwards
and therefore releasing glutamate into the extracellular space. Adapted from Rossi et
al. (2000).
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Figure 1.11
Mechanisms of intracellular calcium concentration rise during ischaemia. 1 Due to the
change in ionic concentrations (i.e. increase in [K+]o and [Na+]i), and associated
depolarization, Na+/Ca2+ exchangers reverse (large arrow) and transport Ca2+ into the
cell. 2 ATP depletion leads to the inhibition of ATP-dependent Ca2+ pumps, blocking
Ca2+ removal from the cell. 3 Similarly, Ca2+ pumps on the endoplasmic reticulum
(ER) fail during ischaemia, while an excess of Ca2+ influx through Ca2+ uniporters
leads to mitochondrium depolarization and a release of proapoptotic signals. 4 The
depletion of the membrane potential leads to Ca2+ entry through voltage-dependent
Ca2+ channels. 5 At the same time, a massive release of glutamate in ischaemia causes
overactivation of NMDA receptors (and AMPA receptors, not shown in the picture)
and permits excessive calcium influx. 6 Glutamate binds also to Gq-coupled
metabotropic glutamate receptors that activate phospholipase C (PLC). PLC breaks
down the phospholipid, phosphatidylinositol biphosphate (PIP2), into diacylglycerol
(DAG) and inositol trisphosphate (IP3), which activates its receptors (IP3R) on the ER
and causes additional Ca2+ release. 7 In addition, an acid shift of extracellular pH
activates Ca2+-permeable ASICs, release of ATP activates a Ca2+ influx through P2X7
receptors (Xiong et al., 2004), and reactive oxygen and nitrogen species trigger
transient receptor potential (TRP) channel opening and a further Ca2+ influx (Aarts et
al., 2003). ATP, adenosine triphosphate; ADP, adenosine diphosphate. Adapted from
Nestler et al. (2008).
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Figure 1.12
The formation of the free radicals during ischaemia. Various intracellular mechanisms
induce the overproduction of reactive oxygen and nitrogen species in ischaemia,
among them mitochondrial dysregulation, activation of phospholipases and oxidases,
and autooxidation. The excess of superoxide anion (O2·¯) that is formed during these
processes is transformed by superoxide dismutase (SOD) into hydrogen peroxide
(H2O2) (which under normal condition is broken down into water by glutathione
peroxidase, GSHPx, or to water and oxygen by catalase) and that results in an
excessive formation of hydroxyl radical (·OH). In parallel with this, the rise of [Ca2+]i
that occurs in ischaemia leads to the formation of Ca2+/calmodulin complex, which
binds to nitric oxide synthase (NOS), inducing overproduction of NO. This
subsequently reacts with O2·¯ to form peroxynitrite (ONOO¯). Peroxynitrite can be
later changed into ·OH and nitrogen dioxide (NO2·) or into nitrosoperoxycarbonate
(ONOOCO2·¯), which leads to the further formation of other reactive species. All the
free radicals react with many components of the cell, damaging them and eventually
leading to the cell death.
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Figure 1.13
During anoxia, in the white matter, axons and oligodendrocytes release glutamate by
the reversal of sodium-dependent glutamate transporters. Antibody labelling for
glutamate showed that, in anoxic conditions, the glutamate concentration in axons
and oligodendrocytes (but not in astrocytes) decreased, suggesting that these two
components of the white matter released glutamate during anoxia. This release was
inhibited by a specific blocker of sodium-dependent glutamate transporters, L-trans-
pyrrolidine-2-4-dicarboxylic acid (L-trans-PDC), indicating that reversal of these
transporters is the mechanism of glutamate release in anoxia (*p<0.01,**p<0.05).
From Li et al. (1999).
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Figure 1.14
Ionotropic glutamate receptors on cerebellar oligodendrocyte lineage cells are
activated during ischaemia. A Ischaemia induces an inward current in an OPC (at -63
mV), which is partly blocked by AMPA and NMDA receptor blockers (NBQX and
AP5, respectively) applied together, in 2 mM Mg2+. B Ionotropic glutamate receptor
blockers, applied together (in 2 mM Mg2+, in OPCs) or separately (in 0 mM Mg2+, in
OPCs and mature cells), block the ischaemia-induced current. The current is blocked
in OPCs to a greater extent than in mature cells. Adapted from Káradóttir et al. (2005).
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Figure 1.15
Ischaemia activates purinergic P2X7 receptors in cultured oligodendrocytes. A The
ischaemia-induced current was blocked to a great extent by BBG, a specific P2X7
receptor antagonist. The cell was held at -70 mV. B A broad-spectrum purinergic
receptor blocker, PPADS, a preferential non-reversible antagonist of P2X7 receptors
(oATP) and the specific reversible antagonist of P2X7 receptors (BBG), all blocked the
ischaemia-induced current to a similar level as the ionotropic glutamate receptor
blockers, CNQX and APV. There was an additive effect of simultaneous application of
BBG and CNQX with APV. BBG, Brilliant Blue G; PPADS, pyridoxal phosphate 6-
azophenyl-2,40-disulphonic acid; oATP, oxidized ATP. Adapted from Domercq et al.
(2010).
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Figure 1.16
Metabolic pathways of NAA and NAAG. NAA is synthesized in neurons from
aspartate and acetyl-CoA by the enzyme aspartate N-acetyltransferase (NAT8L) and
may then be transported to oligodendrocytes through the Na+-dependent dicarboxylate
transporter 3 (NaDC3). In oligodendrocytes, NAA is converted to aspartate and acetate
by aspartoacylase (ASPA, the enzyme lost in Canavan disease) and may thus be
converted into lipids that form part of the myelin. Alternatively, NAA can be
converted to NAAG in neurons by NAAG synthetase (NAAGS), and released (most
probably, via synaptic vesicle release) to the extracellular space. There, NAAG is
broken down to NAA and glutamate by glutamate carboxypeptidase II and III (GCP-II
and III), expressed on the extracellular surface of astrocytes. NAA can be then taken
up by oligodendrocytes or astrocytes. The role of NAA in astrocytes is unknown, but it
is suggested that NAA may be transported to oligodendrocytes through gap junctions
(formed by astrocytic Cx43 and oligodendrocytic Cx47, the latter being lost in some
cases of Pelizaeus-Merzbacher-like disease). Alternatively, astrocytes may extrude
NAA into the circulation.
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Figure 1.17
NAA is transported from axons to oligodendrocytes where it is transformed into lipids
in the myelin sheath. Axonal transport and myelin incorporation of radiolabelled NAA
([14C]NAA) was assessed using the rat optic nerve and tract, and the lateral geniculate
and superior colliculus. [14C]NAA was administered into the right eye of six rats, and
the four anatomical areas of the optic system were harvested at the times indicated,
followed by tissue homogenization and myelin extraction. Then, myelin radioactivity
was measured, and the results were corrected for the values from the control condition
(which was the uninjected left eye, i.e. giving values for the left optic nerve, right
optic tract, right lateral geniculate and right superior colliculus, since in the rat only a
small percentage of optic nerve axons make ipsilateral projections to the lateral
geniculate nucleus). Additionally, the ratio of radioactivity of the injected pathway vs.
control was measured (numbers in brackets). Results indicate time-dependent axonal
transport of NAA into oligodendrocytes and a subsequent incorporation of liberated
acetyl groups into myelin lipids. DPM, disintegration per minute; L. Geniculate,
lateral geniculate nucleus; S. Colliculus, superior colliculus. Adapted from
Chakraborty et al. (2001).
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Figure 1.18
NAAG acts on neuronal NMDA receptors. The response of a cultured mouse spinal
cord neuron to NAAG (2 mM) was reversibly blocked by the application of a specific
NMDA receptor blocker, DL-2-amino-5-phosphoveneric acid (APV, 250 µM). The
cell was voltage-clamped at -50 mV and NAAG was applied for 10 msec. Adapted
from Westbrook et al. (1986).
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Figure 1.19
NAAG can antagonize glutamate’s action on NMDA receptors. A Example of an
NMDA receptor current (pharmacologically isolated from the total excitatory
postsynaptic current, EPSC), and its inhibition by NAAG (20 µM). B Mean NMDA
current component in the absence (Control) and presence of NAAG application.
EPSCs were recorded from CA1 pyramidal neurons following electrical stimulation of
the Schaffer collaterals. N, number of cells; *p < 0.05. Adapted from Bergeron et al.
(2007).
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Chapter 2: Materials and methods
This chapter explains the general methods used for experiments throughout the
thesis. All experiments were carried out in brain slices to allow patch-clamping and
Ca2+-imaging of oligodendrocytes, whilst applying pharmacological agents at a known
concentration.
2.1 Preparation of cerebellar slices
Sprague-Dawley rats, aged postnatal day 12 (P12) were used for the preparation
of the cerebellar brain slices employed for the experiments in Chapters 3-6. This age
was chosen because at this stage of cerebellar maturation cells all the developmental
stages of the oligodendrocyte lineage are present (Káradóttir et al., 2005) and the
relatively uncompacted white matter allows better visualization of the cells and easy
access for patch clamping. Also, as the P12 cerebellum is routinely used by others in the
laboratory, the results of my work could be directly compared with those obtained in
related experiments. Animals were killed by cervical dislocation followed by
decapitation, and the head was immediately immersed in ice-cold oxygenated slicing
medium, composed of (in mM): NaCl 124, NaHCO3 26, NaH2PO4 1, KCl 2.5, CaCl2
2.5, MgCl2 2, D-glucose 10 (gassed with 95% O2/5% CO2), pH 7.4, and containing
1 mM kynurenic acid to block glutamate receptors during the slicing process and thus
reduce damage to the cells. The scalp was removed and the skull was opened by cutting
between the eyes, followed by lateral cuts on either side of the head from anterior to
posterior. The excised region of the skull was lifted with forceps, and the whole brain
was quickly removed and placed in ice-cold oxygenated slicing medium. To obtain
parasagittal slices of the cerebellar vermis, cuts were made through the inferior
colliculus and spinal cord (to separate the cerebellum from the rest of the brain) and the
cerebellar hemispheres on either side of the vermis were removed (to isolate the
vermis). The cerebellar block was then mounted on one of its cut surfaces on the stage
of a vibrating tissue slicer (Vibratome) using Superglue and mechanically stabilised
using an agar block attached to the Vibratome stage. The cerebellum was immersed in
ice-cold oxygenated slicing medium throughout the cutting process. Sagittal slices of
the cerebellar vermis, 225 µm thick, were cut and placed in oxygenated slicing medium
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at room temperature until used for recording, which was less than 9 hours after the
animal was killed. At the time of a recording the slice was placed in a recording
chamber (volume ~1 ml) on the stage of an upright fixed stage microscope (Olympus
BX50WI), and held in place by a “harp”, made of a parallel array of nylon threads
(separated from each other by 0.5-1.0 mm) strung on a platinum frame (Fig. 2.1A).
2.2 Standard solutions used and model system for ischaemia
2.2.1 External solutions used
Oxygenated external solutions that mimic cerebrospinal fluid were used to
maintain cells alive. In general a HEPES-based external solution was used for drug
application experiments at room temperature (Chapters 5 and 6), since that allowed
more rapid solution changes, and a bicarbonate-based external solution was used for
ischaemia experiments at 33±2°C (Chapters 3 and 4).
The HEPES-based solution contained (in mM): 144 NaCl, 10 HEPES, 1
NaH2PO4, 2.5 KCl, 2.5 CaCl2, 10 D-glucose (1 MgCl2 was added where indicated),
with pH adjusted to 7.3 using 1 M NaOH, and was oxygenated with 100% oxygen. The
perfusion system consisted of containers (150 ml syringes) filled with the solution and
connected to the recording chamber via tubing and valves to switch the flow on or off.
The flow was driven by gravity, with the tubes from the syringes containing different
solutions emerging near the bath at a rate of 2-4 ml/min. The bath volume was ~1 ml,
giving a bath turnover time of 15-30 sec.
Bicarbonate-based solution contained (in mM): NaCl 124, NaHCO3 26,
NaH2PO4 1, KCl 2.5, CaCl2 2.5, MgCl2 1, D-glucose 10, and was bubbled with 95%
O2/5% CO2, pH 7.4 (the same solution as described in section 2.1, but without the
kynurenic acid). A peristaltic pump pumped the solution from its container to the
recording chamber, passing through a heating block on the way to allow solution to
reach close to physiological temperature (33±2°C). The temperature was set by
adjusting the current through resistors attached to the heating block. It was chosen to be
33°C rather than 37°C, because slices lived longer at this temperature. The flow rate
was 2-4 ml/min, giving a bath turnover time of 15-30 sec.
87
2.2.2 Internal solutions used
The whole-cell clamp experiments were performed using different intracellular
(i.e. pipette) solutions appropriate for each experiment. A caesium-based internal
solution was used for most voltage-clamp recordings in Chapters 3-6, as caesium does
not pass well through most potassium channels and so increases the membrane
resistance. Consequently, caesium increases the cell’s electrical space constant and the
voltage-clamp quality. However, to assess cell properties during ischaemia in Chapter 5,
both caesium- and potassium-based internal solutions were used, the potassium-based
solution being used to assess responses with the physiological cation present inside the
cell. In each chapter the intracellular solutions used will be described, and these are
collected for convenience in Table 2.1.
2.2.3 Ischaemic solution used
To mimic brain ischaemia in vitro, both glycolytic and mitochondrial ATP
productions were blocked by removing glucose and O2. In addition, because in open
recording chambers oxygen from the room air can rapidly diffuse through the solution
to the tissue, preventing the true inhibition of oxidative phosphorylation that would
occur in vivo, metabolic blockers were added (Reiner et al., 1990). To do this I used a
bicarbonate-based solution with 7 mM sucrose (substituted for 10 mM D-glucose),
bubbled with 95% N2/5% CO2, (substituted for 95% O2/5% CO2). Glycolysis was
blocked with iodoacetate (2 mM) and oxidative phosphorylation was blocked with
antimycin (25 μM) (Allen et al., 2005).
2.3 Pipettes and electrical set-up
Patch pipettes were made from thick-walled filament-containing borosilicate
glass capillaries (outer diameter 1.5 mm, inner diameter 0.86 mm, type GC150F-10
from World Precision Instruments), and they were produced using a two step vertical
puller (Narishige PC-10). The electrode was then filled with the appropriate
intracellular solution (see Table 2.1).
The recording electrode was inserted into the pipette holder of a patch-clamp
headstage (Axopatch CV203BU, Axon Instruments), which was attached to and moved
by an electric micro-manipulator (SM-5, Luigs and Neumann). The electrode had a
resistance of 5-8 MΩ when placed in the bath. An Ag/AgCl pellet was placed in the 
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recording chamber to serve as the bath electrode. Membrane currents were recorded
with an Axopatch 200B amplifier (filtered at 2 or 10 kHz, Axon Instruments), digitised
at 1-10 kHz with a Digidata 1320 (Axon Instruments) and stored on a personal
computer using pClamp9.2 and Axoscope9.2 (Axon Instruments). The data were
analysed off-line using Clampfit 9.2 (Axon Instruments).
2.4 Optical set-up for electrophysiology
Slice experiments (Fig. 2.1) were carried out on a set-up equipped with an
Olympus BX50WI upright microscope, with a fixed stage and microscope-moving
table. Slices were viewed using an Olympus 4x objective or a 40x water immersion
objective, with differential interference contrast (DIC) optics. The microscope was
equipped with a Xenon arc lamp and a filter cube for viewing Lucifer yellow filled cells
(excitation wavelength 425±25 nm, dichroic mirror wavelength 460 nm, and emission
above 515 nm; Chroma Technology; see Table 2.2). A CCD video camera (COHU,
2700 series) was attached to the microscope, so that the cells could also be visualized
using a TV monitor, and their pictures were taken and stored on a computer using
Dazzle Video Creator (Pinnacle Systems Inc.) with Pinnacle Studio software.
2.5 Dye filling and cell identification
Cells for the recording were chosen based on their position in the cerebellar
slice (the granular layer for granule cells and the white matter for oligodendrocytes),
their morphology under bright light (i.e. the size and apparent health of their soma), the
size of their input resistance, and their morphology visualised with Lucifer yellow
during and after recording. Fixable fluorescent Lucifer yellow dye was present in the
pipette internal solution in Chapters 3-5 (Table 2.1) and as the dye diffused into the cell
it revealed the cell’s morphology (Fig. 2.1), allowing immediate cell identification. In
addition, each cell was marked onto a map of the cerebellum, to simplify the later
search for the cell in the confocal microscope when trying to image the morphology of
cells that were recorded from. In Chapter 6, the Ca2+-imaging dye, Fura-2, was used in
the internal solution (Table 2.1), in which case the final identification of the cell was
made at the end of the experiment, after the dye diffused into the cell. Sequential
pictures of the cell were taken every 1 sec, with a progressively increasing depth for the
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picture plane, starting from the top of the cell, which allowed the acquisition of a full
picture of the cell body with processes attached.
Mature oligodendrocytes were distinguished from other cells in the white matter
by their big, oval soma, low membrane resistance (≤150 MΩ) and multiple long parallel 
processes, each of which forms one internode (Figs. 1.2 and 2.1). White matter
precursor cells (OPCs) were distinguished by their high membrane resistance (~1 GΩ) 
and numerous processes spreading radially from the cell soma. Voltage step application
revealed a transient inward current in a number of OPCs, which is mediated by voltage-
gated sodium channels (Karadottir et al., 2007). Immature oligodendrocytes in the white
matter were identified by their intermediate membrane resistance (>150 MΩ and <1 
GΩ) and the presence of some cell processes forming parallel internodes while the rest 
were non-specifically oriented, possibly “looking” for an axon to myelinate. Granule
cells were identified from their position in the granule cell layer, their small soma
attached to approximately four dendrites and their high input resistance (≥ 3 GΩ).  
After recording from an oligodendrocyte, some slices were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) for an hour at room temperature
with slight agitation. Then the slice was washed three times for 15 min in 0.1 M PBS.
After the wash, the slice was kept in the fridge (with 0.05% NaN3 added to the 0.1 M
PBS solution) until being used for immunocytochemistry and imaging of the cell’s
morphology to confirm the mature phenotype of the patch-clamped cell (as in
Káradóttir et al., 2005; Káradóttir and Attwell, 2006; see also section 2.11 and Fig. 2.2).
2.6 Patch-clamp recordings
All recordings were performed in the conventional whole-cell configuration
(Hamill et al., 1981; Edwards et al., 1989).
After selecting the cell, the pipette was lowered into the bath, its resistance
being monitored by application of 10 mV voltage step every 200 ms. A positive
pressure was applied to keep the pipette tip clean, preventing the attachment of any
debris flowing in the bath solution or of tissue when entering the slice. When closely
approaching the cell soma, gentle suction was applied to produce a high resistance seal
(usually 1-10 G) between the cell membrane and the tip of the glass patch pipette. The
holding potential was then brought to -60 mV, i.e. a value close to the resting potential
of oligodendrocytes and granule cells. The leak current in cell-attached mode (the
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current that flows through the pipette while attached to the cell membrane, representing
mainly an imperfect seal with the membrane) was less than -20 pA. At this stage,
electronic compensation of the pipette capacitance transient was applied.
After formation of a high resistance seal in the cell-attached mode, further
suction was applied to break through the piece of membrane at the tip of the pipette and
thus gain diffusive and electrical access to the cell’s interior (Fig. 2.1).
Owing to the different composition of the pipette solution and the bath solution,
a junction potential (i.e. potential difference) exists at the end of the electrode before
sealing onto the cell (Fig. 2.3), which is not present when the pipette solution has filled
the cell in whole-cell mode (Fenwick et al., 1982). For the gluconate-based pipette
solutions used in the experiments, due to slower gluconate diffusion into the bath than
chloride diffusion into the pipette, and due to sodium diffusing more slowly into the
pipette than caesium and potassium diffuse out, a junction potential of -14 mV is
present (Ng and Barry, 1995).
2.7 Series resistance
Pipette series resistance is the resistance between the cell’s interior and the
pipette’s interior when in the whole-cell patch-clamp configuration, and can be
measured as outlined below, in equation 2.1. A low series resistance (in the range of 4-
20 M, measured as described in section 2.8 below) implies a good electrical and
diffusion pathway into the cell. A good diffusion pathway is essential for the efficient
exchange of molecules between the pipette and the cell. A good electrical pathway to
the cell interior is important because current flowing between the pipette and the
cytoplasm will result in a voltage drop across the pipette tip, the value of which depends
on the series resistance and the size of the current. A high series resistance or large
current flow will result in a high voltage drop, and the real membrane potential in the
soma will differ from the apparent membrane potential because of the voltage drop.
Series resistance compensation (typically 50-70%) was employed to minimise such
voltage errors in granule cells. In mature oligodendrocytes, series resistance
compensation was not applied as the non-spherical shape of these cells, with thin and
long processes, most probably results in a lack of uniformity of the voltage in the
processes even when the soma voltage is well controlled (similar to CA1 neurons in
hippocampus, where voltage control at most dendritic sites was shown to be extremely
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poor: Major, 1993). The multiexponential decay of the capacity current discussed below
supports this idea. There will therefore be a different resistance between the cell soma
and different parts of the cell membrane, preventing accurate series resistance
compensation of the whole cell.
For experiments on oligodendrocytes, the series resistance was typically Rs ~10-
20 MΩ. At the resting potential, where no current is flowing before a drug or ischaemia 
solution were applied, from the equation
Verror = IRs (2.1)
for a typical NMDA- or ischaemia-evoked current of ~200 pA, only a small voltage
error of Verror ~ 2-4 mV will occur, which can be neglected. Similarly, for experiments
on granule cells, the series resistance of 10-20 MΩ, compensated by 50-70%, for a 
typical NMDA-evoked current of 50 pA at the resting potential, will cause a negligible
voltage error of 0.15-0.5 mV.
2.8 Capacity transient analysis
By analysing the current response to a voltage step, it is possible to measure the
pipette series resistance, cell membrane resistance and conductance, and cell
capacitance, and to assess whether the cell is uniformly voltage-clamped. Two cases
were considered: first a spatially-compact voltage-uniform cell (such as the granule
cells studied in Chapter 5), and a cell with long processes where the voltage is non-
uniform (such as the mature oligodendrocytes studied in Chapters 3-6). The membrane
acts as a capacitor and resistor connected in parallel, and the series resistance is in series
with these elements (Figs. 2.4 and 2.5).
For a spatially-compact voltage-uniform cell (Fig. 2.4), the current flow, I,
through this circuit in response to a voltage step, Vs, is predicted to be (Tessier-Lavigne
et al., 1988):
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where t is the time after the onset of the voltage step, Rm is the membrane resistance, Rs
is the series resistance, and  the decay time constant of the current transient.
At the onset of the voltage step, at t = 0, the capacitor is uncharged and the
voltage across it is zero. Consequently, just as the voltage step is applied, the voltage
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across the series resistance is the applied voltage step, and the initial current flowing
(I(t = 0)=Vs/Rs from equation 2.2) allows calculation of the series resistance as:
0)I(t
VR ss

 (2.3)
In the steady state, i.e. at t = , the capacitor is fully charged and no current flows
through it. The membrane resistance can then be calculated from the voltage step and
the current at t = . Since I(t = )=Vs/(Rm+Rs) from equation 2.2,
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Similarly, the cell conductance, Gm=1/Rm, at the steady state is calculated from the
equation
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and the membrane capacitance can be calculated as (Tessier-Lavigne et al., 1988):
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The time constant, , was obtained by fitting the current transient with a single
exponential using Clampfit. An example of a fitted capacity transient is shown in Fig.
2.4. The current change at t = 0 was obtained by extrapolating this exponential back to
the time of the voltage step.
This analysis assumes that the cell is isopotential, and predicts a
monoexponential decay of the capacity current. This is the case for electrically compact
cells such as cerebellar granule cells. For cells with complex morphology, however,
such as mature oligodendrocytes, the resistance of the processes makes the cell non-
uniform in voltage, and the capacity current decays as the sum of 2 or more
exponentials (Fig. 2.5). The current response was then fitted with the sum of two
exponentials:
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where I1 and are the amplitude and time constant for the first exponential, I2 and 
are the amplitude and time constant for the second exponential, respectively, and
I(t = ∞) is the steady state current. For this model the series resistance is still given by 
equation 2.3, but it is not possible to derive the membrane resistance or capacitance in
the different compartments of the cell without making further assumptions.
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2.9 Calcium imaging
This technique allows the recording of intracellular calcium concentration
([Ca2+]i) changes by using specific calcium indicators (dyes). Calcium indicators can be
generally divided into non-ratiometric and ratiometric ones.
For non-ratiometric dyes (e.g. Fluo-4), binding of calcium ions causes a change
in dye conformation that results in increased brightness (increased efficiency of
fluorescence emission) upon light excitation. This allows recording of a [Ca2+]i increase,
but cannot distinguish a change of [Ca2+]i concentration from a change of dye
concentration (e.g. due to cell damage or movement).
For ratiometric dyes (e.g. Fura-2), the change in conformation upon calcium ion
binding results in a shift of the dye excitation wavelength. This allows recording of the
change in [Ca2+]i by taking the ratio of the emitted fluorescence evoked by two different
exciting wavelengths. This provides a measurement of [Ca2+]i change that is independent
of the concentration of the dye, and thus less susceptible to artefactual errors.
2.9.1 Calcium imaging using acetoxymethyl ester dye loading
To image intracellular calcium changes in many cells of the grey and white
matter without the need to load dye by patch-clamping, a slice was loaded with a cell-
permeable calcium dye, the acetoxymethyl (AM) ester of Fluo-4 (Fluo-4-AM,
Molecular Probes). Fifty micrograms of Fluo-4-AM were dissolved in 11.5 µl of
dimethyl sulfoxyde (DMSO, Sigma) and 11.5 µl of Pluronic acid (used to facilitate dye
dispersion in aqueous media; Molecular Probes). This stock solution (2 mM) was
diluted in the external solution in order to incubate the slice for 2 h in 5 µM Fluo-4-AM.
Before fluorescence measurements, the slice was washed in an indicator-free solution to
remove any dye that was not taken up by the cells, and then incubated for at least 30
min to allow de-esterification of the intracellular AM esters to occur (Fig. 2.6). Regions
of interest in the white and grey matter were identified from the morphology and
anatomy of the slice. Fluo-4 was excited at 480±10 nm, and the emitted light was
collected at 535±22 nm, using a dichroic at 505 nm (see Table 2.2).
2.9.2 Calcium imaging of single cells
To image intracellular calcium changes in a single cell, mature oligodendrocytes
in the white matter or granule cells in the grey matter were patch-clamped with pipettes
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containing a caesium-based internal solution with Fura-2 (free acid, not AM ester) as
the calcium-sensing dye (Molecular Probes) (see Table 2.1). Fluorescence was excited
sequentially at 340±10 and 380±10 nm, and the emitted light was collected at
510±20 nm, using a dichroic at 415 nm (see Table 2.2). The ratio of the emission
intensities (340 nm/380 nm) was used as a measure of [Ca2+]i change. Only ratios that
reflected both a decrease of fluorescence excited at 380 nm and an increase in
fluorescence excited at 340 nm were used since if, for example, the signal decreased at
both wavelengths, it suggests that dye has been lost from the cell due to membrane
damage or dye bleaching, or the cell has moved partly out of the field of view.
2.9.3 Optical set-up for calcium imaging
The microscope (see section 2.4) was equipped with a xenon lamp and filter sets
for viewing Fluo-4 or Fura-2 dyes (see sections above and Table 2.2). A CCD video
camera (iXON, Andor) was attached to the microscope, and the cells were visualised on
a computer screen. Data were acquired and analysed using Meta Imaging 6 software
(Molecular Devices).
2.10 Cell death assay
Cell death was assessed by using propidium iodide (PI, Sigma). PI is a
fluorescent molecule that binds to DNA by intercalating between its bases and, once
bound, its fluorescence is enhanced 20- to 30-fold (using an excitation wavelength 543
nm, dichroic wavelength 488/543/633 nm, and an emission wavelength 570-600 nm see
Table 2.3). PI is generally excluded from passing across the surface membrane of viable
cells, so it can only reach the nucleus of cells if they have a permeable surface
membrane which is generally associated with necrotic (and, in some cases, late
apoptotic: Rieger et al., 2011) cell death.
To perform the experiment, slices were bathed in an external solution containing
appropriate drugs (see Chapter 6), or in control solution, at 36ºC for 6 hr, with
propidium iodide (37 µM) added from the beginning. After incubation, slices were
fixed in 4% paraformaldehyde in PBS overnight, then washed three times for 15 min in
0.1 M PBS. After the wash, slices were kept in the fridge (with 0.05% NaN3 added to
the 0.1 M PBS solution) until being used for assessment of PI labelling and antibody
labelling against myelin basic protein (MBP, see below) to quantify the (mainly
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necrotic) death of cells in white matter identified as mature oligodendrocytes. During
the mounting procedure, a mounting solution containing 300 nM DAPI (excitation
wavelength 364 nm and emission wavelength above 385 nm, see Table 2.3; Fluoro-
Gel II, EMS) to stain all cell nuclei was used, so that dead cells (stained with PI) could
be quantified as a fraction of the pool of all the cells in the slice (stained with DAPI).
Images were acquired using a confocal microscope.
2.11 Immunocytochemistry
2.11.1 Antibody labelling
Fixed slices (see section 2.5) were collected from the fridge and washed three
times for 20 min with 0.1 M PBS. Then, slices were treated with a blocking and
permeabilizing solution, containing 10% goat serum, 0.05% Triton X-100, 0.05% NaN3
and 0.1 M PBS, for 4-6 hr at room temperature with slight agitation. This was followed
by incubation with a primary antibody against myelin basic protein, a protein specific
for mature oligodendrocytes (mouse anti-MBP, Chemicon), at a dilution of 1:200 in
PBS containing 0.05% NaN3 for 12-18 hr at room temperature with slight agitation.
Then, slices were washed three times for 20 min with 0.1 M PBS. To reveal labelling
with the primary antibody, a secondary antibody (goat anti-mouse IgG, conjugated to
AlexaFluor 488, excitation wavelength 488 nm, dichroic wavelength 488 nm, and
emission wavelength above 505 nm, see Table 2.3; Invitrogen) was used, diluted to
1:200 in 0.1 M PBS containing 0.05% NaN3, for 8 hr at room temperature with slight
agitation. Next, the slices were washed three times for 20 min and mounted on a
microscope slide (BDH) with Citifluor (glycerol/PBS, Citifluor), covered with a
0.17 mm thick glass cover slip, and sealed with nail varnish (Boots, UK). A control
experiment for antibody labelling was performed each time by omitting the primary
antibody during the staining procedure.
2.11.2 Confocal imaging
All fixed slices were imaged with a confocal laser scanning microscope (LSM),
either a Zeiss LSM 510 inverted microscope or a Zeiss LSM Pascal upright microscope.
For high resolution images of single cells, a 63x oil DIC objective was used; for high
resolution images of slices, a 40x DIC objective was used. All imaging with multiple
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wavelengths was done with sequential scans at the different wavelengths (see Table 2.3
for excitation, dichroic and emission wavelengths), which reduces ‘bleed through’ of
emitted fluorescence from one channel to another.
For single cell imaging, scanning was done in x-y and z directions, and averaged
2-4 times depending on the signal. The size of the z stack depended largely on the depth
of the cell of interest, ranging from 15-90 μm, taken in ~0.2 μm sections. The signal 
gain and zero offset were initially set for each image depending on the signal being
detected, and those settings were then held constant for the control slices lacking
primary antibody. Projections of images were made in LSM Examiner software, and
control slices were treated in the same way with respect to brightness and contrast
adjustments.
2.12 Data analysis and statistics
Data are presented as mean + s.e.m. and the significance of changes was
normally assessed with 2-tailed Student’s t-tests. T-tests were either paired, as when
analysing whether events within the same group of cells had altered over time or with a
drug treatment, or were unpaired, as when comparing whether the mean responses of
different groups of cells were significantly different. When comparing more groups than
two in Chapters 3 and 4, a one-way ANOVA was used followed by a Holm-Bonferroni
correction for multiple comparisons. Conventionally this is done as follows. For a
desired level of significance such as p<0.05, if N comparisons are made the most
significant p value is compared with 0.05/N (rather than 0.05), the second most
significant is compared with 0.05/(N-1), and the third most significant is compared with
0.05/(N-2), etc. In order to present p values on graphs in a form which could all be
simply compared directly with 0.05, I calculated corrected p values by multiplying the
most significant p value by N, the second most significant by N-1, the third most
significant by N-2, etc. This procedure is formally equivalent to the Holm-Bonferroni
correction, but has the advantage that any of the corrected p values which are shown on
the graphs are significant if they are less than 0.05.
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Type of
internal
solution
Cs-based K-based Ca2+-imaging
Main
Ions
Cs-Gluconate
130 mM
K-Gluconate
130 mM
Cs-Gluconate
130 mM
NaCl
NaCl
4 mM
NaCl
4 mM
NaCl
4 mM
pH buffer
HEPES
10 mM
HEPES
10 mM
HEPES
10 mM
Calcium
chelator
BAPTA
10 mM
BAPTA
10 mM
BAPTA
0.01 mM
Added calcium
CaCl2
0.5 mM
CaCl2
0.5 mM
GTP
Na2GTP
0.5 mM
Na2GTP
0.5 mM
Na2GTP
0.5 mM
ATP
MgATP
4 mM
MgATP
4 mM
MgATP
4 mM
Phosphocreatine
Phosphocreatine
10 mM
Fluorescent dye
Lucifer yellow
2 mM
Lucifer yellow
2 mM
Fura-2
1 mM
pH adjusted to
7.3 with
CsOH KOH CsOH
Table 2.1
List of the internal solutions and their composition used for the experiments presented in this
thesis.
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Fluorophore
Excitation
wavelength
(nm)
Dichroic
wavelength
(nm)
Emission
wavelength
(nm)
Light source
Fluo-4 488±10 505 535±22
Xenon arc lamp
with
monochromator
Fura-2
340±10 and
380±10
415 510±20
Xenon arc lamp
with
monochromator
Lucifer yellow 425±25 460 LP >515 Xenon arc lamp
Table 2.2
List of fluorophores, with the excitation, dichroic and emission wavelengths of filters
when the fluorescence microscope on the patch-clamping rig was used. LP=Long Pass
Filter.
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Fluorophore
Excitation
wavelength
(nm)
Dichroic
wavelength
(nm)
Emission
wavelength
(nm)
Light source
Alexa Fluor 488 488 HFT 488 LP 505 Argon laser
DAPI 364 LP>385 UV laser
Lucifer yellow 458
HFT 458/514
NFT 545
BP 505-600 Argon laser
Propidium
iodide
543 HFT 488/543/633 BP 570-600 HeNe laser
Table 2.3
List of fluorophores, with the excitation lines, and dichroic and emission wavelengths of
filters when the confocal microscope was used. Abbreviations: BP=Band Pass Filter,
LP=Long Pass Filter, HFT=Main Dichroic Beam Splitter, NFT=Secondary Dichroic
Beam Splitter.
AB
C
Electrode
Grey
Matter
White
Matter
White
Matter
Grey
Matter
80 µm
20 µm 20 µm
20 µm20 µm
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Figure 2.1
Patch-clamping of a cerebellar white matter mature oligodendrocyte in a P12 rat.
A Low power picture of the cerebellum, where the white matter (darkest areas) is
distinguishable from the grey matter. The arrow shows the area which is magnified in
B and C (note that the strings are part of the harp which maintains the slice immobile
in the bath). B Left: same picture at higher magnification: the arrow shows the cell
about to be patch-clamped. Right: dotted lines show the position of an electrode, filled
with Lucifer yellow, which was contacting the cell. C Left: Lucifer yellow labelling
(pseudocolor): picture taken just after breaking through the cell membrane. Right:
same cell 10 minutes later; the dye had diffused through the processes.
Figure 2.2
Confirmation of mature oligodendrocyte phenotype with immunostaining. A mature
oligodendrocyte was filled with Lucifer yellow (green) during whole-cell patch-
clamping and the slice was subsequently immunolabelled against myelin basic protein
(MBP, red), which is expressed on oligodendrocyte processes. The merged image
reveals an association between the patched cell’s processes and the MBP staining.
Scale bar, 10 µm.
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Figure 2.3
Capacity transient of a spatially compact cell such as a granule cell. A Schematic diagram 
of a granule cell with short electrically compact processes. B Effective circuit diagram of 
a whole-cell patch-clamped granule cell. C Trace shows the current response to a -5 mV 
pulse in a whole-cell patch-clamped cell. This could be fitted with a single decaying 
exponential (purple line). The series resistance is calculated from the peak current 
recorded when the voltage pulse is applied (see arrow) while the membrane resistance is 
obtained by measuring the current (I∞) recorded after the membrane been charged, as 
described more detail in the text associated with equation 2.2.
Rs = 23 MΩ
Rm = 2.9 GΩ
The current response is fitted with a decaying exponential f function of the form:
 I ∞ + (I 0 - I ∞) .  e
- t / τ where
 I∞ the steady state current, is -1.5 pA
 I0 the current at the onset of the voltage step is -212 pA 
and τ, the decay time constant, is 0.22 ms
A
B
C
Rs to represent 
pipette series resistance
Cm to represent
membrane lipids
Rm to represent
membrane ion channels
= Voltage step
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Figure 2.4
Capacity transient of a complex cell such as a mature oligodendrocyte cell which is 
not voltage-uniform. A Schematic diagram of a whole-cell clamped mature 
oligodendrocyte. Each process is treated as a series of electrical compartments.  
B Effective circuit diagram of a mature cell with numerous long processes. C Trace 
shows the current response to a -5 mV pulse in a whole-cell patch-clamped mature 
oligodendrocyte. This current could be fitted with the sum (purple line) of two 
exponentials (blue and red lines). The series resistance is calculated from the peak 
current recorded when the voltage pulse is applied (see arrow), while the input 
resistance of the cell is obtained by measuring the steady-state current recorded after 
the membrane has been charged.  
Rs=15 MΩ
Rm=74 MΩ
The current response is fitted (in purple) with the sum of two exponentials:
  I∞ +  
  +  I 
2
  .   e- t / τ 2   
I∞=-52.7 pA, I1=-140 pA, τ1=0.84 ms, I2=-105 pA, τ2=9.5 ms
where
resistance along
    processes
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Gluconate
[CsGlu] = 130 mM
[NaCl] = 124 mM
[NaCl] = 4 mM
[KCl] = 2.5 mM
[NaHCO3] = 26 mM
Sodium
Caesium
Chloride
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Figure 2.5
A junction potential exists at any interface between different solutions, such as
between the pipette solution and the bath solution. It depends on the different diffusion
coefficient values for the principal cations and anions, which cause them to diffuse at
different rates (depending on their molecular weight and charge) across the interface.
(Note that only the main ions are represented here).
Cell permeant
Fluorescence is calcium-independent
Esterases
Fluo 4 - AM
Cell impermeant
Fluorescence depends on [Ca2+]i
Fluo 4
Free acid
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Figure 2.6
Using the acetoxymethyl (AM) ester form of a Ca2+-sensing dye. Slices were
incubated in the presence of 5 µM of the cell permeant Fluo-4 dye for 60 minutes.
Following the loading, the slice was washed and kept in medium without dye, while
deesterification was taking place. The esterases inside the cell remove the ester group
on Fluo-4 making it able to bind calcium (resulting in [Ca2+]i-dependent fluorescence),
and becoming membrane impermeant so it cannot leave the cell again.
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Chapter 3: The electrical response of white matter
oligodendrocytes to simulated ischaemia
3.1 Introduction
As reviewed in Chapter 1, the ischaemia, which occurs in stroke or when blood
vessels are damaged in spinal cord injury, and possibly in conditions leading to
periventricular leukomalacia, damages oligodendrocyte lineage cells in the white
matter. It is conventionally assumed that, as for ischaemic damage to neurons,
ischaemic damage to oligodendrocytes may in large part reflect a release of glutamate,
and subsequent activation of an inward current across the cell membrane which includes
damaging Ca2+ entry (see Chapter 1). Indeed, oligodendrocytes and their precursors
have been reported to generate an inward current at the onset of ischaemia (Káradóttir et
al., 2005; Káradóttir et al., 2008), which could be a prelude to the rise of [Ca2+]i (Micu
et al., 2006) and loss of myelinating processes (Salter and Fern, 2005) that mature
oligodendrocytes suffer in the first 30-60 min of ischaemia. However, previous studies
of oligodendrocyte damage have mainly employed methods such as immunolabelling
and biochemical assays which, although extending our knowledge about the long-term
effects of ischaemia, do not provide information about the real-time response of
oligodendrocytes to the ischaemic insult.
To investigate in more detail the initial membrane current response of
oligodendrocyte lineage cells to ischaemia, I used whole-cell patch-clamping to record
the membrane currents and voltage changes of white matter oligodendrocyte lineage
cells in brain slices superfused with ischaemia-mimicking solution (in the rest of the
text this will simply be denoted ‘ischaemia’). The results show that, despite the fact that
ischaemia evokes an inward current in oligodendrocytes, the mechanism of this
current’s generation is fundamentally different to that occurring in response to
ischaemia in neurons.
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3.2 Materials and methods
3.2.1 Brain slice preparation
Cerebellar slices were prepared from P12 rats as described in section 2.1. Slices
were immersed and patch-clamped in a bicarbonate-based solution at room temperature
with a flow rate of 2-4 ml/min. After obtaining the whole-cell patch-clamp recording
mode, the temperature was elevated to 33oC and a stable baseline was recorded for ~5
min, before applying ischaemia-mimicking solution. The external solution and the
ischaemic solution are described in sections 2.2.1 and 2.2.3, respectively.
3.2.2 Patch-clamping
White matter oligodendrocytes were whole-cell patch-clamped as described in
section 2.6. Pipettes contained either Cs+ or K+-based internal solutions (for comparison
see Table 2.1). These two different internal solutions were used because the Cs+-based
solution permitted a better voltage clamp of the cell’s membrane at depolarised
potentials (since the K+ channels activated by depolarisation are impermeable to Cs+, so
the membrane resistance and electrical space constant are higher), while the K+-based
solution allowed physiologically-relevant recordings of the voltage changes occurring
across the cell membrane when the cells were not voltage-clamped.
 The series resistance was 10-20 MΩ, and was not compensated. For voltage-
clamp experiments, the membrane voltage was held at -74 mV (including the junction
potential of -14 mV, see section 2.6), while for the voltage recordings in current-clamp
mode no current was applied.
3.2.3 Current and voltage analysis during anoxic depolarisation
For recordings in voltage-clamp mode, the ischaemia-evoked currents were
measured relative to the current flowing at the start of ischaemic solution application. In
current-clamp mode, voltage changes were measured from the resting potential that the
cell assumed without injected current (the mean value of which was -73±2 mV with K+
inside, n=6, and -64±4 mV with Cs+ inside, n=6).
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3.2.4 Capacitance measurement
For small and electrically compact cells (e.g. cerebellar granule cells or
oligodendrocyte precursor cells), which show a monoexponential decay to their capacity
current, the capacitance of the cells can be calculated from the current response to a
small voltage step, using equation 2.6:
ms
ms
m
RR
RR
 τ C



where  is the decay time constant of the capacity current and Rs and Rm are given by
equations 2.3 and 2.4. However, for myelinating oligodendrocytes the capacity current
could not be well fitted by a single decaying exponential (see section 2.8), implying that
the processes of the cell are not well voltage-clamped, but it could be approximately
fitted by the sum of 2 exponential components as in equation 2.7:
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The slower of these components was assumed to reflect charging of the more distant
parts of the cell processes, which Salter and Fern (2005) have reported to be lost after
30-60 min ischaemia, so I examined whether the parameters of the slower exponential
changed in ischaemia in a manner consistent with a loss of cell processes, i.e. whether
its amplitude decreased or its time constant decreased. For this analysis, values were
calculated from capacity current transients evoked by 5 mV voltage steps, which were
applied every 1.5 min from 7.5 min before ischaemia until 7.5 min after the start of
ischaemia, and again at 15 min and 21 min after the start of ischaemia.
3.2.5 Membrane resistance and conductance measurements
The apparent membrane resistance was calculated from equation 2.4:
s
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by subtracting the pipette series resistance from the total input resistance (note that for
mature oligodendrocytes, which have imperfectly voltage-clamped processes, part of
this resistance may be contributed by the internal resistance of the cells’ processes).
The slope conductance of each measured I-V relation (ignoring the presence of
the series resistance) was calculated, at the resting potential and at 0 mV, as the current
change between two adjacent points of the I-V relation (bracketing either the resting
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potential or 0 mV) divided by the voltage difference between the two points (i.e.
20 mV).
3.2.6 Statistics
Data are presented as mean+s.e.m. P values are from Student’s 2-tailed t-tests or
from ANOVA and post-hoc Student’s 2-tailed t-tests. A Holm-Bonferroni correction
was applied for multiple comparisons as described in Chapter 2, in such a way that
differences are significant if the p values presented are less than 0.05.
3.3 Results
3.3.1 Ischaemia evokes an inward current in mature oligodendrocytes
I identified mature oligodendrocytes as described in section 2.5, and whole-cell
voltage-clamped them at -74 mV with Cs+-based internal solution. Upon applying
ischaemic solution (i.e. lacking oxygen and glucose, and with iodoacetate and antimycin
added to block ATP production by glycolysis and oxidative phosphorylation, see
section 2.2.3), the cells displayed an inward current which usually showed three
characteristic phases (Fig. 3.1). After a few minutes of the current slowly becoming
more inward (phase 1), the increase of inward current accelerated (phase 2) until the
response reached a peak. This second component of the response has a time course
similar to the anoxic depolarisation described in neurons (Hansen, 1985) and to the
ischaemia-evoked current seen in cerebellar Purkinje cells (Hamann et al., 2005). After
this peak, the current became less inward (phase 3) and eventually tended towards a
stable level that was more inward than before ischaemia (Fig. 3.1A).
The amplitude of the peak current evoked by ischaemia averaged over all the
179 mature oligodendrocytes studied was -209±10 pA (Fig. 3.2C). However, when the
time courses of the current responses from the different cells were averaged together,
the different time of occurrence of the peak AD current in the different cells (ranging
from 160 sec to 920 sec, average 439±11 sec from the start of ischaemic solution
application, see Fig. 3.5) led to an average current time course (Fig. 3.1B) that did not
display a sharp peak as was seen in most cells, and which had a somewhat smaller
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amplitude than that obtained (Fig. 3.2C) by averaging over the peak currents in the
individual cells.
3.3.2 The amplitude of the ischaemia-evoked inward current depends on the
developmental stage of the cell
I compared the ischaemia-evoked inward current displayed by mature
oligodendrocytes to that induced in OPCs and immature oligodendrocytes, which were
identified morphologically as described in section 2.5, and shown in Fig. 3.2A.
Although the time course of the current response to ischaemia was broadly similar at all
three developmental stages, the amplitude of the peak inward current increased with the
stage of cell development, with OPCs displaying a peak current of -61±10 pA (n=15),
immature cells of -107±25 pA (n=8) and mature cells of -209±10 pA (n=179) (Fig. 3.2).
The increase in peak inward current seen with development may suggest an increasing
expression of the channels or receptors responsible for the generation of the ischaemia-
evoked current, or could simply reflect the cells increasing in size with no change of the
density of channels and receptors in the membrane.
3.3.3 Using K+ instead of Cs+ as the main intracellular cation does not affect the
ischaemia-evoked current, but reduces the ischaemia-evoked voltage change
I mainly used a Cs+-based internal solution for voltage-clamp recordings,
because Cs+ does not permeate through many K+ channels and thus increases cell
membrane resistance. This will increase the cell’s electrical space constant and the
voltage-clamp quality. However, to investigate the cells’ responses in a more
physiological condition, I used a K+-based internal solution (see Table 2.1) and
compared the results.
First, I compared data obtained when voltage-clamping mature oligodendrocytes
with either Cs+ or K+ as the main ion in the internal solution. Upon application of
ischaemic solution, with either of the internal solutions the cells displayed an inward
current with a similar time course and amplitude (Fig. 3.3A): the average peak
amplitude was -209±10 pA (n=179) for Cs+- and -191±41 pA (n=10) for K+-based
solutions (not significantly different, p=0.67, Fig. 3.3B). Thus, the presence of Cs+
rather than K+ in the internal solution does not influence the oligodendrocyte current
response to ischaemia when voltage-clamped to -74 mV.
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Next, I investigated the oligodendrocyte voltage response to ischaemia in
current-clamp mode. With Cs+ in the internal solution, ischaemia caused an initial slow
depolarisation of about 15 mV followed by a more rapid and large depolarisation of the
cell membrane by ~50 mV (giving an overall depolarisation of 62±7 mV, n=6) that
lasted until the end of the recording (~15 min: Fig. 3.4A). In contrast, when a K+-based
internal solution was used, the initial depolarisation of the cell membrane in ischaemia
(by 18.7±1.8 mV, n=6) was followed by a slow recovery of the cell membrane potential
towards its pre-ischaemic baseline (Fig. 3.4B). The mean time course of the voltage
response for these two conditions is shown in Fig. 3.4C, and the mean peak
depolarisation (averaged over all the cells) is shown in Fig. 3.4D.
The much greater ischaemia-evoked depolarisation that occurs with Cs+ in the
cell than with internal K+ suggests that, with K+ (but not with Cs+) present, outward K+
currents are activated at depolarised potentials and oppose further depolarisation.
Many K+ channels are blocked when K+ is replaced by Cs+ (Hille, 2001). Indeed,
experiments presented below (Fig. 3.12A-C) show that this is true for the K+ currents
active in oligodendrocytes at depolarised potentials: around 0 mV the slope conductance
of oligodendrocytes studied with internal Cs+ was 3.8-fold (p=7.45x10-3) smaller than
that seen with K+ in the cell (Fig. 3.12C). However, near the resting potential the slope
conductance with internal Cs+ was only 2.2-fold smaller (p=0.01) than with internal K+
(Fig. 3.12C). These data suggest that, as for astrocytes (Zhou et al., 2009), the main ion
channels open near the resting potential have a reasonably high permeability to Cs+ as
well as to K+, possibly because two-pore K+ channels contribute to the resting
conductance of the cells as in astrocytes (Zhou et al., 2009).
According to this framework, once the membrane potential is displaced
sufficiently positive from the resting potential, the inward current evoked by ischaemia
(the origin of which is explored below, and in the next chapter) will depolarise cells
more if they have Cs+ inside than if they have K+ inside, because the ion channels that
pass large outward K+ currents at depolarised potentials do not allow significant Cs+
efflux. Complicating this picture, however, is the fact that the voltage response seen
with K+ inside the cell is not merely smaller than with Cs+ inside, but after about 10
minutes returns towards the original resting potential (Fig. 3.4C). This suggests that,
with K+ (but not with Cs+) inside the cell, late in the response to ischaemia there is an
extra outward current produced, presumably as channels permeable to K+ (but not to
Cs+) are either activated by ischaemia (e.g. as the result of a rise of [Ca2+]i or a fall of
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[ATP]i in the distal parts of their processes despite the presence of ATP in the pipette)
or their conductance increases as a result of the ischaemia-evoked accumulation of
extracellular K+ (as is known to occur for inward rectifier channels: Hille, 2001).
3.3.4 The time needed for ischaemia to alter the oligodendrocyte membrane
current
I first measured the time of the peak current reached by the cells in voltage-
clamp mode, with caesium or potassium in the internal solution. There was no
significant difference (p=0.96) in this parameter between the two internal solutions,
which was 439±11 sec in 179 cells studied using Cs+ and 442±52 sec in 10 cells studied
using K+ (Fig. 3.5). Similarly, when I compared the time of the peak depolarisation
reached by the cells in current-clamp mode with Cs+ or K+ in the internal solution, this
parameter also did not differ significantly (p=0.15) between the two internal solutions
used: 670±111 sec for 6 cells using Cs+ and 476±44 sec for 6 cells using K+ (Fig. 3.5).
There was also no significant difference between the time of the peak AD recorded in
voltage- and current-clamp mode for either of the internal solutions used (Fig. 3.5).
Thus, neither the composition of the internal solution nor the patch-clamp mode
employed influenced the time to the peak of the ischaemia-induced response in
oligodendrocytes.
These results closely resemble those obtained for the response of cerebellar
Purkinje cells to ischaemia (Hamann et al., 2005), where the clamp mode and the main
ion used in the internal solution did not influence the time of the peak response of the
neurons to the ischaemic insult.
As noted in section 3.3.1, the time to the peak of the current response varied
greatly between cells, and this was also true for the amplitude of the peak current. To
test whether the size of the peak current varied with the time of the peak, I analysed the
distributions of the time and the size of the peak current in all the voltage-clamped cells
that I studied (179 for Cs+- and 10 for K+-based internal solution, pooled together).
The distribution of the size of the peak current could be approximately fitted by
a truncated Gaussian distribution (r2=0.56) with the peak at an inward current of
152±23 pA (Fig. 3.6A), slightly less than the mean inward current of 209±10 pA
reported in section 3.3.1. The distribution of the times to the peak of the current could
also be approximately fitted by a Gaussian distribution (r2=0.75), with the peak at
390±9 sec (Fig. 3.6B), slightly less than the 439±11 sec average time reported in section
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3.3.4. Plotting the size of the peak current against the time of the peak for each cell (Fig.
3.6C), the time increased weakly with the size of the inward current. Although the data
are scattered (r2=0.06), the slope of the line in Fig. 3.6C is significantly different from
zero (p=0.001, calculated from the t-statistic obtained from the mean and s.e.m.
estimated for the slope).
In summary, the peak current varied significantly between different
oligodendrocytes, perhaps correlating with differences in cell size (e.g. due to different
numbers of axons being myelinated) or cells being recorded from at different depths in
the slice which might result in a different amount of K+ accumulation around the cell. In
addition, there was a weak dependence of the time needed to reach the peak ischaemia-
evoked current on the size of that current, which might reflect intrinsic differences in
cell properties or differences in the depth of the cell in the slice.
3.3.5 The membrane resistance increases during ischaemia
In neurons, the membrane resistance decreases dramatically shortly after the
start of ischaemia (Hansen et al., 1982; Xu and Pulsinelli, 1996), mostly due to the
activation of glutamate ionotropic receptors (Rossi et al., 2000; Hamann et al., 2005),
although the cell’s potassium conductance can also increase as a result of a rise in
[Ca2+]i activating calcium-activated K+ channels (Liao et al., 2010) and a fall of [ATP]
leading to activation of ATP-gated K+ channels (Kulik et al., 2002). In oligodendrocytes
it has been suggested that activation of glutamate receptors contributes to the ischaemia-
evoked current (Káradóttir et al., 2005) and rise of [Ca2+]i (Micu et al., 2006), so a
decrease in membrane resistance might also be expected in these cells. To investigate
how the membrane resistance of mature oligodendrocytes changes in simulated
ischaemia, and how any change depends on the composition of the internal solution, the
membrane resistance was calculated repeatedly from the current response to 5 mV
depolarizing pulses from the holding potential of -74 mV, applied from 7.5 min before
ischaemia until 21 min after the start of ischaemia.
Surprisingly, the membrane resistance (with either K+ or Cs+ in the internal
solution) increased continuously after the start of ischaemia (Fig. 3.7). The change was
more prominent for the Cs+-based internal solution. This may in part be due to a K+
conductance being activated later in ischaemia and reducing the membrane resistance
when K+ is present inside the cell (see section 3.3.3), but to a large extent simply
reflects the fact that the initial resistance is higher with Cs+ inside the cell (as will be
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explained in section 3.3.7). However, the significant increase in cell membrane
resistance observed with the K+-based internal solution later in ischaemia indicates that
the rise in resistance does not depend solely on having the non-physiological Cs+ ion
present in the internal solution. Thus, the membrane resistance change in ischaemia
differs between oligodendrocyte and neurons.
The increase in the membrane resistance might be explained by two different
phenomena. First, it has been suggested that during the first hour of exposure to
ischaemic solution, oligodendrocytes lose some of their myelinating processes (Salter
and Fern, 2005) and on exposure to glutamate (which is released in ischaemia: Li et al.,
1999; Káradóttir et al., 2005) they retract their processes from the node of Ranvier (Fu
et al., 2009). If the membrane re-sealed after process loss, and/or if process retraction is
achieved by endocytosis of the cell membrane, this would cause a loss of surface
membrane area and conductance and hence produce an increase in resistance. To test
this hypothesis I carried out the experiments described in section 3.3.6, measuring the
membrane capacitance, since a loss of oligodendrocyte processes would also cause a
loss of cell capacitance. An alternative explanation for the increase in membrane
resistance observed in ischaemia could be a decrease in the number or conductance of
the channels that are open in physiological conditions. To investigate the nature of the
membrane current that might be modulated in ischaemia, I performed current-voltage
relation measurements as described in section 3.3.7.
3.3.6 Cell capacitance does not change significantly in mature oligodendrocytes
during ischaemia
To try to detect a loss of oligodendrocyte cell processes or process retraction at
the node of Ranvier (Salter and Fern, 2005; Fu et al., 2009), as a measure of the cell size
I calculated the cell membrane capacitance from the current transient evoked by a small
voltage step, as described in section 3.2.4. The membrane capacitance is generally
assumed to be constant per unit area of the cell (and represents the amount of charge
necessary to change the membrane potential by a certain amount). Thus, the capacitance
is proportional to the cell area and so indirectly indicates the size of the cell.
Furthermore, a correlation of the membrane conductance of cerebellar oligodendrocytes
with the length of myelinating processes that they make has suggested that more than
80% of the cell conductance and capacitance are located in the cell processes (Bakiri et
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al., 2011), indicating that an ischaemia-evoked loss of the processes (Salter and Fern,
2005) ought to be detectable as a change of the total capacitance of the cell.
First, I simplistically applied monoexponential fitting (see Fig. 2.3) to capacity
current transients evoked by 5 mV pulses that were obtained continuously every 1.5 min
from 7.5 min before ischaemia till 21 min after the start of ischaemia. Using
monoexponential fitting assumes that the cell is well voltage-clamped (isopotential)
without any voltage gradients along the cell processes (see Chapter 2, and below).
According to this analysis the cell capacitance did not change significantly at any stage
of the recording, compared to its pre-ischaemia value (Fig. 3.8). This analysis was,
because of its time-consuming nature, only performed for a limited number of cells.
However, even if the (statistically insignificant) ~17% decrease in capacitance shown in
Fig. 3.8B became statistically significant with the addition of many more cells, and thus
represented a ~17% loss of cell surface area, this could explain only a very small
fraction of the ~4-fold increase in membrane resistance shown for the Cs+-filled cells in
Fig. 3.7.
As described in Chapter 2, the fits of the mature oligodendrocyte capacity
currents with single decaying exponentials were not very accurate, because the cells
form more than a single electrical compartment: charging of the soma capacitance
provides a fast decaying exponential to the current, while charging of the more distant
membrane in the processes is limited by the axial resistance of the processes and
contributes at least one more slower exponential component (see Fig. 2.4). I considered
it possible that limitations in the accuracy of the single exponential fit were preventing
me from detecting a change in the capacitance of the distant processes, and so fitted the
capacity currents with the sum of two exponentials. Although the parameters of the two
exponentials do not relate simply to the areas of the soma compartment and of the
distant process compartment, changes in the membrane area of the latter compartment
are expected to affect the amplitude (Aslow) and time constant (slow) of the slower
component more than those (Afast, fast) of the faster component. As shown in Fig. 3.9,
none of these parameters changed significantly when ischaemic solution was applied.
This suggests no changes in the surface membrane area of either the cell soma or the
cell processes up to 21 min after the start of ischaemic insult.
These findings rule out the possibility that cell process loss is responsible for the
early increase in membrane resistance during ischaemia. They also indicate that
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oligodendrocytes remain physically intact during the initial 20 min of ischaemia,
without major damage to their soma or processes. However, at the longest time period
studied here, Salter and Fern (2005) reported only about a 20% loss of cell processes. In
addition, I cannot rule out the possibility that whole-cell clamping the oligodendrocyte
protects it from process loss (e.g. by maintaining the intracellular ATP level, or by
providing the pipette as a route for the exit of water which enters across the cell
membrane). Thus, my data do not contradict the observation of Salter and Fern (2005)
that a more prolonged application of ischaemic solution to unclamped oligodendrocytes
leads to process loss from the cells.
3.3.7 The membrane resistance increase reflects a loss of K+ conductance
The existence of an ischaemia-evoked inward current implies that ischaemia
either increases a conductance with a reversal potential that is more positive than the
holding potential used (-74 mV) or decreases a conductance with a reversal potential
more negative than the holding potential. The increase of resistance documented in Fig.
3.7 implies that the latter of these scenarios is the cause of the inward current, but this
cannot be attributed to an ischaemia-evoked loss of oligodendrocyte processes (see
above). This suggests that ischaemia might decrease the activity of ion channels with a
reversal potential more negative than -74 mV (i.e. K+, or possibly Cl-, channels)
In Müller glia, ischaemia causes a strong reduction of potassium conductance
(Pannicke et al., 2004; Pannicke et al., 2005), which is probably mediated by a
downregulation of the inwardly rectifying potassium channel Kir4.1 (Iandiev et al.,
2006). Kir4.1 is found in mature oligodendrocytes (Kalsi et al., 2004; Cahoy et al.,
2008) and its knock-out causes a strong increase in oligodendrocyte membrane
resistance (Neusch et al., 2001). The loss of Müller cell K+ conductance reported by
Pannicke et al. (2004) takes 1-3 days to occur after ischaemia, but Schwartz (1993) has
reported that activation of metabotropic glutamate receptors (which might occur when
glutamate is released in ischaemic conditions) reduces the conductance on a time scale
of seconds to minutes. I therefore thought it worth investigating whether a down-
regulation of K+ conductance is induced by ischaemia in oligodendrocytes.
Figures 3.10A and B show the membrane current response of a mature
oligodendrocyte (using a Cs+-based internal solution) to voltage steps applied in 20 mV
increments from a holding potential of -74 mV to potentials between -134 mV and
+6 mV, in the control solution and after 4.8 min exposure to ischaemic solution. At
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voltages positive to -60 mV and more negative than -120 mV the current in ischaemia is
less than in the control solution. Subtracting the two I-V relations shows a current that
reverses at around -95 mV (Fig. 3.10C). In Figs. 3.11A-C, similar data are shown for a
cell studied with the K+-based internal solution. Again the subtracted current reverses
around -110 mV, i.e. close to the calculated Nernst potential for K+ which is ~105 mV.
Figure 3.12 presents the average I-V data obtained from experiments performed as in
Figs 3.10 and 3.11.
Comparing first the pre-ischaemic I-V relations in Fig. 3.12A (for the Cs+
internal solution) and Fig. 3.12B (for the K+ internal solution), near the resting potential
the slope conductance with internal K+ is about 2.2-fold greater than with internal Cs+
(Fig. 3.12C), implying that Cs+ permeates the cell membrane roughly 46% as well as K+
does. This is a surprisingly high Cs+ permeability, but a similar result has previously
been reported for astrocytes (PCs/PK=0.43: Zhou et al., 2009). In comparison, around
0 mV, the slope conductance is 3.8-fold higher with K+ than with Cs+ inside the cell
(Fig. 3.12C), reflecting the fact that Cs+ does not permeate well through the K+ channels
that are activated at depolarised potentials, as was postulated in section 3.3.3as an
explanation for the different voltage response to ischaemia recorded with Cs+ and K+ as
the main intracellular cation.
The current suppressed by ischaemia (obtained by subtracting the control and
ischaemia I-V data for each cell and then averaging over all cells) is similar at -74 mV
with Cs+ or K+ as the main internal cation (Fig. 3.12D). Furthermore, from the slope of
the subtracted I-V data, ischaemia suppressed the same amount of conductance
whichever ion was present (3.3±1 nS for Cs+; 3.3±0.9 nS for K+; p=0.98). The larger
baseline conductance of the cell with intracellular K+ present explains why there is a
much smaller fractional change of resistance in Fig. 3.7 for K+ inside the cell than for
Cs+ inside. This can be seen as follows. For the cells studied in Fig. 3.12, Fig. 3.12C
gives the initial conductance at the resting potential as being 6.9 nS with Cs+ and 15 nS
with K+ inside. At 9 min into ischaemia when 3.3 nS of K+ conductance has been
suppressed (either with Cs+ or with K+), the new conductance values will be 6.9-3.3 =
3.6 nS with Cs+ and 15-3.3 = 11.7 nS with K+. The normalised resistance will therefore
become 6.9/3.3 = 2.09, i.e. a 109% increase, for Cs+, and 15/11.7 = 1.28, i.e. only a 28%
increase for K+ (approximately 4-fold smaller than the percentage increase with Cs+
inside). These values are similar to those seen 9 min into ischaemia for a larger number
of cells in Fig. 3.7A. Thus, suppression of the same magnitude of conductance by
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ischaemia leads to a much smaller percentage rise of resistance with K+ inside than with
Cs+ inside because the initial resistance is lower with K+ inside.
3.4 Discussion
Ischaemia disrupts the function of the white matter, initially by impairing axonal
action potential propagation and thus preventing neuronal signalling between different
brain regions. Part of the inhibition of action potential propagation results from the run-
down of ion gradients across the axonal membrane, but part also reflects ischaemia-
evoked damage to the oligodendrocytes that surround axons and speed their conduction
velocity by reducing their effective membrane capacitance. As reviewed in Chapter 1,
ischaemia releases glutamate which activates oligodendrocyte glutamate receptors, it
raises oligodendrocyte [Ca2+]i, and it produces physical disruption of the myelin sheath
and a loss of myelinating processes (Dewar et al., 2003; Káradóttir et al., 2005; Salter
and Fern, 2005; Micu et al., 2006). The loss of myelin around axons may then lead to
the axon dying (Nave, 2010; Pohl et al., 2011).
Although many studies have employed electrophysiological techniques to study
the neuronal response to ischaemia (Xu, 1995; Tanaka et al., 1997; Rossi et al., 2000;
Allen et al., 2004; Hamann et al., 2005), only a few have investigated the changes in
glial cell electrophysiology produced by this pathological condition (e.g. Xie et al.,
2008). Indeed, most of the previous studies of ischaemia’s effects on oligodendrocyte
lineage cells lacked the ability to record rapid changes occurring in oligodendrocyte
membrane physiology and therefore did not describe a real-time cellular response to the
ischaemic insult. A few previous studies of the electrical response to simulated
ischaemia in oligodendrocytes have shown that these cells respond to the insult with an
inward current (Káradóttir et al., 2005; Bakiri et al., 2008), but the nature of this current
was not fully investigated, because it was assumed to be generated, as in neurons, by a
cation influx through glutamate-gated channels. The work described in this (and the
following) chapter is the first that aimed at giving a more comprehensive analysis of the
oligodendrocyte electrical response to ischaemia. The main results obtained are: (i) the
time course of the oligodendrocyte response to ischaemic insult; (ii) that although a
similar ischaemia-evoked inward current is seen with Cs+ or K+ inside the cell, the
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resulting voltage response differs significantly; and (iii) that the inward current evoked
by ischaemia is the result of a decrease of K+ conductance, rather than an increase in
non-selective cation conductance as occurs in neurons. The implications of these results
will now be discussed.
Ischaemia evokes an inward current in oligodendrocytes which develops over a
period of 10 min with a characteristic shape (Fig. 3.1) and an amplitude which increased
as the cells developed (Fig. 3.2). At -74 mV, neither the time course of the current nor
its amplitude depended on whether the main ion used in the internal solution was Cs+ or
K+ (Fig. 3.3), which, as discussed below, has implications for the identification of the
underlying ionic channels. The time course of the current in Fig. 3.1, with a slowly
developing inward current followed by (or with superimposed on it) a more rapidly
developing transient inward current, might suggest that there are two components to the
response, although my data provide no information on this. Notably, the fast phase of
the response is similar to that recorded in neurons in the cerebellum during ischaemia
(Hamann et al., 2005), and it would be interesting to test whether, at the time of this
current transient in the oligodendrocytes, there is a rise of [K+]o produced in the white
matter by the neuronal anoxic depolarisation.
Although the ischaemia-evoked current amplitude was unaffected by replacing
intracellular K+ by Cs+ (Fig. 3.3), when not voltage-clamped, the cell depolarisation
occurring was much larger with Cs+ inside than with K+ inside (Fig. 3.4), presumably
because intracellular Cs+ cannot permeate through K+ channels that normally generate
an outward current at depolarised potentials and thus limit depolarisation. Thus, in vivo,
oligodendrocytes presumably only undergo an ischaemia-evoked depolarisation of less
than 20 mV, much less than the 50-60 mV depolarisation that neurons undergo at the
time of the anoxic depolarisation (Hansen, 1985; Hamann et al., 2005). This may
correlate with the smaller [K+]o rise occurring in the white matter during ischaemia (14
mM: Ransom et al., 1992) than occurs in the grey matter (50-60 mM: Hansen, 1985).
It is well established that a large release of glutamate by reversal of uptake
carriers during ischaemia leads to the generation of a massive inward current in neurons
by activation of ionotropic (AMPA and NMDA) glutamate receptors (Olney and de
Gubareff, 1978; Choi et al., 1987; Choi, 1988; Rossi et al., 2000; Arundine and
Tymianski, 2004). Similarly, glutamate release by reversed uptake (Li et al., 1999) and
activation of similar receptors on oligodendrocytes has been assumed to account for the
inward current evoked in these cells by ischaemia (Káradóttir et al., 2005). It was
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surprising to find, therefore, that the inward current was associated with a conductance
decrease rather than a conductance increase (Fig. 3.7) and, furthermore, that the reversal
potential of the suppressed current was close to that for K+ ions (Fig. 3.12). Thus, the
origin of the ischaemia-induced response in oligodendrocytes is not dominated by an
opening of sodium- or calcium-permeable channels and so differs significantly from the
anoxic depolarisation observed in neurons.
Capacitance measurements (Figs. 3.8 and 3.9) were used to demonstrate that the
decrease of conductance was not a result of a loss of cell processes induced by
ischaemia (Salter and Fern, 2005) implying that ischaemia reduces the number of ion
channels open (or the conductance per channel) to below the normal value. The resting
conductance of the cell is only ~2-fold larger with K+ inside than with Cs+ inside (Fig.
3.12C), and the conductance decrease evoked by ischaemia had a similar magnitude and
reversal potential (Fig. 3.12) with either Cs+ or K+ inside the cell. This suggests that the
resting conductance that is being suppressed by ischaemia is not highly selective for K+
over Cs+. It is also worth bearing in mind that some of the current changes induced by
ischaemia might not be due to changes in the number of ion channels open, but could
reflect a rise of extracellular [K+] evoked by ischaemia (Hansen, 1985). This will
increase the inward current through ohmic K+ channels, but can increase the outward
current (at voltages more positive than the Nernst potential for K+) through inward
rectifier channels by increasing their conductance (Nichols and Lopatin, 1997).
The molecular identity of the potassium channels that are open at the resting
potential (and thus are candidates for being closed by ischaemia) is uncertain for
oligodendrocytes (Gipson and Bordey, 2002), though it seems likely to include Kir4.1
inward rectifying channels (Poopalasundaram et al., 2000; Neusch et al., 2001; Kalsi et
al., 2004), as well as some two-pore domain potassium channels, such as TREK-1 and
TWIK-1 which have a relatively high Cs+-permeability (Zhou et al., 2009) and have
been found to contribute significantly to the potassium conductance of astrocytes along
with Kir4.1 (Skatchkov et al., 2006; Seifert et al., 2009; Zhou et al., 2009). Since the
I-V relation of oligodendrocytes shows little inward rectification, the two-pore channels
may be more dominant. Interestingly, inhibition of the activity of the two-pore channel
THIK-1 by low oxygen levels has been suggested to contribute to the anoxic
depolarisation of neurons (Campanucci et al., 2003) and THIK-1 is expressed in
myelinating oligodendrocytes (Cahoy et al., 2008). The fact that some of the two-pore
channels are suppressible by pharmacological agents such as halothane (Campanucci et
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al., 2003) suggests future experiments that might be able to identify the main channel
type whose conductance is suppressed by ischaemia.
To summarize, my results suggest that the ischaemia-evoked depolarisation in
mature oligodendrocytes is generated not by the activation of a non-specific (e.g.
glutamate-gated) cation conductance, but by the closing of potassium channels that are
open at the resting potential and are quite permeable to Cs+. The repolarisation that
follows presumably depends on voltage-gated potassium channels that are very slowly
activated by depolarisation, on activation of ATP-gated K+ channels when intracellular
[ATP] falls, or on a rise of [K+]o increasing the outward current through inward rectifier
channels. These findings demonstrate that the oligodendrocyte response to ischaemia is
strikingly different to that observed in neurons. Consequently, if the membrane current
changes that I have characterised are found to contribute to damage to the
oligodendrocytes, for example by evoking a Ca2+ influx through voltage-gated Ca2+
channels, then therapeutic modulation of this response to try to rescue oligodendrocytes
from the damage caused by ischaemic insult may require a different therapeutic
approach to that needed for neuronal protection. This raises the question of the role of
glutamate in all of these events, since glutamate’s activation of its ionotropic receptors
has been suggested to contribute to damaging both oligodendrocytes and their
precursors in conditions of energy deprivation (Agrawal and Fehlings, 1997; Wrathall et
al., 1994; McDonald et al., 1998; Fern and Möller, 2000; Follett et al., 2000; Volpe,
2001; Tekkök and Goldberg, 2001; Dewar et al., 2003; Stys, 2004; Káradóttir et al.,
2005; Salter and Fern, 2005; Micu et al., 2006; Fu et al., 2009). This is investigated in
the next chapter.
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Figure 3.1
Mature oligodendrocyte response to ischaemia. A The specimen response of one cell
to ischaemia can be divided into three phases. In phase 1, the cell develops a slow
inward current which then becomes inward more rapidly and reaches a peak - the
anoxic depolarisation current - in phase 2. Then, in phase 3, the current recovers and
reaches a stable plateau that is more inward than the starting baseline level. B The
average response of 179 mature oligodendrocytes to ischaemia lacks a clear
distinction between these three phases as the peak current was reached by each cell at
a different time (see Fig. 3.5). The start of ischaemia is denoted by t=0. The internal
solution was Cs+-gluconate based.
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Figure 3.2
The size of the ischaemia-induced current in oligodendrocyte lineage cells depends on
the developmental stage of the cell. A Representative pictures of a whole-cell patch-
clamped oligodendrocyte precursor cell (OPC), immature and mature oligodendrocyte
filled with internal solution containing Lucifer Yellow fluorescent dye. B The average
ischaemia-induced current time course in OPCs (n=15), immature (n=8) and mature
(n=179) oligodendrocytes. The time course for the mature cells is reproduced from
Fig. 1B for ease of comparison. The start of ischaemia is at t=0. C The amplitude of
the inward current induced by ischaemia increased with the developmental stage of
the oligodendrocytes. The current was measured at the peak of the response in each
cell, and then averaged over the cells of each class (in contrast to panel B which shows
the time course averaged over all the cells recorded from. Cells were held at -74 mV
and the Cs+-based internal solution was used.
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Figure 3.3
The time course and amplitude of the ischaemia-induced current in mature
oligodendrocytes is independent of the main ion used in the internal solution. A
Average over all the cells recorded from of currents evoked at -74 mV by ischaemia in
cells filled with Cs+- or K+-based internal solutions. Independent of whether the
internal cation was mainly Cs+ or K+, the currents showed a similar time for the start
of the response, and a similar subsequent time course. B The peak of the ischaemia-
evoked current, measured in each cell and then averaged over the different cells, was
not significantly different between cells filled with Cs+- or K+-gluconate based internal
solutions.
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Figure 3.4
The time course and amplitude of the ischaemia-induced voltage response in mature
oligodendrocytes (recorded in current-clamp mode) depends strongly on the main ion
used in the internal solution. A Representative trace of voltage change in a cell filled
with Cs+-based internal solution. B Representative trace of voltage change in a cell
filled with K+-based internal solution. C Averaged time courses of voltage changes
evoked by ischaemia in cells filled with Cs+- or K+-based internal solutions. D The
peak of the ischaemia-evoked depolarisation, measured in each cell and then averaged
over all the recorded cells, was significantly different between cells filled with Cs+- or
K+-based internal solutions.
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Figure 3.5
The time to reach the peak of the ischaemia-evoked response in oligodendrocytes does
not depend on the clamp mode used nor on the main ion present in the internal
solution. Bars show the time to the peak of the response to ischaemia, measured in
each cell and then averaged over all cells. There was no significant difference in the
time of the response peak between the cells in voltage-clamp or current-clamp
configurations, nor between the cells filled with Cs+- or K+-based internal solutions.
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Figure 3.6
Variability in the peak amplitude and the time to peak of the ischaemia-induced
inward current in oligodendrocytes. A The amplitude (plotted as a negative number to
denote inward current) can be fitted by a truncated Gaussian distribution (r2=0.56)
with a peak value at -152±23 pA. B The time to reach the peak of the current can be
fitted by a Gaussian distribution (r2=0.75) with a peak value at 390±9 sec. C The
amplitude of the inward current evoked by ischaemia plotted as a function of the time
to the peak current: each point is a separate cell. Although the data are scattered
(r2=0.06), the slope of the line is significantly different from zero (p=0.001, calculated
from the t-statistic obtained from the mean and s.e.m. estimated for the slope). All the
cells were held at -74 mV and include those filled with Cs+- (n=179) or K+- (n=7)
based internal solutions.
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Figure 3.7
The membrane resistance (Rm) increases in oligodendrocytes during ischaemia. A
During ischaemia the value of Rm (normalised to its pre-ischaemic value) increases by
a small amount in cells filled with K+-based internal solution, but much more in cells
filled with Cs+-based internal solution. B The increase in Rm measured at 7.5 min (the
approximate time of the peak AD current), at 15 min and at 21 min after the start of
ischaemia shows a statistically significant change in Rm for the cells filled with Cs+-
based internal solution at all the three time intervals. The change in Rm for the cells
filled with K+-based internal solution is statistically significant at 21 min after the start
of ischaemia. The cells were held at -74 mV. * indicates statistically significant
difference (p<0.05) in comparison to the pre-ischaemic values.
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Figure 3.8
Change in oligodendrocyte membrane capacitance (Cm) during ischaemia, measured
by fitting a monoexponential decay to the capacity transient evoked by a 5 mV voltage
step and deriving the parameters from the eqn. 2.6. A The normalised Cm changes
during ischaemia show no significant decrease of this parameter with time. The
greater variability at later times is due to the earlier cessation of the experiment for
several cells, which resulted in a decreasing number of cells contributing data at late
times. B The changes in Cm measured at 7.5 min (the approximate time of the peak
inward current), 15 min and 21 min after the start of ischaemia indicate no statistically
significant decrease at any of these times. There was no difference in the (lack of)
capacitance change between Cs+- and K+- based internal solutions (12 and 8 cells
respectively, data not shown), and therefore the data shown in this figure are pooled
from both internal solutions. The cells were held at -74 mV.
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Figure 3.9
Results of fitting the capacity current transients with the sum of two exponentials, a
fast exponential with amplitude A1 (mean initial value -206±53 pA in 20 cells) and
time constant t1 (mean initial value 657±141 µsec), and a slow exponential with
amplitude A2 (mean initial value -73±13 pA) and time constant t2 (mean initial value
11±2 msec). For each panel the left hand graph shows the time course of the parameter
normalised to its value at the start of ischaemia, averaged over all the cells, while the
right hand graphs show the fold change in the average values at 3 times (7.5 min
which is the approximate time of the peak inward current, 15 min and 21 min after the
start of ischaemia), and p values assessing whether the change from the pre-ischaemic
value is significant. A, B The amplitude (A) and time constant (B) of the fast
component, A1, do not change during ischaemia. C, D The amplitude (C) and time
constant (D) of the slow component, A2, do not change during ischaemia. There was
no difference in the (lack of) capacitance change between Cs+- and K+- based internal
solutions (12 and 8 cells respectively, data not shown), and therefore the data shown in
this figure are pooled from both internal solutions. The cells were held at -74 mV.
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Figure 3.10
Membrane current response of a mature oligodendrocyte to voltage steps, using a Cs+-
based internal solution. Voltage steps of 200 ms duration were applied from -134 mV
to +6 mV in 20 mV increments from a holding potential of -74 mV. A In the control
solution, the voltage steps induced large passive currents. B After 4.8 min exposure to
the ischaemic solution, the passive currents were substantially reduced, indicating an
increase in the membrane resistance. C Subtraction of the currents in ischaemic
solution (B) from the currents in control solution (A) shows that the increase in
membrane resistance is due to the closing of channels with a reversal potential at
~-95 mV.
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Figure 3.11
Membrane current response of a mature oligodendrocyte to voltage steps, using a K+-
based internal solution. Voltage steps of 200 ms duration were applied from -134 mV
to +6 mV in 20 mV increments from a holding potential of -74 mV. A In the control
solution, the voltage steps induced large passive currents. B After 3.1 min exposure to
the ischaemic solution, the passive currents were substantially reduced, indicating an
increase in the membrane resistance. C Subtraction of the currents in ischaemic
solution (B) from the currents in control solution (A) shows that the increase in
membrane resistance is due to the closing of channels with a reversal potential at
~-110 mV.
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Figure 3.12
Ischaemia evokes a decrease in the oligodendrocyte membrane conductance. A, B
Mean current-voltage (I-V) relations measured at the end of 200 msec pulses from
experiments as in Fig. 3.10 (A, using Cs+ internal solution; n=5) and Fig. 3.11 (B,
using K+ internal solution; n=7). Graphs show the steady state I-V relations before
ischaemia (control; filled circles), and after ~9 min ischaemia (ischaemia; open
circles). C Slope conductance of the I-V relations in control solution at the resting
potential (R.P.) and 0 mV for Cs+- and K+-based internal solutions. The slope
conductance for K+ is significantly higher than for Cs+ in both of the conditions, but
the relative permeability to Cs+ is higher at the R.P. than at 0mV. D The I-V relations
of the current suppressed in ischaemia (current before ischaemia minus current in
ischaemia), using Cs+- (filled circles) or K+-based internal solution (open circles),
show no difference between the two internal solutions. The current suppressed shows
characteristic of a passive conductance with a reversal potential at ~100 mV.
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Chapter 4: The role of glutamate in the
oligodendrocyte response to ischaemia
4.1 Introduction
As described in Chapter 3, oligodendrocytes respond to ischaemia with an
inward current that reflects a closing of potassium channels. The experiments in this
chapter investigate the mechanism of this phenomenon. Ischaemia could cause a
reduction in potassium channel open probability by directly altering a factor affecting
the channels, for example lowering the level of intracellular ATP or raising the
intracellular calcium concentration (although normally these changes would increase
the conductance, by opening ATP- or Ca2+-gated K+ channels), or causing cell swelling
and membrane stretch. Alternatively, the effect could be more indirect, and be a
secondary consequence of the activation of another receptor or channel expressed by
oligodendrocytes.
Various factors have been reported to be released during white matter
ischaemia, among them: glutamate (Tekkök et al., 2007), GABA (Lee et al., 1993;
Fern et al., 1995) and ATP (Domercq et al., 2010). An abnormally increased level of
glutamate has been suggested to be the main damaging agent during white matter
ischaemic insult (Stys, 2004; Jensen, 2005; Matute et al., 2007), but the mechanism by
which this neurotransmitter is released by ischaemia in the white matter remains
controversial. As reviewed in Chapter 1, it has been suggested that, as in the grey
matter (Rossi et al., 2000), loss of the energy supply to the white matter causes
glutamate transporters to reverse and release glutamate (Li et al., 1999), but increased
exocytosis induced by a rise of [Ca2+]i is also a possibility since there are synapses
from unmyelinated axons to oligodendrocyte precursor cells (Kukley et al., 2007;
Ziskin et al., 2007). Alternative mechanisms include astrocyte swelling and rupture
(releasing intracellular glutamate) caused by an activation of astrocytic NKCC1 co-
transporters (Su et al., 2000; Wilke et al., 2004), microglial cystine-glutamate
antiporters (Domercq et al., 2007), or gap junctional hemichannel opening (reported in
grey matter ischaemia: Thompson et al., 2006). In this chapter I investigate the role of
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glutamate in the current response of oligodendrocytes to ischaemia, and assess the
likely release mechanism.
As reviewed in Chapter 1, glutamate is a major damaging agent in white matter
ischaemia, acting through AMPA/KA and NMDA receptors and causing calcium
overload, loss of cell processes and later cell death (McDonald et al., 1998; Tekkök and
Goldberg, 2001; Li et al., 1999; Káradóttir et al., 2005; Salter and Fern, 2005; Micu et
al., 2006). As a result of these actions, myelinated axons lose their sheath and the
action potential fails (Li et al., 1999; Tekkök and Goldberg, 2001; Bakiri et al., 2008).
In addition, high levels of ATP have been reported to overactivate oligodendrocyte
purinergic receptors, especially P2X7 receptors, and cause severe cell damage by
generating a calcium influx in ischaemic condition (Domercq et al., 2010). It is also
possible that GABA, the concentration of which rises fivefold in ischaemia (Shimada et
al., 1993), acts on oligodendrocytes GABAA receptors, resulting in Cl- influx and cell
swelling, as was reported for gray matter neurons (Allen et al., 2004). Finally, in
neurons, the low pH level that occurs in ischaemia (Siesjö, 1988; Lipton, 1999) was
found to activate acid-sensing ion channels (ASICs) leading to cell damage and death
(Xiong et al., 2004), and these channels are also expressed by oligodendrocytes
(Feldman et al., 2008). I therefore tested whether any of these factors may have an
influence on the closing of oligodendrocyte potassium channels evoked by ischaemia
with the aim of establishing a possible mechanism for the oligodendrocyte current
response to the ischaemic insult.
4.2 Materials and methods
4.2.1 Brain slice preparation
Cerebellar slices were prepared from P12 rats as described in section 2.1. Slices
were immersed and patch clamped in a bicarbonate-based solution for most of the
mechanism-blocking drugs studied, or in a HEPES-based solution for experiments with
Gd3+ which binds to bicarbonate. The solution was initially at room temperature and
had a flow rate of 2-4 ml/min. After obtaining the whole-cell patch clamp mode, the
temperature was changed to 33ºC and a stable current baseline was recorded for 5 min.
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The external solutions and the ischaemic solution are described in section 2.2.1 and
2.2.3, respectively.
4.2.2 Patch-clamping
White matter oligodendrocytes were whole-cell patch-clamped as described in
section 2.6. Pipettes contained a Cs+-based internal solution (see Table 2.1) to provide a
better voltage-clamp quality. The series resistance was 10-20 MΩ, and was not 
compensated. The membrane potential was held at -74 mV (including the junction
potential of -14 mV, see section 2.6). During recording drugs were usually added
~2 min before the application of ischaemic solution, which is an approach similar to
that taken by Hamann et al. (2005). For preloading of L-trans-pyrrolidine-2,4-
dicarboxylic acid (PDC, a slowly transported antagonist of Na+-dependent transporters)
into the cells, slices were incubated in this drug (1 mM) at room temperature for 30 min
(with 1 mM Na+-kynurenate present to prevent activation of ionotropic glutamate
receptors when the extracellular glutamate concentration rises in the presence of PDC:
Volterra et al., 1996), before recording from the cells. PDC was omitted from the
recording solution.
4.2.3 Statistics
Data are presented as mean+s.e.m. P values are from Student’s 2-tailed t-tests
or by ANOVA and post-hoc Student’s 2-tailed t-tests. A Holm-Bonferroni correction
was applied for multiple comparisons, as described in Chapter 2, in such a way that
differences are significant if the p values presented are less than 0.05.
4.3 Results
4.3.1 Glutamate is a major trigger of the ischaemia-evoked current in white
matter oligodendrocytes
An excessive glutamate level has been reported to exert an excitotoxic effect on
cells in the white matter (Wrathall et al., 1994; Agrawal and Fehlings, 1997), especially
on oligodendrocytes (Oka et al., 1993), through activation of ionotropic glutamate
receptors (Li et al., 1999; Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al.,
2006). However, the experiments in the previous chapter showed that the ischaemia-
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induced current in oligodendrocytes is caused by a closing of potassium channels. This
raises the question of whether the effect of glutamate seen by previous workers
somehow precedes this response, e.g. by generating an agent that decreases the activity
of potassium channels.
To test if the ischaemia-induced current in oligodendrocytes is triggered by
ionotropic glutamate receptors, I applied the AMPA/KA receptor blocker NBQX
(25 µM), together with the NMDA receptor blocker AP5 (50 µM), from the start of
ischaemia, to block both types of ionotropic glutamate receptor. A significant decrease
in the ischaemia-evoked current was observed, confirming that these receptors play an
important role in the response to ischaemia (Fig. 4.1).
To quantify this effect, I measured the peak ischaemia-evoked current in each
cell and averaged this value over cells from control and from glutamate receptor
blocker-treated slices. The mean peak current was reduced by 51±11% in 12 NBQX
and AP5-treated cells (p=6.3x10-4, Fig. 4.2A) when compared with all 179 control
cells, or by 68±4% (p=0.1, Fig. 4.2B) when comparing 6 NBQX and AP5 treated cells
with 6 interleaved control cells recorded on the same day as NBQX and AP5 were
studied (the insignificant p value most probably occurs due to the increased variability
of the control group).
I attempted to test which ionotropic glutamate receptor class contributes more
to triggering the ischaemia-evoked current, by applying NBQX (25 µM) and AP5 (200
µM) separately. Although NBQX, an AMPA/KA receptor blocker, reduced the
ischaemia-evoked current (Fig. 4.3), the reduction of the peak response (measured for
each cell and then averaged over cells) did not reach statistical significance. The mean
peak current in 10 cells studied in NBQX was reduced by 23±21% compared with all
the 179 controls (p=0.63, Fig. 4.5A), and by 43±16% compared with 11 interleaved
control cells recorded on the same day (p=0.09, Fig. 4.5B). Despite the reduction in the
peak current not reaching significance, examination of the time course of the averaged
current in Fig. 4.3A and B shows that NBQX does significantly reduce the current
(p<0.05, indicated with stars on the graphs) over much of the 10 minute period studied.
This suggests that activation of AMPA/KA receptors does play a significant role in
triggering the ischaemia-evoked current in oligodendrocytes, but that not enough cells
were recorded from to convincingly demonstrate a reduction of the peak current.
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D-AP5 (200 M), an NMDA receptor blocker, applied from the start of
ischaemia, did not significantly alter the time course of the ischaemia-evoked current
(Fig. 4.4). Similarly, AP5 did not significantly alter the mean value for the peak
ischaemia-evoked current (measured for each cell and then averaged over cells), which
was increased by 32±36% in 5 AP5-treated cells compared with all 179 control cells
(p=0.51, Fig. 4.5A), and was reduced by 5±26% compared with 3 interleaved control
cells recorded on the same day (p=0.89, Fig. 4.5C).
These results suggest that AMPA/KA receptors play the more important role in
triggering the ischaemia-evoked current. However, since NBQX+AP5 gives a more
convincing block of the current than does NBQX alone, they leave open the possibility
that to fully trigger the ischaemia-evoked current the simultaneous activation of both
AMPA/KA and NMDA receptors is needed.
To assess the possible role of metabotropic glutamate receptors in triggering the
ischaemia-evoked current, I applied MCPG (1 mM), a broad spectrum metabotropic
glutamate receptor antagonist. The ischaemia-evoked current was significantly reduced
(Fig. 4.6). Measuring the peak ischaemia-evoked current for each cell, and then
averaging over cells, the mean peak current was reduced by 50±6% in 6 MCPG-treated
cells compared with all 179 controls (p=9.7x10-5, Fig. 4.7A) and by 63±5% compared
with 6 interleaved control cells recorded on the same day (p=2.3x10-3, Fig. 4.7B). This
reduction is comparable to that produced by the combined block of AMPA/KA and
NMDA classes of ionotropic glutamate receptors.
These experiments, together with those in the previous chapter, show that
glutamate is the major trigger of the oligodendrocyte current response to ischaemia,
acting both on its ionotropic and metabotropic receptors and causing the closing of
oligodendrocyte potassium channels. In the remainder of this chapter I investigate the
mechanism of glutamate release, study when glutamate has to be present to trigger the
ischaemia-evoked current in oligodendrocytes, and assess the possible contribution of
other ion channels to the response.
4.3.2 Glutamate is released by reversed transport in white matter ischaemia
To assess whether the glutamate, which triggers the ischaemia-evoked current,
is released by a reversal of glutamate transporters, as occurs in the anoxic spinal cord
(Li et al., 1999), I preloaded slices with PDC (1 mM), a broad-spectrum Na+-dependent
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glutamate transporter antagonist. PDC is transported on glutamate transporters at only
~25% the rate of glutamate (Sarantis et al., 1993). During exposure to PDC, cells take
up this substance and accumulate it in their cytoplasm (glutamate receptors were
blocked with 1 mM Na+-kynurenate during this loading to prevent damage by the rise
of extracellular glutamate concentration that occurs due to heteroexchange with PDC
on the carrier: Volterra et al., 1996). When the transmembrane ion gradients run down
in ischaemia, promoting transporter reversal (Szatkowski et al., 1990), the preloaded
intracellular PDC occupies the transporters and prevents glutamate release (Roettger
and Lipton, 1996; Li et al., 1999; Rossi et al., 2000). As shown in Fig. 4.8, PDC
preloading reduced the ischaemia-evoked current in oligodendrocytes. To quantify this,
I measured the peak ischaemia-evoked current in each cell and averaged this value over
cells from control and from PDC-treated slices. The mean peak current was reduced by
72±6% in 5 PDC-treated cells (p=1.2x10-7), when compared with all 179 control cells,
or by 62±12% (p=6.8x10-3), when compared with 7 interleaved control cells recorded
on the same day as the PDC was studied (Fig. 4.9).
Next, I tested three other possible mechanisms of glutamate release that could
add to the rise of extracellular glutamate concentration produced by the reversal of
glutamate transporters. Astrocytic NKCC1 co-transporters have been proposed to
release glutamate upon ischaemia by generating an excessive ionic flux into the cells
which leads to astrocyte swelling and death, and thus the release of intracellular
glutamate (Su et al., 2000; Wilke et al., 2004). After application of bumetanide
(50 µM, Wilke et al., 2004) to inhibit NKCC1 co-transporters in 10 slices, the
ischaemia-evoked current showed a later onset and smaller amplitude when compared
with all the 179 control cells (Fig. 4.10A), but showed an indistinguishable onset time
course and amplitude when compared with 10 interleaved control cells recorded on the
same day (Fig. 4.10B). This difference from the data for all 179 control cells
presumably reflects day to day variation in the amplitude and time course of the
response to ischaemia. The mean value of the peak current amplitude was reduced by
31±11% in 10 cells in bumetanide-treated slices compared with the mean for all 179
control cells (p=0.08, Fig. 4.13), but not significantly reduced when compared with the
data from 10 interleaved control cells recorded on the same day (reduced by 2%±15%,
p=0.93, Fig. 4.14A). This suggests that there is little or no influence of NKCC1 co-
transporters on the early ischaemia-evoked release of glutamate in the white matter
(and hence on the suppression of oligodendrocyte K+ current that ischaemia produces).
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I also investigated the possibility of exocytosis from unmyelinated axons being
involved in white matter glutamate release. Recently, unmyelinated axons in the white
matter have been shown to release glutamate at synapses onto oligodendrocyte
precursor cells (Kukley et al., 2007; Ziskin et al., 2007) and this release may increase
in ischaemia, as has been reported for glutamate and GABA in the grey matter
(Katchman and Hershkowitz, 1993; Allen et al., 2004). However, after application of
Cd2+ (100 µM, Kukley et al., 2007), an exocytosis blocker, there was no significant
change in the time course or magnitude of the ischaemia-induced current in
oligodendrocytes (Fig. 4.11). The mean value of the peak current amplitude was
insignificantly increased by 24±30% in 13 cells in Cd2+-treated slices compared with
the mean for all 179 control cells (p=0.87, Fig. 4.13), while comparing the Cd2+ data
with that from 8 interleaved control cells on the same day a non-significant decrease of
15+23% (p=0.71) was seen (Fig. 4.14B).
Finally, I ruled out activation of cystine-glutamate antiporters as another
possible mechanism of ischaemia-induced glutamate release. It has been suggested that
microglial cystine-glutamate antiporters can release excessive glutamate during
exposure to lipopolysaccaride, causing oligodendrocyte death (Domercq et al., 2007),
so I examined whether this also occurs in ischaemia. However, application of the
cystine-glutamate exchange blocker (S)-4-carboxyphenylglycine (CPG, 50 µM,
a concentration demonstrated to be effective by Cavelier and Attwell (2005)) did not
have any significant effect on the time course of the ischaemia-induced current in these
cells (Fig. 4.12). The mean value of the peak current amplitude was insignificantly
increased by 6±42% in 5 cells in CPG-treated slices compared with the mean for all
179 control cells (p=0.90, Fig. 4.13), while comparing the CPG data with that from 4
interleaved control cells on the same day an insignificant increase of 58+63% (p=0.42)
was seen (Fig. 4.14C).
In conclusion, these experiments demonstrate that a reversal of glutamate
uptake transporters is the main mechanism of glutamate release early in ischaemia of
the white matter, excluding a significant contribution to this process from NKCC1
co-transporter overactivation, exocytosis from unmyelinated axons or activation of
microglial cystine-glutamate antiporters.
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4.3.3 The contribution of gap junctional hemichannel opening and activation of
P2X7 receptors to the ischaemia-induced current in oligodendrocytes
Despite its importance, glutamate is not the only factor that affects cell survival
during ischaemic insult, and it has been shown that gap junctional hemichannel
opening and activation of ATP-gated P2X7 receptors can also contribute to the
ischaemia-evoked damage. A recent study in oligodendrocytes linked these two
phenomena, showing that the activation of P2X7 receptors in ischaemia is directly
caused by a release of intracellular ATP mediated by hemichannel opening (Domercq
et al., 2010).
Hemichannels can open during ischaemia, possibly releasing agents (such as
glutamate and ATP) responsible for ionic dysregulation, and decreasing the
intracellular levels of ATP and glucose (Ye et al., 2003; Thompson et al., 2006). I
therefore investigated the effect of blocking hemichannel opening with La3+ (100 µM,
Ye et al., 2003). Lanthanum decreased the amplitude of the peak ischaemia-evoked
current in 11 cells from La3+-treated slices when compared with all 179 control cells
(reduced by 40±10%, p=6.7x10-3, Figs. 4.15A and 4.17A), but not when compared with
12 interleaved control cells recorded on the same day (reduced by 10±16%, p=0.65,
Figs. 4.15B and 4.17B). This difference presumably reflects day to day variation in the
amplitude of the ischaemia-evoked current: on the days that La3+ was studied, the
ischaemia-evoked currents in the control cells were smaller than average. Although
more experiments are needed to confirm the result, the lack of effect of La3+ when
compared with control cells studied on the same day suggests that La3+ does not have a
significant effect on the glutamate release mechanism.
ATP, released from cells upon injury and acting through P2X7 receptors, causes
excessive neuronal firing, an irreversible calcium overload and death of spinal cord
neurons (Wang et al., 2004). The expression of P2X7 receptors is significantly
upregulated as a consequence of ischaemic insult (Franke et al., 2004) and P2X7
receptors are also found in oligodendrocytes (Agresti et al., 2005). Nevertheless,
blocking P2X7 receptors with BBG (10 µM, Domercq et al., 2010) did not significantly
affect the initial time course nor the average peak value for the ischaemia-evoked
current (Fig. 4.16). The mean peak current was reduced by 22±17% in 6 BBG-treated
cells when compared to all 179 control cells (not significant, p=0.27, Fig. 4.17A), and
by 6±21% when compared with 7 interleaved control cells recorded on the same day
(p=0.85, Fig. 4.17B).
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These results suggest that, compared to glutamate, hemichannel opening and
P2X7 receptor activation make a negligible contribution to the oligodendrocyte
response to ischaemia.
4.3.4 ASICs, GABAA receptors and neuronal action potentials do not influence
the oligodendrocyte response to ischaemia
In addition to a release of glutamate, an acid extracellular pH shift activating
acid sensitive ion channels (ASICs), a release of GABA that activates GABAA
receptors, and excessive neuronal firing, have also been described as general features
of grey matter ischaemia (see Chapter 1 and section 4.1 above), so I investigated
whether any of these factors contributed to the generation of the ischaemia-evoked
current in oligodendrocytes
Acidotoxicity may contribute to ischaemic damage, as neuronal ASIC channels
open in ischaemia (Xiong et al., 2004), their block reduces the size of the infarct in vivo
(Pignataro et al., 2007) and oligodendrocytes also express ASICs (Feldman et al.,
2008). However, blocking ASIC channels with amiloride (100 µM, Feldman et al.,
2008) did not significantly affect either the time course (Fig. 4.18) or the magnitude of
the ischaemia-evoked current in oligodendrocytes: the averaged peak current in 6 cells
studied with amiloride was reduced by 17±15% compared to all 179 control cells
(p=0.64, Fig. 4. 21) and was increased by 8±20% compared with 6 interleaved control
cells studied on the same day (p= 0.76, Fig. 4.22A).
Action potentials occurring in neurons at the start of ischaemia (Hamann et al.,
2005) may lead to an excessive vesicular release of neurotransmitter from synapses
made in the white matter onto OPCs (Kukley et al., 2007; Ziskin et al., 2007). In the
cerebellar white matter this could include glutamate released from afferent mossy and
climbing fibres, and GABA released from Purkinje cell axons. Action potentials could
also generate extracellular K+ accumulation. However, blocking action potentials with
TTX (1 µM) had no significant effect on the time course of the ischaemia-evoked
current in oligodendrocytes (Fig. 4.19), nor on its mean magnitude (which in 13 cells
studied in TTX was reduced by 19±13% compared to that in all 179 control cells
(p=0.59, Fig. 4.21), and increased by 7±17% compared to 10 interleaved control cells
recorded on the same day (p=0.75, Fig. 4.22B)).
During ischaemic insult in the grey matter, neurons release GABA which
activates GABAA receptors, causing a Cl- influx and cell swelling (Allen et al., 2004)
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that might lead to cell membrane rupture and the release of intracellular agents. To
investigate the possible contribution of such a GABA effect to the ischaemia-induced
current in white matter oligodendrocytes, I applied bicuculline (100 µM), a GABAA
receptor blocker. Bicuculline did not alter the time course of the ischaemia-evoked
current (Fig. 4.20). It also did not alter the averaged peak inward current produced by
ischaemia in 5 bicuculline-treated cells (reduced by 7±19% compared with all 179
controls (p=0.74, Fig. 4.21) and by 6±19% compared with 4 interleaved controls
studied on the same day (p=0.80, Fig. 4.22C)).
4.3.5 Ionotropic glutamate receptor block does not inhibit the ischaemia-evoked
current when applied after the start of ischaemic insult
Although previous studies that examined the effect of blocking ionotropic
receptors on the oligodendrocyte response to ischaemia reported a protective effect
(described above and in Chapter 1), there are still no effective therapies using these
blockers to treat white matter injury after ischaemic insult. This may be explained by
the fact that all the laboratory studies were performed by applying AMPA/KA and
NMDA receptor blockers 20 min to 1 h before the exposure to ischaemia (Li and Stys,
2000; Tekkök and Goldberg, 2001; Micu et al., 2006; McCarran and Goldberg, 2007;
Bakiri et al., 2008), while a medical treatment needs to be effective during or after the
exposure to the ischaemic insult. I therefore tested the efficiency of ionotropic
glutamate receptor blockers for inhibiting the ischaemia-evoked current when applied
after the initiation of white matter ischaemia.
Surprisingly, unlike in neurons where the ischaemia-evoked current is largely
produced by an ion influx through ionotropic glutamate receptors (Rossi et al., 2000;
Hamann et al., 2005), when NBQX (25 µM) and AP5 (50 µM) were applied from 3-4
min after the start of ischaemia, they did not block the already developing ischaemia-
evoked current (Fig. 4.23). The peak inward current evoked by ischaemia occurred on
average at 439+11 sec after the start of ischaemia for control cells (as described in
Chapter 3) and at 487±52 sec after the start of ischaemia (not significantly different,
p=0.4) for the 6 cells to which NBQX and AP5 were applied 3-4 min after the start of
ischaemia. In contrast to the 51-68% reduction in ischaemia-evoked current seen when
NBQX and AP5 were applied together from before the ischaemia started, in the cells to
which NBQX and AP5 were applied 3-4 min after the start of ischaemia the mean peak
current was insignificantly reduced by 1±16% (p=0.95) compared to all 179 control
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cells and was increased by 17±19% (p=0.55) compared to 5 interleaved control cells
studied on the same day (Fig. 4.24).
The fact that ionotropic glutamate blockers inhibit the ischaemia-evoked current
when applied before ischaemia, but not when applied after the start of ischaemia
closely resembles a neuronal phenomenon called the extended neuronal depolarisation
(END) - an inward current observed in neurons upon prolonged exposure to glutamate
that is maintained even when the initial trigger, glutamate, is removed (Coulter et al.,
1992; Limbrick et al., 2003).
4.3.6 The mechanism of the extended inward current in oligodendrocytes is
different from that producing the END in neurons
In neurons, the END is induced by excessive activation of glutamate receptors
and largely depends on the duration of the exposure to glutamate. It is mediated by an
influx of extracellular calcium and causes delayed neuronal cell death. As such, END
can be linked to the pathophysiology of stroke or traumatic brain injury (Coulter et al.,
1992; Limbrick et al., 2003). A similar phenomenon has not been reported in
oligodendrocytes so far, but the results from the previous experiments mimic many of
those observed in END, namely a dependence on an initial activation of ionotropic
glutamate receptors, a failure to abolish the response (once initiated) with ionotropic
receptor blockers, and an insensitivity to block by TTX and amiloride (Coulter et al.,
1992; Limbrick et al., 2003; Deshpande et al., 2007).
In neurons, the END was found to be blocked by 100 M Gd3+, or by the
omission of extracellular calcium (Coulter et al., 1992; Limbrick et al., 2003), even
when these manipulations were applied after the depolarisation was established, and so
its effect is most probably exerted through calcium-permeable channels. However,
Gd3+ (100 µM) did not block the ischaemia-evoked inward current in oligodendrocytes,
either when added from ~4 min after the start of ischaemia (Fig. 4.25) or when present
from before the start of ischaemia (Fig. 4.26). When Gd3+ was applied after the start of
ischaemia in 3 cells the mean peak ischaemia-evoked current was 61±45% larger than
that in all 179 control cells (p=0.31, Fig. 4.28) and 38±39% larger than in 3 interleaved
control cells studied on the same day (p=0.47, Fig. 4.29A). When Gd3+ was applied
throughout ischaemia to 7 cells the mean peak current was reduced by 30±19%
compared with all 179 control cells (p=0.57, Fig. 4.28) and increased by 4±28% when
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compared with 6 interleaved control cells studied on the same day (p=0.19, Fig.
4.29B).
Similarly, removing extracellular calcium (and with trace calcium chelated by
the addition of 50 µM EGTA to the external solution) did not prevent or reduce the
ischaemia-evoked current (Fig. 4.27). In the absence of calcium the mean peak
ischaemia-evoked current in 6 cells was 43±35% larger than the mean for all 179
control cells (p=0.55, Fig. 4.28) and 48±36% larger than the mean for 10 interleaved
control cells recorded on the same day (p=0.26; Fig. 4.29C). The lack of an effect of
Ca2+ removal is interesting in that previous data suggested that an excessive influx of
calcium exerts a damaging effect on white matter oligodendrocytes during ischaemia
(Deng et al., 2003; Salter and Fern, 2005; Micu et al., 2006; Domercq et al., 2010).
This result implies that the suppression of K+ conductance that is evoked by ischaemia
does not depend on Ca2+ entry.
These data show that the mechanism of the extended depolarisation evoked by
glutamate in neurons differs from that induced by ischaemia in oligodendrocytes.
4.4 Discussion
The white matter is vulnerable to anoxia or ischaemia, particularly in the
immature brain (McCarran and Goldberg, 2007; Hertz, 2008), and the energy supply
failure occurring in conditions such as stroke, perinatal asphyxia leading to
periventricular leukomalacia, and spinal cord injury causes a loss of oligodendrocytes
or their precursors (Park et al., 2004; Stys, 2004; Ludwin, 2006; Khwaja and Volpe,
2008). Since oligodendrocytes are crucial for proper propagation of neuronal action
potentials in the white matter, it is of critical importance to identify the causative agents
responsible for their damage in such pathological conditions.
In the previous chapter I showed that the oligodendrocyte membrane current
response to ischaemia is dominated by an inward current that is caused by the closing
of potassium channels. In this chapter I investigated the possible mechanism of this
response and demonstrated that its main trigger is glutamate, released into the white
matter by the reversal of glutamate transporters (and not by the activation of NKCC1
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co-transporters, cystine-glutamate antiporters or synaptic release), and that glutamate
acts on oligodendrocytes through its ionotropic and metabotropic receptors.
Other factors, such as ATP activating P2X7 receptors, hemichannel opening,
GABA acting on GABAA receptors, low pH activating ASICs, or neuronal action
potentials, had a negligible influence on the ischaemia-evoked current. It should,
however, be born in mind that it may be necessary to study a larger number of cells for
each drug condition than was possible in the finite time of this PhD to establish small
effects on the ischaemia-evoked current: consequently, although glutamate seems to
have the dominant influence, I cannot rule out the possibility that some of the other
agents which gave insignificant effects might show small effects if a much larger
number of cells were studied.
The response to ischaemia in oligodendrocytes was strongly reduced by the
application of either ionotropic glutamate receptor blockers (by ~50%) or of a
metabotropic glutamate receptor blocker (~50%), and so it is likely that the combined
application of these inhibitors together would completely abolish the current. Further
experiments are needed to investigate this possibility.
The lack of a significant contribution of oligodendrocyte NMDA receptors to
the ischaemia-induced current was surprising, as Káradóttir et al. (2005) have
demonstrated previously that NMDA receptor blockers inhibit the current evoked in
oligodendrocytes in ischaemia. However, in that paper the block in mature cells was
shown to be only ~15% and so the variability of my responses might have concealed
such a small reduction in the current. In order to definitely reject such a possibility, the
experiment would have to be repeated on a considerably larger number of cells.
It is surprising that although glutamate triggers the ischaemia-evoked current,
the current is not mediated by an ion flux through ionotropic glutamate receptors, but
by a suppression of potassium conductance (see previous chapter). However, activation
of glutamate receptors has previously been reported to exert a suppressive effect on
potassium channels in glia. Gallo et al. (1996) found that delayed rectifier K+ channels
in oligodendrocyte precursors can be closed by the activation of AMPA/KA receptors
(the mechanism being an influx of Na+ ions which blocks the channels from the inside:
Knutson et al., 1997), while in Müller glial cells Schwartz (1993) described potassium
channel inhibition by glutamate metabotropic receptors. It is plausible therefore, that
glutamate induces a similar effect in myelinating oligodendrocytes, acting both through
ionotropic and metabotropic receptors.
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Surprisingly, ionotropic glutamate receptor blockers were effective only when
applied before ischaemia, not once the ischaemia-evoked current had been activated. It
would be interesting to test whether this is also the case for the effect of mGluR
blockers. This result was unexpected, as it differs from that obtained in neurons, where
the ischaemia-evoked current can be immediately abolished by AMPA/KA and NMDA
receptor blocker application even after the current has been activated (Rossi et al.,
2000; Hamann et al., 2005). Although in oligodendrocytes, like in neurons, ionotropic
glutamate receptor blockers also blocked the majority of the ischaemia-evoked current
if present throughout ischaemia, the current could not be abolished by these blockers
once it had been established. This phenomenon appears similar to one described in
neurons, in which exposure to glutamate for more than a certain duration leads to the
irreversible activation of a depolarizing current (termed the extended neuronal
depolarisation, or END: Sombati et al., 1991; Coulter et al., 1992; Limbrick et al.,
2003; Deshpande et al., 2007). However, the hypothesis that the events in
oligodendrocytes were identical to the END phenomenon in neurons had to be
excluded based on the fact that Gd3+ and calcium removal did not reduce the
ischaemia-evoked current in oligodendrocytes, while in neurons they block the END
even when applied after it has been activated.
The experiments with La3+ and Gd3+, used as blockers of hemichannels and of
the END effect, respectively, also excluded the possibility of transient receptor
potential (TRP) channels being involved in the induction of the ischaemia-evoked
current. It was shown in neurons that TRPM7 (which is blocked by La3+ and Gd3+) is
responsible for a death mechanism in ischaemia, allowing Ca2+ influx and ROS
production even when ionotropic glutamate receptor blockers were applied (Aarts et
al., 2003; Lipski et al., 2006). This effect was also shown in vivo (Sun et al., 2009).
However, my results rule out an important role for TRP channel activation in the white
matter oligodendrocytes’ current response to ischaemia.
In conclusion, my results indicate that in white matter ischaemia glutamate is
released through a reversal of glutamate transporters and acts on ionotropic and
metabotropic glutamate receptors, evoking a membrane current response in
oligodendrocytes that is dominated by the closing of potassium channels. I show for the
first time that the majority of ischaemia-evoked current in oligodendrocytes is caused,
but not maintained, by the activation of glutamate receptors, as blocking these
receptors did not reduce the inward current once it was established. This phenomenon,
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although similar to the neuronal END effect, has a different and as yet obscure
mechanism. All of the above results indicate that the oligodendrocyte response to
ischaemia is a complex phenomenon that differs substantially from the one described in
neurons.
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Figure 4.1
Combined application of the AMPA/KA receptor blocker NBQX (25 µM) and the
NMDA receptor blocker AP5 (50 µM) significantly reduces the ischaemia-induced
current in oligodendrocytes. A Comparison between the averaged time course of the
ischaemia-evoked current from 12 cells in slices treated with NBQX and AP5 and
from all 179 control cells shows a significant decrease of the current amplitude in the
presence of NBQX and AP5. B Comparison between the averaged time course of the
ischaemia-evoked current in 6 cells studied with NBQX and AP5 and in 6 interleaved
control cells (i.e. recorded on the same day) shows a decrease of the current in the
presence of the blockers (although not significant due to the high variability in the
amplitude of the control cell responses). Ischaemia starts at t=0. * indicates
statistically significant difference at the time point indicated (p<0.05).
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Figure 4.2
Comparison of the mean values for the peak of the ischaemia-induced inward current
(measured for each cell and then averaged over all cells in the same condition), for
control cells and for cells with NBQX and AP5 applied, shows that ionotropic
glutamate receptor blockers significantly reduced the ischaemia-induced current. A
Comparison between the average peak current in 12 cells studied in NBQX and AP5
and the current in all 179 control cells shows a significant decrease of the current
amplitude when the blockers were applied. B Comparison between the average peak
current in 6 cells with NBQX and AP5 and in 6 interleaved control cells studied on the
same day also shows a decrease of the current amplitude when the blockers were
applied (although not significant due to the high variability in the amplitude of the
control cell responses).
time (sec from start of ischaemia)
-200 0 200 400 600
cu
rr
en
t(
pA
)
-200
-150
-100
-50
0
50
all control cells
NBQX
cu
rr
en
t(
pA
) -50
0
50
interleaved control cells
NBQX
A
B
*
***
*
*
*
*
**
*
*
* * *
**
**
*
*
***
**
*
*
*
*
***
*
*
ischaemia
ischaemia
time (sec from start of ischaemia)
-200 0 200 400 600
cu
rr
en
t(
pA
)
-200
-150
-100
151
Figure 4.3
Effect of the AMPA/KA receptor blocker, NBQX (25 µM), applied alone, on the
ischaemia-induced current in oligodendrocytes. A Comparison between the averaged
time course of the ischaemia-evoked current from 10 cells in slices treated with
NBQX and from all the 179 control cells shows a delay in the current response to
ischaemia and a reduced amplitude before 600 sec in the presence of NBQX. B
Comparison between the averaged time course of the ischaemia-evoked current in 10
cells in slices treated with NBQX and in 12 interleaved control cells (studied on the
same day as application of NBQX) shows a delay in the response but a similar
amplitude in the presence of NBQX. Ischaemia starts at t=0. * indicates statistically
significant difference at the time point indicated (p<0.05).
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Figure 4.4
Effect of the NMDA receptor blocker, D-AP5 (200 µM), applied alone, on the
ischaemia-induced current in oligodendrocytes. A Comparison between the averaged
time course of the ischaemia-evoked control current from 5 cells in slices treated with
AP5 and from all 179 control cells, n=179) and the current with AP5 (n=5) shows little
difference between them. B Comparison between the averaged time course of the
ischaemia-evoked current from 5 cells in slices treated with AP5 and from 3
interleaved control cells (studied on the same day as application of AP5) shows little
difference between them. Ischaemia starts at t=0.
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Figure 4.5
Comparison of the mean values for the peak of the ischaemia-induced inward current
(measured for each cell and then averaged over all cells in the same condition), for
control cells and for cells with either NBQX (25 µM) or AP5 (200 µM) applied alone,
shows that these blockers did not significantly affect the size of the current. A
Comparison between the average peak current from all 179 control cells and from 10
cells in NBQX and 5 cells in AP5 shows no significant effect of the blockers.
B Comparison between the average peak current in 10 cells in NBQX and in 11
interleaved control cells (studied on the same day as NBQX). C Comparison between
the average peak current in 5 cells studied in AP5 and in 3 interleaved control cells
shows no significant effect of the blocker.
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Figure 4.6
The metabotropic glutamate receptor blocker, MCPG (1 mM), significantly reduced
the ischaemia-induced current in oligodendrocytes. A Comparison between the
average time course of the ischaemia-evoked current in 6 cells studied with MCPG
and in all 179 control cells shows a significant decrease of the current when the
blocker was applied. B Comparison between the average time course of the ischaemia-
evoked current in 6 cells studied with MCPG and in 6 interleaved control cells
(studied on the same day as MCPG) shows a significant decrease of the current when
the blocker was applied. Ischaemia starts at t=0. * indicates statistically significant
difference at the time point indicated (p<0.05).
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Figure 4.7
MCPG (1 mM) significantly blocks the ischaemia-induced current in
oligodendrocytes. A Comparison of the mean values for the peak of the ischaemia-
induced inward current (measured for each cell and then averaged over all cells in the
same condition), for all 179 control cells and for 6 cells with MCPG present shows a
significant decrease of the current when the blocker was applied. B Comparison
between the average peak current in 6 cells with MCPG and in 6 interleaved control
cells (studied on the same day as MCPG) shows a significant decrease of the current
when the blocker was applied.
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Figure 4.8
Preloading with the Na+-dependent glutamate transporter antagonist, PDC (1 mM),
significantly reduces the ischaemia-induced current in oligodendrocytes. A
Comparison between the averaged time course of the ischaemia-evoked current from 5
cells in slices preloaded with PDC and from all 179 control cells shows a significant
decrease of the current amplitude when the slice was preloaded with the antagonist. B
Comparison between the averaged time course of the ischaemia-evoked current in 5
cells studied with PDC-preloading and in 7 interleaved control cells (i.e. recorded on
the same day) also shows a significant decrease of the current when the slice was
preloaded with the antagonist. Ischaemia starts at t=0. * indicates statistically
significant difference at the time point indicated (p<0.05).
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Figure 4.9
The peak ischaemia-induced current is reduced by preloading with the glutamate
transport blocker PDC (1 mM). A Comparing the average value of the peak of the
ischaemia-induced current in all 179 control cells, and the average peak current in 5
cells in slices preloaded with PDC (n=5) shows a significant decrease of the current
amplitude when the cells were preloaded with the antagonist. B Comparing the
average peak ischaemia-induced control current in 7 control cells interleaved with 5
cells in slices preloaded with PDC also shows a significant decrease of the current
when the cells were preloaded with the antagonist.
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Figure 4.10
Effect of the NKCC1 co-transporter blocker, bumetanide (50 µM), on the ischaemia-
induced current in oligodendrocytes. A Averaged time course of the ischaemia-evoked
control current from all 179 control cells and from 10 cells in slices treated with
bumetanide. B Averaged time course of the ischaemia-evoked current in 10 cells in
slices treated with bumetanide and in 10 control cells interleaved with the bumetanide-
treated cells. Ischaemia starts at t=0. * indicates statistically significant difference at
the time point indicated (p<0.05).
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Figure 4.11
Effect of the voltage-gated calcium channel blocker cadmium (Cd2+, 100 µM) which
blocks exocytosis, on the ischaemia-induced current in oligodendrocytes. A Averaged
time course of the ischaemia-evoked current from all 179 control cells and from 13
cells in slices treated with Cd2+. B Averaged time course of the ischaemia-evoked
current in 13 cells in Cd2+ and in 8 interleaved control cells. Ischaemia starts at t=0.
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Figure 4.12
Effect of the cystine-glutamate exchanger (XC-) blocker, CPG (50 µM) on the
ischaemia-induced current in oligodendrocytes. A Averaged time course of the
ischaemia-evoked current in all 179 control cells, and in 5 cells from CPG-treated
slices. B Averaged time course of the ischaemia-evoked current in 5 cells from slices
treated with CPG and in 4 interleaved control cells. Ischaemia starts at t=0.
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Figure 4.13
Comparison of the mean values for the peak of the ischaemia-induced inward current
(measured for each cell and then averaged over all cells in the same condition) for all
the 179 control cells and for cells with the different blockers applied shows that
bumetanide (50 µM), Cd2+ (100 µM) and CPG (100 µM) had no effect on the peak
ischaemia-evoked current.
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Figure 4.14
Comparison of the mean value for the peak of the ischaemia-induced inward current
(measured for each cell and then averaged over all cells in the same condition) in the
presence of various candidate drugs to block glutamate release and in interleaved
control cells studied on the same day as each drug was studied. The blockers used
were bumetanide (50 µM), Cd2+ (100 µM) and CPG (100 µM). A Comparison
between the average peak current in 10 cells studied in bumetanide-treated slices and
in 10 interleaved control cells shows no significant effect of the blocker.
B Comparison between the average peak current in 13 cells studied in Cd2+ and in 8
interleaved control cells shows no significant effect of the blocker. C Comparison
between the average peak current in 5 cells studied in CPG and in 4 interleaved
control cells shows no significant effect of the blocker.
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Figure 4.15
Effect of the gap junctional hemichannel blocker, lanthanum (100 µM) on the
ischaemia-induced current in oligodendrocytes. A Averaged time courses of the
ischaemia-evoked current in 11 cells from slices treated with La3+ and in all 179
control cells. B Averaged time courses of the ischaemia-evoked current in 11 cells
from slices treated with La3+ and in 12 interleaved control cells (studied on the same
day as La3+). Both graphs show a late recovery of the current with the hemichannel
blocker present that is absent in the control cells’ current. Ischaemia starts at t=0. *
indicates statistically significant difference at the time point indicated (p<0.05).
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Figure 4.16
Effect of the P2X7 receptor blocker, BBG (10 µM) on the ischaemia-induced current
in oligodendrocytes. A Averaged time courses of the ischaemia-evoked current in 6
cells with BBG present and in all 179 control cells show that the current with BBG
reaches an early peak and then shows a tendency to recovery which is not seen in the
control current. B Averaged time courses of the ischaemia-evoked current in 6 cells
with BBG and in 7 interleaved control cells (studied on the same day as BBG).
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Figure 4.17
Effect of the gap junctional hemichannel blocker La3+ (100 µM) and the P2X7 receptor
blocker BBG (10 µM) on the peak ischaemia-evoked current (measured in each cell
and then averaged across cells). A Average peak ischaemia-induced current in all 179
control cells, in 11 cells in the presence of La3+, and in 6 cells in BBG. B Average peak
ischaemia-induced current in 11 cells studied with La3+ and in 12 interleaved control
cells. C Average peak ischaemia-induced current in 6 cells studied with BBG and in 7
interleaved control cells.
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Figure 4.18
Effect of the ASIC blocker amiloride (100 µM) on the ischaemia-induced current in
oligodendrocytes. A Averaged time courses of the ischaemia-evoked current in 6 cells
studied with amiloride and in all 179 control cells. B Averaged time courses of the
ischaemia-evoked current in 6 cells studied with amiloride and in 8 interleaved control
cells studied on the same day as amiloride. Ischaemia starts at t=0.
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Figure 4.19
Effect of the action potential blocker TTX (1 µM) on the ischaemia-induced current in
oligodendrocytes. A Averaged time courses of the ischaemia-evoked current in 13
cells studied with TTX and in all 179 control cells. B Averaged time courses of the
ischaemia-evoked current in 13 cells studied with amiloride and in 10 interleaved
control cells studied on the same day as TTX. Ischaemia starts at t=0.
time (sec from start of ischaemia)
-200 0 200 400 600 800
cu
rr
en
t(
pA
)
-250
-200
-150
-100
-50
0
50
all control cells
bicuculline
-50
0
50
interleaved control cells
bicuculline
A
B
ischaemia
ischaemia
time (sec from start of ischaemia)
-200 0 200 400 600 800
cu
rr
en
t(
pA
)
-250
-200
-150
-100
168
Figure 4.20
Effect of the GABAA receptor blocker bicuculline (100 µM) on the ischaemia-induced
current in oligodendrocytes. A Averaged time courses of the ischaemia-evoked current
in 5 cells studied with bicuculline and in all 179 control cells. B Averaged time
courses of the ischaemia-evoked control current in 5 cells studied with bicuculline and
in 4 interleaved control cells studied on the same day as bicuculline. Ischaemia starts
at t=0.
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Figure 4.21
Comparison of the mean peak ischaemia-induced inward current of all 179 control
cells with the mean peak current with the blockers applied shows that amiloride
(100 µM), TTX (1 µM) and bicuculline (100 µM) had no effect on the size of the peak
of the ischaemic response.
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Figure 4.22
Comparison of the mean peak ischaemia-induced inward current in interleaved control
cells (studied on the same day as the blockers) with the peak current evoked in the
blockers shows that amiloride (100 µM), TTX (1 µM) and bicuculline (100 µM) had
no effect on the size of the peak ischaemia-evoked current. A Average peak ischaemia-
induced current in 6 cells in amiloride and in 6 interleaved control cells. B Average
peak ischaemia-induced current in 13 cells studied with TTX and in 10 interleaved
control cells. C Averaged peak ischaemia-induced current in 5 cells studied in
bicuculline and in 4 interleaved control cells.
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Figure 4.23
The AMPA/KA receptor blocker NBQX (25 µM) and NMDA receptor blocker AP5
(50 µM) do not block the ischaemia-induced current in oligodendrocytes once it has
started. NBQX and AP5 were applied ~3.5 min after the start of ischaemia. A
Averaged time courses of the ischaemia-evoked current in 6 cells to which NBQX and
AP5 were applied ~3.5 min after the start of ischaemia and in all 179 control cells. B
Averaged time courses of the ischaemia-evoked current in 6 cells to which NBQX and
AP5 were applied ~3.5 min after the start of ischaemia and in 4 interleaved control
cells. Ischaemia starts at t=0.
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Figure 4.24
Comparison of the averaged peak ischaemia-induced current in control cells and in
cells with NBQX (25 µM) and AP5 (50 µM) applied ~3.5 min after the start of
ischaemia shows that the ionotropic receptor blockers had no effect on the peak
response. A Average peak of the ischaemia-induced current in 6 cells to which NBQX
and AP5 were applied after the start of ischaemia and in all 179 controls cells. B
Average peak ischaemia-induced current in 6 cells to which NBQX and AP5 were
applied ~3.5 min after the start of ischaemia and in 5 interleaved control cells studied
on the same day.
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Figure 4.25
The extended neuronal depolarization (END) blocker, gadolinium (100 µM), when
applied from ~4 min after the start of ischaemia, does not block the ischaemia-induced
current in oligodendrocytes. A Averaged time course of the ischaemia-evoked current
in 3 cells studied with Gd3+ applied from ~4 min after the start of ischaemia and in all
179 control cells. B Averaged time course of the ischaemia-evoked current in 3 cells
studied with Gd3+ applied from ~4 min after the start of ischaemia and in 3 interleaved
control cells studied on the same day. Ischaemia starts at t=0.
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Figure 4.26
The extended neuronal depolarization (END) blocker, gadolinium (100 µM), when
applied throughout ischaemia, does not block the ischaemia-induced current in
oligodendrocytes. A Averaged time courses of the ischaemia-evoked current from 7
cells in Gd3+ and in all 179 control cells. B Averaged time courses of the ischaemia-
evoked current in 7 cells in Gd3+ and in 6 interleaved control cells studied on the same
day as Gd3+. Ischaemia starts at t=0.
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Figure 4.27
The omission of calcium (with 50 µM EGTA added to bind trace calcium) throughout
ischaemia, which blocks the extended neuronal depolarization in neurons, does not
block the ischaemia-induced current in oligodendrocytes. A Averaged time courses of
the ischaemia-evoked current in 6 cells in zero Ca2+ external solution and in all 179
control cells. B Averaged time courses of the ischaemia-evoked current in 6 cells in
zero Ca2+ external solution and in 10 interleaved control cells studied on the same day
as the omission of Ca2+. Ischaemia starts at t=0.
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Figure 4.28
Average peak ischaemia-induced inward current for all 179 control cells and for 3
cells studied with Gd3+ present from ~4 min after the start of ischaemia, 7 cells studied
with Gd3+ present throughout ischaemia and 6 cells studied in the absence of
extracellular Ca2+ throughout ischaemia.
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Figure 4.29
Comparing the peak ischaemia-induced inward current for manipulations that block
the END and for interleaved control cells shows that Gd3+ (100 µM) applied after the
start or throughout ischaemia, as well as the omission of extracellular Ca2+ throughout
ischaemia (with EGTA, 50 µM), had no significant effect on the size of the peak
ischaemia-evoked current. A Average peak ischaemia-induced current in 3 cells with
Gd3+ applied ~4 min after the start of ischaemia and in 3 interleaved control cells.
B Average peak ischaemia-induced current in 7 cells with Gd3+ present throughout
ischaemia and in 6 interleaved control cells. C Average peak ischaemia-induced
current in 6 cells recorded in zero external calcium solution throughout ischaemia and
in 10 interleaved control cells.
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Chapter 5: Oligodendroglial and neuronal electrical
responses
to NAA and NAAG
5.1 Introduction
Elevations of the levels of N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-
aspartate (NAA) are associated with myelin loss in the leukodystophies Canavan
disease (CD) and Pelizaeus-Merzbacher-like Disease (PMLD) which, respectively, are
caused by mutations in the genes for aspartoacylase (which converts NAA into
aspartate and acetate: see Fig 1.16) and – in some cases of PMLD - by mutations in the
gene for a gap junctional protein, Cx47 (which makes heterologous gap junctions with
astrocytes; Pastor et al., 1998; Orthmann-Murphy et al., 2008). As reviewed in Chapter
1, NAAG and NAA have been reported to activate and antagonise neuronal NMDA
receptors (Westbrook et al., 1986; Sekiguchi et al., 1992; Burlina et al., 1994; Koenig
et al., 1994; Valivullah et al., 1994; Rubinet al., 1995; Pliss et al., 2000; Bergeron et
al., 2005), as well as to act on metabotropic glutamate receptors (NAAG acts on group
II mGluRs (Wroblewska et al., 1997; 1998), while NAA activates an unknown class of
mGluRs to evoke a membrane current (Yan et al., 2003)). Oligodendrocytes and their
precursors have recently been shown to express NMDA receptors, the activation of
which in ischaemia leads to the death of oligodendrocyte precursors and the loss of
myelin (Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al., 2006). This raises
the possibility that the failure to develop myelin (dysmyelination) or the loss of already
formed myelin (demyelination) occurring in the leukodystrophies could reflect an
action of NAAG or NAA on oligodendrocyte NMDA receptors.
To examine this possibility, I performed electrophysiological recordings from
mature oligodendrocytes in the cerebellar white matter and compared their responses to
NAA and NAAG with those evoked in neurons (cerebellar granule cells). I wanted to
characterise the oligodendrocyte and neuron membrane current responses to NAAG
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and NAA, determine which receptor is responsible for any evoked current detected, and
ascertain whether any current generated in oligodendrocytes reflects a direct action of
NAAG and NAA on oligodendrocyte receptors or an indirect action mediated by
neurons. Since the actions of NAA and NAAG on NMDA receptors have been reported
at relatively high concentrations (Westbrook et al., 1986; Valivullah et al., 1994; Rubin
et al., 1995), a specific aim was to determine whether responses were evoked by
pathologically-relevant concentrations of these substances, as are measured to occur in
Canavan disease and Pelizaeus-Merzbacher-like disease.
5.2 Materials and methods
5.2.1 Brain slice preparation
Cerebellar slices were prepared from P12 rats as described in section 2.1. Slices
were immersed and patch clamped in a HEPES-based solution (described in section
2.2.1) at room temperature with a flow rate of 2-4 ml/min. Usually MgCl2 was omitted
from the solution, and glycine (100 µM, to ensure activation of the glycine site of
NMDA receptors) and strychnine (5 µM, to block glycine-gated chloride channels)
were added. A single set of experiments, shown in Fig. 5.11, was performed in
physiological (1 mM) Mg2+ and with no added glycine. NAA and NAAG were from
Tocris, UK. HPLC data supplied by Tocris showed that 1 mM NAAG contained less
than 0.2 µM contaminating glutamate.
5.2.2 Patch-clamping
White matter oligodendrocytes and cerebellar granule cells were identified (as
described in section 2.5), and whole-cell patch-clamped (as described in section 2.6).
Pipettes contained Cs+-based internal solution (see Table 2.1) to provide a better
voltage-clamp quality. Series resistance was 10-30 MΩ, and was not compensated. The 
membrane potential was held at -74 mV (including the junction potential of -14 mV). 
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5.2.3 Statistics
Data are presented as mean + s.e.m. P values are from Student’s 2-tailed t-tests.
5.3 Results
5.3.1 The effect of NAA and NAAG on oligodendrocyte and granule cell currents
Both NAAG and NAA have been previously described to induce an inward
current in neurons (Westbrook et al., 1986; Yan et al., 2003), and both can activate
neuronal NMDA receptors (Westbrook et al., 1986; Valivullah et al., 1994; Rubin et
al., 1995). It was not known, however, whether these substances can activate the
recently reported oligodendrocyte NMDA receptors that have an unusual subunit
composition (Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al., 2006).
To test if NAAG and NAA can induce a current in oligodendrocytes, I applied
high concentrations of NAAG (1 mM) and NAA (1 mM), and used NMDA (60 µM) as
a positive control. These high concentrations of NAA and NAAG were used to
determine whether there was any possibility of these agonists activating the cells’
NMDA receptors, because earlier work (Westbrook et al., 1986; Valivullah et al., 1994;
Rubin et al., 1995) demonstrated a low potency for these compounds’ action on
neuronal NMDA receptors. NAA, NAAG and NMDA were usually applied in Mg2+-
free solution containing glycine (100 µM) to ensure adequate activation of the
receptors’ glycine/D-serine site (although, at least in the gray matter of the cerebellum,
this site is saturated by endogenously released glycine or D-serine: Billups and Attwell,
2003).
NAAG (1 mM) evoked a significant inward current in oligodendrocytes of
mean amplitude -11.4±1.5 pA, which was 6.1±0.8% of the current evoked by NMDA
(60 M) in the same cells (this mean value also includes data for NMDA in a small
number of cells to which NAA, but not NAAG, was applied). However, NAA evoked
no detectable current (Figs. 5.1A and B). In contrast, in cerebellar granule neurons,
NAAG evoked a current of -37.1±8.3 pA which was 69±15% of the current evoked by
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NMDA in the same cells, and NAA also evoked a small but significant current of -
2.6±0.5 pA (Figs. 5.1C and D).
5.3.2 Pharmacology of the NAAG-evoked current
As mentioned above, in neurons NAAG has been found to be a low-potency
NMDA receptor agonist (Westbrook et al., 1986; Valivullah et al., 1994; Rubin et al.,
1995). However, it was also reported that NAAG is a non-competitive antagonist of
NMDA receptors (Burlina et al., 1994; Yourick et al., 2003; Bergeron et al., 2005;
2007), as well as an agonist for metabotropic glutamate receptor type 3 (mGluR3)
(Wroblewska et al., 1997; 1998). Hence, it is still controversial which receptor is the
main target for NAAG and NAA.
To investigate whether the NAAG-evoked inward current is caused by
activation of NMDA receptors, I applied D-AP5 (100 µM), a selective NMDA receptor
blocker. D-AP5 reversibly blocked the current both in oligodendrocytes (by 76±24%,
Figs. 5.2A and B) and in granule cells (by 108±14%, Figs. 5.2C and D). The
incomplete block of the NAAG-evoked current in oligodendrocytes in Fig. 5.2B
probably reflects the inaccuracies of measuring the very small current evoked by
NAAG in the presence of small baseline current variations.
Since NAAG has also been reported to act on mGluR3 receptors (Wroblewska
et al., 1997; 1998), I tested the effect of EGLU ((2S)-α-ethylglutamic acid), a selective 
blocker of group II mGluR receptors, on the NAAG-evoked current. At a concentration
of 200 µM, i.e. 3 times the Ki value for mGluR3 receptor inhibition (Jane et al., 1996),
EGLU had no effect on the NAAG-evoked current in oligodendrocytes (Figs. 5.3A and
B) and only caused a small (but significant block) in granule cells (Figs. 5.3C and D),
leading to the conclusion that in both cells the current is mostly the result of NAAG
activating NMDA receptors. The possible contribution of mGluR3 receptor activation
to the NAAG-evoked current in granule cells is considered in the Discussion.
To test if the NAA-evoked current in granule cells was also a result of NMDA
receptor activation, I applied D-AP5 (200 µM). This completely blocked the NAA-
evoked current (Fig. 5.4), confirming that this molecule has a low affinity for neuronal
NMDA receptors.
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5.3.3 Part of the oligodendrocyte NAAG response is produced by hydrolysis to
glutamate
Extracellular NAAG, whether generated endogenously or applied exogenously,
can be converted to glutamate by carboxypeptidases II and III on the extracellular
surface of astrocytes (Fig. 1.16; Berger et al., 1999; Bzdega et al., 2004). To test
whether the response of oligodendrocytes to NAAG was generated in part by
secondarily derived glutamate, I blocked these enzymes with 10 µM 2-PMPA (2-
(phosphonomethyl)-pentanedioic acid (Jackson et al., 1996): the IC50 values for
inhibition of GCP II and III are 6.7 and 0.9 nM respectively: Bzdega et al., 2004). This
concentration of 2-PMPA does not significantly block NMDA receptors (Tortella et al.,
2000).
I found an interesting variability in the effect of 2-PMPA. In some
oligodendrocytes (Fig. 5.5A) the NAAG response was unaffected by blocking this
enzyme, suggesting that the NAAG-evoked current was produced by NAAG itself
(because HPLC data provided by Tocris showed that 1 mM NAAG solution contained
less than 0.2 µM contaminating glutamate), while in other cells the enzyme blocker
significantly reduced the response (Fig. 5.5B) implying that part of the response was
produced by conversion of NAAG to glutamate by endogenous carboxypeptidases. On
average, 49±23% of the response was blocked by 2-PMPA (Fig. 5.5C), strongly
suggesting that in part NAAG acts indirectly on oligodendrocytes due to its conversion
to glutamate.
Surprisingly, when 2-PMPA was applied during NAAG-evoked response in
granule cells, there was no significant block of the current (Fig. 5.6). This difference
may stem from the difference in the methodological approach used in these
experiments – in the experiments performed on oligodendrocytes, NAAG was first
applied alone, then NAAG with 2-PMPA, followed by another application of NAAG
alone, while in granule cells 2-PMPA was applied during a continuous NAAG
response. With this protocol desensitisation of the current during the maintained
presence of NAAG (Fig. 5.6A) may make it hard to observe a clear effect of the 2-
PMPA, leading to the block of the current by 2-PMPA being underestimated. To check
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this hypothesis, further experiments using the same method of drug application in both
cell types would be required.
5.3.4 The NAAG response in oligodendrocytes is partly produced by neuronal
action potentials
Superfusion of NAAG (or NMDA) could in principle evoke a current in
oligodendrocytes either by acting directly on oligodendrocyte NMDA receptors, or by
acting on neuronal NMDA receptors to increase neuronal firing and hence increase the
release of factors like K+ from axons which may generate a current in oligodendrocytes.
The large NMDA-evoked current is not significantly affected by TTX (Káradóttir et al.,
2005), suggesting that essentially all of the NMDA-evoked current is generated by a
direct action on oligodendrocytes. However, TTX (1 µM) reduced the NAAG-evoked
current by 76±8% (Figs. 5.7A and B), suggesting that much of the NAAG response is
generated indirectly by NAAG activating neuronal NMDA receptors and increasing
action potential firing (see Discussion). In contrast, TTX did not affect the NMDA-
evoked current in granule cells (Figs. 5.7C and D).
5.3.5 NAAG and NAA are not strong blockers of NMDA receptors
Since the role of NMDA receptors in controlling and maintaining myelination is
not yet known, it seemed possible that a demyelinating action of NAAG or NAA might
occur if these agents blocked NMDA receptors and thus inhibited normal signalling
from axons to oligodendrocytes or their precursors. Block of neuronal NMDA receptors
by NAAG has been reported previously (Burlina et al., 1994; Bergeron et al., 2005;
2007).
However, when NAAG (1 mM) or NAA (1 mM) were applied during the
response to NMDA in white matter oligodendrocytes, any reduction in the NMDA-
evoked current they produced was small compared to the reduction occurring anyway
as a result of receptor desensitisation (Fig. 5.8; the reduction of the response by
NAAG/NAA was estimated by fitting a straight line to the desensitisation, and
measuring the actual current at the end of the NAAG/NAA application relative to the
interpolated value that would occur without NAAG/NAA). In some granule cells both
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NAA and NAAG produced a small reduction of the NMDA-evoked current (Figs. 5.9A
and B), but in others the reduction was minimal (the mean reduction is shown in Fig.
5.9C). Thus, even using 1 mM NAAG or NAA produced much less inhibition of the
oligodendrocyte or granule cell NMDA response than the 80% block reported to be
produced by NAAG concentrations above 20 µM in hippocampal pyramidal neurons
(Bergeron et al., 2005).
5.3.6 The effect of pathologically relevant levels of NAAG
In Canavan disease the extracellular NAA concentration (assessed in the CSF)
rises from its baseline value of ~1.5-100 µM (Jakobs et al., 1991; Sager et al., 1997;
Chakraborty et al., 2001) to ~0.4-0.9 mM (Wevers et al., 1995; Burlina et al., 1999),
i.e. less than the 1 mM concentration we have applied which produces no effect on
oligodendrocytes, and the NAAG level rises from its normal value of 1-10 µM to
~20 µM (Burlina et al., 1999). In Pelizaeus-Merzbacher-like disease the NAAG
concentration has been reported to rise to ~50 µM (Sartori et al., 2008) or ~200 µM
(Wolf et al., 2004). I therefore tested the effect of 50 and 200 µM NAAG on the
membrane current of oligodendrocytes and granule cells. In both oligodendrocytes
(Figs. 5.10A and B) and granule cells (Figs. 5.10C and D) 50 µM NAAG produced a
barely detectable current, while 200 µM NAAG evoked a significant current in 0 mM
Mg2+ (in oligodendrocytes this measured -4.5±1.0 pA). NAAG (200 µM and 1 mM)
also evoked a detectable current in some oligodendrocytes in the presence of
physiological (1 mM) Mg2+ concentration (Fig. 5.11).
5.4 Discussion
The levels of NAA and NAAG rise in several leukodystrophies, and these
agents have previously been shown to activate neuronal NMDA receptors. My data
show, for the first time, that the rise of NAAG concentration occurring in the
leukodystrophies should also evoke a small membrane current in oligodendrocytes.
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The NAAG-evoked current, in both cerebellar granule cells and
oligodendrocytes, was largely blocked by D-AP5 and was also blocked to a small
extent by a blocker of mGluR3 receptors in granule cells, showing that the current is
produced mainly by activation of NMDA receptors. However, my data show that
NAAG and NAA have less effect on the type of NMDA receptor that generates the
current in oligodendrocytes than on the NMDA receptors in granule cells, presumably
because the oligodendrocyte receptors have a different subunit composition (Káradóttir
et al., 2005; Salter and Fern, 2005; Micu et al., 2006). Thus, in granule cells 1 mM
NAAG evokes a current which is about 3/4 the size of that evoked by 60 µM NMDA,
and 1 mM NAA evokes a detectable current, while in oligodendrocytes the NAAG-
evoked current is only about 7% of the NMDA-evoked current, and NAA does not
evoke a detectable current (Fig. 5.1).
The small effect exerted on the NAAG-evoked current by the mGluR3 receptor
blocker EGLU in granule cells suggests a possible contribution of mGluRs to
generating this current. It was shown before that activation of group II mGluR receptors
causes a block of calcium channels (Chavis et al., 1995), as well as an opening of
potassium channels (Benarroch, 2008) and of non-specific cation channels (Guérineau
et al., 1995). Opening of non-specific cation channels would result in an inward current
upon NAAG application and so could possibly explain the partial block of the NAAG-
evoked current by the mGluR3 receptor blocker.
The potency of NAAG at oligodendrocyte NMDA receptors is even less than is
suggested by inspection of Fig. 5.1, because a significant fraction of the NAAG
response in oligodendrocytes is generated indirectly. A major part of the response is
blocked by TTX (Fig. 5.7), and so presumably reflects NAAG acting on neuronal
NMDA receptors to increase neuronal firing, which then releases a substance, perhaps
K+, which generates an inward current in the oligodendrocytes. Blocking
carboxypeptidases also reduced the response to NAAG in oligodendrocytes (Fig. 5.5),
implying that part of the NAAG-evoked current is generated by NAAG being
converted to glutamate (see Fig. 1.16), and this will presumably also be the case for
endogenously generated NAAG. Surprisingly, the blocker of carboxypeptidases had no
effect on the NAAG-evoked current in granule cells – however, this lack of effect may
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be explained by a difference in the methodological approach applied in this experiment
(see section 5.3.3) and requires further investigation.
When assessing the effect of the pathologically-relevant concentrations of
NAAG reported in Pelizeus-Merzbacher-like disease (Wolf et al., 2004; Sager et al.,
1997), NAAG evoked a statistically significant current at a concentration of 200 µM,
but only when no external magnesium was present (which removes the NMDA receptor
channel block; compare Figs. 5.10 A,B and 5.11), while 1 mM NAA did not evoke a
detectable current even in the absence of Mg2+. These results suggest a very low
affinity of NAAG and NAA for oligodendrocyte NMDA receptors, and thus very much
lower the possibility of pathological consequences arising from these substances having
a direct effect on oligodendrocytes.
In summary, I have tested the hypothesis that the elevation of NAAG and NAA
concentrations that occurs in the leukodystrophies might damage oligodendrocytes by
acting on oligodendrocyte NMDA receptors. My results show that NAAG evokes an
inward current both in oligodendrocytes and granule cells, however, it is a much less
effective agonist at oligodendrocyte NMDA receptors than at neuronal NMDA
receptors, and the small current generated in oligodendrocytes by NAAG largely
reflects a secondary consequence of its activation of neuronal NMDA receptors. Thus,
if the elevation of NAAG concentration in the leukodystrophies causes white matter
damage, this will most likely be initiated by a change of neuronal activity, not by acting
on oligodendrocyte NMDA receptors. To further investigate the effect of NAAG and
NAA on oligodendrocyte physiology, calcium-imaging and a cell death assay were
employed, as described in Chapter 6.
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Figure 5.1
NAAG, NAA and NMDA-evoked whole cell currents at -74 mV in white matter
oligodendrocytes and cerebellar granule cells. A Representative trace shows the
current response to NAAG (1 mM), NAA (1 mM) and NMDA (60 µM) in a single
oligodendrocyte. B Average responses to NAAG (1 mM, n=20 cells), NAA (1 mM,
n=5) and NMDA (60 µM, n=12) in oligodendrocytes. C Representative trace shows
the response to NAAG (1 mM), NAA (1 mM) and NMDA (60 µM) in a single granule
cell. D Average responses to NAAG (1 mM, n=14 cells), NAA (1 mM, n=14) and
NMDA (60 µM, n=13) in granule cells. P values compare with no response. All
responses in this chapter are in 0 mM Mg2+ solution, apart from those in Fig. 5.11.
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Figure 5.2
The NMDA receptor blocker, D-AP5 (100 mM), significantly reduces the
oligodendrocyte response to NAAG. A Representative trace shows the response to
NAAG (1 mM) and block of the response by AP5 (100 µM) in a white matter
oligodendrocyte (dashed line shows the current baseline). B Mean effect on the
NAAG response of AP5 in 10 white matter oligodendrocytes (dashed line shows the
current baseline). The 2nd and 3rd bars are normalised to the initial NAAG response
(as 100%), and show the response to NAAG in the presence of AP5 and the response
to a subsequent application of NAAG alone. P value compares the response in NAAG
+ AP5 to the average of the preceding and subsequent responses without AP5.
C Representative trace shows response to NAAG (1 mM) alone and block of the
response by AP5 (100 µM) in a granule cell. D Mean effect on the NAAG response of
AP5 in 4 granule cells. P values compare the response in AP5 with the average of the
bracketing current values in the absence of AP5.
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Figure 5.3
The metabotropic glutamate receptor type 3 blocker, EGLU, does not block the
NAAG-evoked current in white matter oligodendrocytes, but to a small extent blocks
the current in granule cells. A Representative trace shows the effect of EGLU
(200 µM) on the response to 1 mM NAAG in a white matter oligodendrocyte (dashed
line shows the current baseline). B Mean effect of EGLU on the response to NAAG in
3 white matter oligodendrocytes. C Representative trace shows effect of EGLU (200
µM) on the response to 1 mM NAAG in a granule cell (dashed line shows the current
baseline). D Mean effect of EGLU on the response to NAAG in 4 granule cells.
Response in EGLU was measured at the end of EGLU application, and response to
NAAG after EGLU was measured at the end of NAAG application. The 2nd and 3rd
bars are normalised to the initial NAAG response (as 100%), and show the response to
NAAG in the presence of EGLU and the response to a subsequent application of
NAAG alone. P values compare the response in EGLU with the average of the
bracketing current values in the absence of EGLU.
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Figure 5.4
The NMDA receptor blocker, AP5, significantly blocked the response to NAA in
cerebellar granule cells. A Representative trace shows response to NAA (1 mM) alone
and block of the response by AP5 (100 µM) in a granule cell (dashed line shows the
current baseline). B Mean effect on the response to NAA of AP5 in 3 granule cells.
The initial response to NAA was measured just before the NAA + AP5 application,
response in AP5 was measured at the end of NAA + AP5 application, and response to
NAA after AP5 was measured at the end of NAA application. The 2nd and 3rd bars are
normalised to the initial NAA response (as 100%), and show the response to NAA in
the presence of AP5 and the response to a subsequent application of NAA alone. P
value compares the response in NAA + AP5 to the average of the preceding and
subsequent current values without AP5.
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Figure 5.5
The effect of blocking carboxypeptidases on the NAAG-evoked current at -74 mV in
white matter oligodendrocytes. A Specimen trace showing a cell where the
carboxypeptidase blocker 2-PMPA (10 mM) had no effect on the NAAG-evoked
current. B Specimen trace showing a cell where 2-PMPA reduced the NAAG-evoked
current. C Mean effect of 2-PMPA on the NAAG-evoked current in 7 cells. The 2nd
and 3rd bars are normalised to the initial NAAG response (as 100%), and show the
response to NAAG in the presence of 2-PMPA and the response to a subsequent
application of NAAG alone. P value compares the response in 2-PMPA to the average
of bracketing responses without 2-PMPA.
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Figure 5.6
The carboxypeptidase blocker 2-PMPA does not significantly block the NAAG-
evoked current at -74 mV in cerebellar granule cells. A Representative trace shows the
response to NAAG (1 mM) and effect on the response of 2-PMPA (10 µM) in a single
granule cell (dashed line shows the current baseline). B Mean effect on the response to
NAAG of 2-PMPA in 3 granule cells. The initial response to NAAG was taken as the
current value just before the 2-PMPA was applied; the response in 2-PMPA was taken
as the current value at the end of 2-PMPA application; the second response to NAAG
was taken as the current at the end of the application of NAAG (after the 2-PMPA).
The 2nd and 3rd bars are normalised to the initial NAAG response (as 100%), and
show the response to NAAG in the presence of 2-PMPA and the response to a
subsequent application of NAAG alone. P value compares the current in NAAG + 2-
PMPA with the average of the bracketing current values in NAAG alone.
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Figure 5.7
The action potential blocker, TTX, partially blocks the NAAG-evoked current at -
74 mV in white matter oligodendrocytes, but has no effect on the current in cerebellar
granule cells. A Representative trace shows effect of TTX (1 µM) on the response
evoked by 1 mM NAAG in a white matter oligodendrocyte (dashed line shows the
current baseline). B Mean effect of TTX on the response to NAAG in 8 white matter
oligodendrocytes. C Representative trace shows effect of TTX (1 µM) on the response
to 1 mM NAAG in a granule cell (dashed line shows the current baseline). D Mean
effect of TTX on the response to NAAG in 4 granule cells. The initial response to
NAAG was measured just before the NAAG + TTX application, response in TTX was
measured at the end of NAAG + TTX application, and response to NAAG after TTX
was measured at the end of NAAG application. The 2nd and 3rd bars are normalised
to the initial NAAG response (as 100%), and show the response to NAAG in the
presence of TTX and the response to a subsequent application of NAAG alone. P
values show the response in TTX compared to the average of the bracketing current
values without TTX.
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Figure 5.8
Test of block of the NMDA-evoked current at -74 mV by NAAG and NAA in white
matter oligodendrocytes. A Representative trace shows block by NAAG (1 mM) of the
response to 60 µM NMDA in an oligodendrocyte (dashed line shows the current
baseline, i.e. current during NMDA application). B Representative trace shows block
by NAA (1 mM) of the response to 60 µM NMDA in an oligodendrocyte (dashed line
shows the current baseline, i.e. current during NMDA application). C Mean effect of
NAAG (5 cells) and NAA (3 cells) on the NMDA-evoked current, calculated
assuming for simplicity that desensitization of the NMDA-evoked current follows a
linear time course (dashed lines in A and B: the NMDA-evoked current at the end of
the NAAG or NAA application was divided by the interpolated current predicted
assuming linear desensitization). P values assess the reduction in current compared
with no reduction from 100%.
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Figure 5.9
Test of block of the NMDA-evoked current at -74 mV by NAAG and NAA in
cerebellar granule cells. A Representative trace shows block by NAAG (1 mM) of the
response to 60 µM NMDA in a granule cell (dashed line shows the current baseline,
i.e. current during NMDA application). B Representative trace shows block by NAA
(1 mM) of the response to 60 µM NMDA in a granule cell (dashed line shows the
current baseline, i.e. current during NMDA application). C Mean effect of NAAG (9
cells) and NAA (5 cells) on the NMDA-evoked current, calculated assuming for
simplicity that desensitization of the NMDA-evoked current follows a linear time
course (dashed lines in A and B: the NMDA-evoked current at the end of the NAAG
or NAA application was divided by the interpolated current predicted assuming linear
desensitization). P values assess the reduction in current compared with no reduction
from 100%.
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Figure 5.10
The current response of white matter oligodendrocytes and cerebellar granule cells to
pathologically relevant concentrations of NAAG, 50 µM, 200 µM and 1 mM, in 0 mM
Mg2+ solution. A Representative responses to 50 µM, 200 µM and 1 mM NAAG in a
white matter oligodendrocyte. Vertical lines on trace are the response to voltage steps
applied to monitor series resistance. B Mean responses to 50 µM, 200 µM and 1 mM
NAAG in 7, 9 and 25 (respectively) white matter oligodendrocytes. C Representative
responses to 50 µM, 200 µM and 1 mM NAAG in a granule cell. D Mean responses to
50 µM, 200 µM and 1 mM NAAG in 3, 4 and 7 (respectively) cerebellar granule cells.
All p values are for comparison with zero response.
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Figure 5.11
The current response of white matter oligodendrocytes to pathologically relevant
concentrations of NAAG, 200 µM and 1 mM, in 1 mM Mg2+ solution with no added
glycine. A Representative responses to 200 µM and 1 mM NAAG in a single
oligodendrocyte. B Mean response to 200 µM and 1 mM NAAG in 10 white matter
oligodendrocytes. The p values are for comparison with zero response.
198
Chapter 6: Oligodendroglial and neuronal [Ca2+]i changes
in response to NAA and NAAG
6.1 Introduction
The intracellular calcium concentration rise that occurs upon opening of
calcium-permeable channels or receptors, or after calcium release from the internal
stores, can affect cell physiology by regulating processes ranging from transcription to
neurotransmitter release. An excessive calcium influx is detrimental to the cell due to
the activation of calcium-dependent proteases, lipases and endonucleases, and the
induction of cell apoptosis. Oligodendrocyte NMDA receptors are assumed to be
calcium-permeable and their overactivation in ischaemia leads to cell damage and
death (Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al., 2006). I showed in the
previous chapter that high concentrations of NAAG evoke an inward current in both
oligodendrocytes and neurons (and NAA evokes a small but significant current in
neurons), by acting on their NMDA receptors. It is possible that these electrical
changes are associated with a calcium influx into the cells, and that overactivation of
NMDA receptors by NAAG in the leukodystrophies causes a calcium influx which,
over a long period, might lead to death of the oligodendrocytes and a loss of myelin.
To investigate this, I recorded changes of intracellular calcium concentration in
the white and grey matter of brain slices (loaded with the acetoxymethyl ester version
of a calcium-sensing dye), determining whether they result solely from NMDA
receptor activation or from an additional action on mGluR3 receptors (the activation of
which might induce cellular responses undetected by electrical recordings, such as
calcium release from the intracellular stores). I then whole-cell patch-clamped single
oligodendrocytes or neurons, filling them with a calcium-sensing dye to simultaneously
record the current and intracellular calcium changes. Finally, I performed a cell-death
assay to examine if any [Ca2+]i rise or current evoked in oligodendrocytes and neurons
by NAAG might be the cause of myelin loss and cell death in the leukodystrophies.
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6.2 Materials and methods
6.2.1 Brain slice preparation
Cerebellar slices were prepared from P12 rats as described in section 2.1. Slices
were immersed in a HEPES-based solution (described in section 2.2.1) at room
temperature with a flow rate of 2-4 ml/min. Usually MgCl2 was omitted from the
solution, and glycine (100 µM, to ensure activation of the glycine site of NMDA
receptors) and strychnine (5 µM, to block glycine-gated chloride channels) were added.
A single experiment, described in section 6.3.5, was performed using a physiological
concentration of Mg2+ (1 mM) and with no added glycine.
6.2.2 Patch-clamping
White matter oligodendrocytes and cerebellar granule cells were identified (as
described in section 2.5), and whole-cell patch-clamped (as described in section 2.6).
Pipettes contained Cs+-based internal solution (see Table 2.1) to provide better voltage-
clamp quality. The series resistance was 10-30 MΩ, and was not compensated. The 
membrane potential was held at -74 mV (including the junction potential of -14 mV).
6.2.3 [Ca2+]i imaging with Fluo-4-AM
Slices were loaded with the acetomethoxy ester of Fluo-4 (Fluo-4-AM) by
incubating slices for 2 h in a 10 µM solution of Fluo-4-AM (for the preparation of the
solution, see section 2.9.1). 95% O2/5% CO2 solution was blown gently over the
solution while loading. Fluorescence was excited at 488 nm and emitted light was
collected at 535 nm. Regions of interest in the white and grey matter were identified
from the morphology and anatomy of the slice. For slices that were not loaded with dye
the baseline fluorescence was 2.99-fold lower for white matter and 3.37-fold lower for
grey matter (comparing 12 loaded and 3 unloaded slices) and there was a negligible
fluorescence (F) change in response to 1 mM NAAG (ΔF/F = -0.00146+0.00146 in 3
unloaded slices, compared to 0.03611+0.0095 in 12 loaded slices as described below).
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6.2.4 Single cell [Ca2+]i imaging
White matter oligodendrocytes and grey matter granule cells were patch-
clamped with pipettes containing a Cs+-based solution including mM of the calcium
dye Fura-2 (see Table 2.1). Fluorescence was excited sequentially at 340 nm and
380 nm, and emitted light was collected at 510 nm. The ratio of the emission intensities
(340 nm/380 nm) was used as a measure of increased [Ca2+]i, and only cells exhibiting
both a decrease of fluorescence excited at 380 nm and an increase in fluorescence
excited at 340 nm were used.
6.2.5 Cell death assay
Slices were bathed in a HEPES-buffered solution (see section 2.2.1) containing
1 mM NAAG, or 1 mM NAAG and 100 µM AP5, or 100 µM NMDA, or no added
drug, at 36ºC for 6 h. Propidium iodide (PI, Sigma, 37 µM) was added to reveal a loss
of membrane permeability associated with cell death (see section 2.10), as might be
expected to occur when oligodendrocytes lose their myelinating processes during the
first hour of ischaemia (Salter and Fern, 2005). Slices were then fixed and
immunolabelled for myelin basic protein (MBP) to identify white matter (as described
in section 2.11.1). Mounting solution containing DAPI was used to label nuclei and the
images were acquired using a confocal microscope.
6.2.6 Confocal microscopy
Confocal images of slices were taken using Zeiss LSM 510 inverted
microscope, with a 40x objective (as described in section 2.11.2). Suitable excitation
and emission wavelengths for DAPI, AlexaFluor 488 and PI were used (see Table 2.3).
The white matter was defined as being MBP-positive and grey matter as MBP-negative,
and the percentage of dead cells was calculated as the number of PI-positive cells
divided by the total number of cells with DAPI-labelled nuclei.
6.2.7 Statistics
Data are presented as mean + s.e.m. P values are from Student’s 2-tailed t-tests.
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6.3 Results
6.3.1 Effects of NAAG and NAA on [Ca2+]i in the white matter and grey matter
To determine whether NAAG or NAA raise [Ca2+]i in cells of the white matter,
I initially used the Ca2+-sensitive dye Fluo-4, which was loaded into the cells of
cerebellar slices as its acetoxymethyl ester. Regions of interest were imaged that
included, separately, the white matter and the grey matter (Fig. 6.1A).
In both the white and the grey matter, NAAG and NMDA evoked an increase in
Fluo-4 fluorescence (NAAG: ΔF/F = 0.0361±0.0095 in 12 regions of the white matter, 
ΔF/F = 0.2635±0.0475 in 12 regions of the grey matter; NMDA: ΔF/F = 
0.0888±0.0148 in 10 regions of the white matter, ΔF/F = 0.1942±0.0365 in 10 regions 
of the grey matter) while NAA did not (Figs. 6.1B-D). As for the membrane currents
shown for grey matter granule cells and white matter oligodendrocytes in Chapter 5
(Fig. 5.1), the response to NAAG, relative to that for NMDA, was larger in the grey
matter than in the white matter, which may in part reflect the oligodendrocyte NMDA
receptors having a different subunit composition to those in neurons. Furthermore, in
both areas the ratio of the NAAG response to that for NMDA tended to be larger for the
calcium response than for the current response (NAAG/NMDA = 0.37+0.14 in 9
regions for white matter [Ca2+]i and 0.07+0.01 in 10 cells for oligodendrocyte current,
significantly different: p=0.03; NAAG/NMDA = 1.74+0.57 in 9 regions for grey matter
[Ca2+]i and 0.77+0.24 in 7 cells for granule cell current, not significantly different:
p=0.18). The latter difference might in part be explained by the calcium dye bleaching
and thus exhibiting a decreased sensitivity toward a subsequent agonist which most
often was NMDA applied as a positive control after the NAAG had been applied.
6.3.2 Block of NAAG-evoked [Ca2+]i rise in the white matter and grey matter
To investigate if the activation of NMDA receptors is responsible for the
NAAG-evoked increase in [Ca2+]i, I applied D-AP5 (100 µM). This reduced the [Ca2+]i
rise evoked by NMDA (not shown) and by NAAG (Fig. 6.2). The NAAG-evoked
[Ca2+]i rise was reversibly reduced in the white matter by 78±5% (Fig. 6.2B and C) and
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in the grey matter by 86±4% (Fig. 6.2B and D), confirming that the observed changes
in [Ca2+]i are largely evoked by a calcium influx through NMDA receptors.
To exclude the possibility that mGluR3 receptors provide an additional
contribution to the observed calcium changes by activating calcium-permeable
channels, I applied EGLU (200 µM), the blocker of group II mGluR receptors. There
was no significant block of the NAAG-evoked rise in [Ca2+]i in the white matter (Fig.
6.3B and C), and only a small but significant block in the grey matter (Fig. 6.3B and
D). Note that the strong run down of the [Ca2+]i response on repeated application of
agonists means that the significance of the EGLU effect had to be assessed by
comparing the response in EGLU with the average of bracketing responses to NAAG
without EGLU, and if the run down was not linear with time this could result in an
apparent block of the response by EGLU where one does not in fact exist. However,
this result may also be consistent with the result obtained in the previous chapter (see
section 5.3.2) where the NAAG-evoked current in granule cells (but not in
oligodendrocytes) was slightly reduced by the application of the mGluR3 blocker,
perhaps reflecting the opening of non-specific cation channels which might contribute
to the rise in [Ca2+]i.
6.3.3 The effect of NAAG on [Ca2+]i in oligodendrocytes and granule cells
Although AM-loading of the calcium dye Fluo-4 led to granule cells generating
sufficient fluorescence for their calcium responses to be reliably distinguished from
those generated in surrounding cells, this was not the case for the very fine processes of
oligodendrocytes in the white matter. To determine whether the cells in the white
matter that respond to NAAG with a [Ca2+]i rise are oligodendrocytes, I therefore
patch-clamped cells whose morphology (assessed after Lucifer yellow filling from the
patch pipette) corresponded to mature oligodendrocytes, using pipettes containing the
ratiometric Ca2+-sensitive dye Fura-2. To confirm the results from the experiments in
slices in grey matter, I also patch-clamped granule cells.
In oligodendrocytes, NAAG (1 mM) did not evoke a significant [Ca2+]i rise in
either the cell body or the processes (Fig. 6.4), despite NAAG evoking an inward
current (Fig. 6.4B), and despite spontaneous [Ca2+]i elevations being observed which
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confirmed that the dye was working. Granule cells, however, responded to NAAG
(1 mM) with a statistically significant [Ca2+]i rise (both in their processes and cell body,
Fig. 6.4C and 6.5B) that was blocked by D-AP5 (Fig. 6.5). The implications of these
results are considered in the Discussion.
6.3.4 The effect of pathologically relevant levels of NAAG
As described in Chapter 5 (section 5.3.6), the NAAG concentration in
Pelizaeus-Merzbacher-like disease (PMLD) rises to ~50 µM (Sartori et al., 2008) or
~200 µM (Wolf et al., 2004). These concentrations were shown to evoke significant
currents in granule cells (see section 5.3.6), so to examine if they would also cause a
[Ca2+]i change in granule cells, I patch-clamped cells and filled them with Fura-2 and
then applied 50 µM and 200 µM NAAG (and 1 mM NAAG as a positive control). Only
200 µM NAAG evoked a detectable [Ca2+]i rise (Fig. 6.6).
6.3.5 The effect of NAAG on cell death in white matter and grey matter
As NAAG evokes an inward current in oligodendrocytes of the cerebellar white
matter, and an inward current and [Ca2+]i rise in granule neurons of the grey matter, I
decided to test if a direct effect or an indirect effect (e.g. via granule cells) of this
molecule on oligodendrocytes may lead to their death and hence to the myelin loss
observed in Canavan and Pelizaeus-Merzbacher-like diseases.
I bathed cerebellar slices in extracellular solution containing a physiological
level of Mg2+ (1 mM), along with NAAG (1 mM), NAAG (1 mM) with AP5 (100 µM),
NMDA (100 µM), or no added drug, at 37°C for 6 h. Afterwards, I immunolabelled the
slices with antibody against MBP protein to define the white matter, and with DAPI to
define cell nuclei, and quantified the percentage of dead cells (i.e. the ones that took up
propidium iodide into their soma, divided by the total number of DAPI-labelled nuclei)
in the white matter and the grey matter.
Although NMDA evoked significant death of granule cells in the grey matter
(p=0.004), NAAG did not, and neither NAAG nor NMDA evoked significant cell death
in the white matter (Fig. 6.7). The relevance of these data to the loss of myelin
occurring in the leukodystrophies is discussed below.
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6.4 Discussion
NAA and NAAG are two of the most abundant substances in CNS (Coyle,
1997; Sager et al., 1997; Chakraborty et al., 2001), but their physiological role remains
elusive. NAA is mainly considered to be involved either in myelin formation
(Chakraborty et al., 2001) or in the regulation of cell osmolarity (Baslow, 2003), while
NAAG has been suggested to be a co-transmitter at glutamatergic synapses (Bergeron
et al., 2005; 2007). In two types of leukodystophy – Canavan disease and Pelizaeus-
Merzbacher-like disease – the concentrations of NAA and NAAG are highly elevated,
but their actual role in these diseases is unknown. In this chapter, I tested the possibility
that these substances lead to an excessive influx of calcium into the oligodendrocytes or
neurons, leading to cell damage, myelin loss and cell death.
I showed that cells in both the white and grey matter respond to NAAG, but not
to NAA, with a significant intracellular calcium concentration ([Ca2+]i) rise that can be
largely blocked by NMDA receptor blockers. Blocking mGluR3 receptors, another
candidate for NAAG to act on, did not reduce the NAAG-evoked [Ca2+]i change in the
white matter, but decreased it slightly in the grey matter. This is similar to the result I
obtained in Chapter 5, where I showed that mGluR3 receptors are not responsible for
the NAAG-evoked inward current in oligodendrocytes, but that in granule cells their
activation by NAAG may contribute a small but significant current. The small [Ca2+]i
rise and inward current contributed by NAAG acting on mGluR3 could be explained by
the opening of cation channels downstream of mGluR3.
When calcium changes were recorded in single cells (along with electrical
changes), oligodendrocytes did not respond to 1 mM NAAG, while granule cells
responded to both 1 mM NAAG and to the pathologically-relevant NAAG
concentration of 200 µM (found in PMLD: Wolf et al., 2004). The lack of response of
oligodendrocytes suggests that the rise seen when imaging AM-loaded dyes in the
white matter may reflect a calcium influx into astrocytes (rather than oligodendrocytes)
through their NMDA receptors (Conti et al., 1996; Schipke et al., 2001; Lalo et al.,
2006). Finally, a cell death assay performed for 6 h showed no influence of NAAG on
either oligodendrocyte or granule cell viability.
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NMDA receptors on oligodendrocyte have been suggested to be calcium-
permeable and actively involved in the cells’ response to ischaemic insult, which leads
to myelin loss and cell death (Káradóttir et al., 2005; Salter and Fern, 2005; Micu et al.,
2006). NAAG, which was found to be either an agonist (Westbrook et al., 1986) or an
antagonist (Bergeron et al., 2005; 2007) at NMDA receptor in neurons, in my
experiments evoked calcium responses in cerebellar granule cells, but not in
oligodendrocytes. This result may stem from the fact that much of the oligodendrocyte
response to NAAG, as I show in Chapter 5, is an indirect one, with NAAG acting on
neuronal NMDA receptors. This presumably increases neuronal firing and results in the
release of a secondary substance (e.g. potassium) that induces the inward current in
oligodendrocytes, so that most of the inward current recorded in a single
oligodendrocyte is not associated with a calcium influx. In addition, the NMDA
receptors that have been suggested to exist on oligodendrocyte lineage cells are
suggested to include NR3 subunits (Káradóttir et al., 2005; Salter and Fern, 2005; Micu
et al., 2006), which reduce the Ca2+ permeability of the receptors (Sasaki et al., 2002).
The lack of cell death after 6 h of 1 mM NAAG application was initially
surprising, especially in the case of granule cells which were found to respond to
NAAG with both an inward current and a calcium influx through NMDA receptors.
Conceivably 6 hours is simply not a long enough duration for a small calcium influx to
damage the cells, especially in the absence of any metabolic compromise to inhibit Ca2+
pumping out of the cell. The lack of a large evoked membrane current and [Ca2+]i rise
evoked in oligodendrocytes by NAAG, and the lack of influence of NAAG on
oligodendrocyte survival, make the hypothesis that this molecule contributes to myelin
loss and cell death in Canavan and Pelizaeus-Merzbacher-like diseases much less
probable, but cannot be entirely excluded. Patients with both CD and PMLD display
their symptoms relatively late, around the first year of their life, and so it is possible
that a constant high concentration of NAAG (and NAA) may lead to a slowly-
developing damaging effect on cells which culminates in their damage, and thus
eventually causes the severe demyelination observed in both of the leukodystrophies.
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Figure 6.1
Change in [Ca2+]i in the white and grey matter on application of NAA (1 mM), NAAG
(1 mM) and NMDA (60 µM). A Specimen image of cerebellar white matter (red
region) and grey matter (black region) loaded with Fluo-4. B Rise of Fluo-4
fluorescence (F) in white matter and grey matter after application of NAAG and
NMDA, and lack of a response after application of NAA. C Average responses of
white matter to NAA, NAAG and NMDA. D Average responses of grey matter to
NAA, NAAG and NMDA. Number on or above each bar indicates number of slices. P
values are from one sample t-tests comparing with zero response.
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Figure 6.2
Block of NAAG-induced rise in [Ca2+]i in white and grey matter by D-AP5 (100 µM).
A Specimen image of cerebellar white matter (red region) and grey matter (black
region) loaded with Fluo-4. B Block of NAAG-induced rise in Fluo-4 fluorescence in
white matter and grey matter by AP5. C Average responses of white matter to NAAG,
NAAG+AP5 and a subsequent application of NAAG, normalised to the amplitude of
the first response. D Normalised average responses of grey matter to NAAG,
NAAG+AP5, and a subsequent application of NAAG. All the experiments were
performed in 4 slices. P values compare the response in AP5 with the average of the
bracketing control responses without AP5.
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Figure 6.3
The group II mGluR blocker EGLU (200 µM) did not reduce the NAAG-induced
[Ca2+]i rise in the white matter, but produced a small but significant decrease in the
NAAG-evoked [Ca2+]i rise in the grey matter. A Specimen image of cerebellar white
matter (red region) and grey matter (black region) loaded with Fluo-4. B Effect of
EGLU on the NAAG-induced rise in Fluo-4 fluorescence in white matter and grey
matter (note that there is a strong run down of the responses to repeated agonist
application, on which the EGLU effect will superimpose). C Average responses of
white matter to NAAG, NAAG+EGLU and a subsequent application of NAAG,
normalised to the amplitude of the first response. D Normalised average responses of
grey matter to NAAG, NAAG+EGLU, and a subsequent application of NAAG. All the
experiments were performed in 3 slices. P values compare the response in EGLU to
the mean of the bracketing control responses (this procedure assumes that the rundown
of the response in the absence of EGLU is linear with time).
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Figure 6.4
No detectable changes occurred in [Ca2+]i in oligodendrocytes after NAAG (1 mM)
application. A Specimen image of a cerebellar white matter oligodendrocyte, patch-
clamped with a pipette containing Fura-2. Black line encircles soma, green and red
rectangles are around processes aligned with axons. B Lack of change of Fura-2
fluorescence in both the soma and processes of the oligodendrocyte in A after
application of 1mM NAAG (upper panel), despite NAAG evoking an inward current
(lower panel). C Average responses of oligodendrocyte and granule cell somata (8 and
7 cells respectively). Granule cell data are from experiments as in Fig. 6.5. P values
are from one sample t-tests comparing with zero response.
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Figure 6.5
NAAG-evoked changes in [Ca2+]i in cerebellar granule cells mediated by NMDA
receptors. A Specimen image of a single granule cell patch-clamped with a pipette
containing Fura-2. Black line encircles soma, red rectangle is around a single dendrite.
B Change of Fura-2 fluorescence (ΔR = change of ratio 340nm/380nm) in the granule
cell in B after application of 1mM NAAG, and block of this response by 100µM D-
AP5 (upper panel), with the simultanously evoked inward current (lower panel).
C Average responses of granule cells to NAAG, NAAG+AP5, and a subsequent
application of NAAG, normalised to the initial response (n=3 cells for each). P value
compares the response in AP5 to the mean of the bracketing control responses.
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Figure 6.6
[Ca2+]i rise in cerebellar granule cells, evoked by pathologically relevant
concentrations of NAAG. A Representative image of a cerebellar granule cell patch-
clamped with a pipette containing Fura-2. B [Ca2+]i rise in a single granule cell upon
application of 50 µM, 200 µM and 1 mM NAAG. C Average responses to 50, 200 and
1000 µM NAAG in 3, 4 and 7 (respectively) granule cells. P values are from one
sample t-tests comparing with zero response. The experiments were performed in
0 mM Mg2+ solution.
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Figure 6.7
The death of white matter (A) and grey matter (B) cells evoked by NAAG (1 mM;
n=11 slices), NAAG+AP5 (1 mM and 100 µM, respectively; n=6 slices), and NMDA
(100 µM; n=10 slices), compared with the death in control solution (n=10 slices).
Slices were incubated at 36ºC for 6 h, and data were averaged from 3 replicate
experiments. The percentage of death was calculated by dividing the number of dead
cells (labelled with PI) by the total number of cells (given by the number of nuclei
labelled with DAPI).
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Chapter 7: Discussion
In this chapter I will give a brief discussion of the results obtained in my PhD, and
point out further experiments that could be done to address remaining interesting
questions that I did not have time to address in the 3 year PhD.
7.1 The electrical response of white matter oligodendrocytes to
simulated ischaemia
In Chapter 3 I characterised the membrane current changes evoked by ischaemia
in oligodendrocytes.
7.1.1 Discussion
Mature oligodendrocytes responded to simulated ischaemia by generating an
inward current which had a stereotypical waveform and an amplitude which increased as
the cells developed. The amplitude and time course of the current were independent of
the main ion used in the internal solution (Cs+ or K+).
When not voltage-clamped, oligodendrocytes responded to the stimulus with
depolarisation that was much larger with Cs+ inside than with K+ inside, suggesting that
K+ channels generate an outward current at depolarised potentials, and/or at late times in
ischaemia, which limits the depolarisation occurring, and that Cs+ is not permeant
through these channels. This suggests that, in vivo, oligodendrocytes will only undergo an
ischaemia-evoked depolarization of less than 20 mV and then repolarise back towards
their initial membrane potential. This feature is unique to oligodendrocytes as it was not
observed in neurons (Hamann et al., 2005) or astrocytes (Xie et al., 2008).
During ischaemia the cell membrane resistance increased significantly. There was
no capacitance decrease, which would have implied that this change could be attributed
to a loss of the cell’s myelinating processes. Interestingly, analysis of the I-V relation of
the cells revealed that the increase in cell membrane resistance was induced by a closing
of potassium channels. This phenomenon has not been reported previously, and is
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dramatically different from the neuronal response to ischaemia, which is dominated by
the opening of glutamate-gated cation channels.
7.1.2 Suggestions for the further work
The closing of potassium channels is apparently followed by the opening of
voltage-gated K+ channels that generate the membrane repolarisation. It would be
interesting to identify the specific potassium channels that are involved in both of these
processes. This is difficult, because of a lack of specific blockers for these channel types,
and because any blockers applied will also affect channels in neurons and astrocytes, thus
altering the change of [K+]o occurring. Nevertheless, Gipson and Bordey (2002) showed
that extracellular Cs+ (5 mM) blocks inward rectifier currents in mature oligodendrocytes
in corpus callosum slices, while Ba2+ (1 mM) blocks both inward and outward passive
currents, and it would be interesting to assess the effect of these agents on the I-V relation
of the oligodendrocytes in ischaemia to try to identify the channels which are closed in
the initial part of the ischaemic response. Gipson and Bordey (2002) also reported the
expression of a TEA-sensitive outward current in mature oligodendrocytes, which they
attributed to the activation of delayed rectifier channels. Testing whether TEA inhibits the
late repolarisation phase in ischaemia might therefore provide a test of my suggestion that
this repolarisation is mediated by the activation of voltage-dependent (delayed rectifier)
channels. Such channels would have to be activated by the relatively small depolarisation
that is evoked by ischaemia in oligodendrocytes.
It would be interesting to test whether, at the time of the ischaemia-induced
current in the oligodendrocytes, there is a rise of [K+]o produced in the white matter. In
order to do that, a K+-sensitive electrode could be used while simultaneously recording
the ischaemia-evoked current from an oligodendrocyte. Of particular interest is whether
the fast component of the inward current evoked after several minutes ischaemia reflects
an increase of [K+]o that is driven by the anoxic depolarization occurring in neurons in the
nearby grey matter. This could be assessed by simultaneously recording (with two patch
clamps) the current changes occurring in a granule or Purkinje cell and in an
oligodendrocyte.
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In all the experiments, ATP was one of the ingredients of the internal solution,
added to better mimic the physiological intracellular solution. However, during ischaemia
the intracellular ATP levels will fall due to the inhibition of glycolysis and oxidative
phosphorylation, but this effect may not occur in the patch-clamped cell due to its
constant perfusion by the ATP-containing pipette solution (in practice this will maintain
the intracellular level better near the soma than at the ends of the long myelinating
processes of the cells). It would be interesting, therefore, to test the oligodendrocyte’s
response to ischaemia using an internal solution devoid of ATP – although such an
approach could induce a response unrelated to ischaemia and produced by ATP depletion
even before the application of the ischaemic solution.
7.2 The role of glutamate in the oligodendrocyte response to
ischaemia
In Chapter 4 I assessed the role of glutamate in generating the ischaemia-evoked
current in oligodendrocytes.
7.2.1 Discussion
I showed that glutamate is released into the white matter in ischaemia primarily
via the reversal of glutamate transporters, which confirmed a previous study by Li et al.
(1999). Glutamate release as a result of the activity of astroglial NKCC1 co-transporters
(Wilke et al., 2006), synaptic release from unmyelinated axons (Kukley et al., 2007;
Ziskin et al., 2007) or microglial system Xc- (Domercq et al., 2009) did not contribute
significantly on the time scale that I investigated.
I also demonstrated that glutamate is the main trigger of the mature
oligodendrocytes’ response to ischaemia. Ionotropic glutamate receptor blockers (NBQX
and AP5 applied together) and a metabotropic glutamate receptor blocker (MCPG),
significantly reduced the inward current, unlike antagonists of P2X7 receptors (Domercq
et al., 2010), hemichannel opening (Domercq et al., 2010), ASICs (Feldman et al., 2008),
neuronal action potential, TRP channels or GABAA receptors.
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Interestingly, once initiated, the ischaemia-evoked inward current could not be
blocked by ionotropic glutamate receptor blockers. This effect is different to that
observed in neurons, where glutamate receptor blockers inhibited the current at any point
of the cell response to ischaemia (Rossi et al., 2000; Hamann et al., 2005). Furthermore,
this effect differs from the irreversible extended depolarization (END) observed in
neurons (Sombati et al., 1991; Limbrick et al., 2003) in that it is not blocked by applying
Gd3+ or removing external calcium. Thus, this response is specific to oligodendrocytes
and has not been described in the literature before.
7.2.2 Suggestions for further work
As ionotropic and metabotropic glutamate receptor blockers reduced the
ischaemia-induced current when applied separately, it would be interesting to test if the
current was completely abolished with these blockers applied together, and if the current
can be blocked by applying MCPG after the current has been initiated. Also, MCPG is a
broad-spectrum mGluR blocker and so the use of the antagonists specific to the different
groups of mGluRs would allow identification of the mGluR subtype involved.
It would be highly desirable to employ Ca2+-imaging as an additional tool to
characterise glutamate’s effect on oligodendrocytes during ischaemia. A previous study,
performed on the whole optic nerve, reported a continuous [Ca2+]i rise in mature
oligodendrocytes from the beginning of ischaemia, which was attributed to an NMDA-
mediated Ca2+ influx into the cell processes (Micu et al., 2006). However, neither
blocking NMDA receptors alone (with 200 µM AP5, i.e. a concentration twice as high as
the one used by Micu et al., 2006) nor omitting Ca2+ from the external solution
(accompanied by 50 µM EGTA, a Ca2+ chelator, to ensure a lack of free external Ca2+)
affected the shape or the amplitude of the ischaemia-evoked current and so it is highly
unlikely that the current response reflects an NMDA receptor mediated Ca2+ entry into
the cell. A study investigating the [Ca2+]i changes evoked by ischaemia performed on a
single cell loaded with Ca2+ dye from the patch pipette (i.e. not in a whole slice loaded
with the AM ester form of the calcium dye), would provide a better approach to define
the existence and source of an ischaemia-evoked [Ca2+]i rise in oligodendrocytes.
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The END-like effect in oligodendrocytes was not reported in the literature before.
Such a response could be unique to oligodendrocytes, but it is also possible that the effect
is more generally present in all glial cells, including astrocytes, Bergmann glia and
Müller cells. It would be interesting to test this possibility, which could give us a better
insight into the glial response to ischaemia, which seems to be significantly different to
the one observed in neurons. Understanding this process could help with the development
of therapies aiming, not only at neuronal, but also at glial cell survival in pathological
conditions.
7.3 Oligodendroglial and neuronal electrical responses to NAA and
NAAG
In Chapter 5 I tested whether NAA or NAAG act on glutamate receptors to evoke
a membrane current in oligodendrocytes, to test the hypothesis that such an action might
contribute to the cell damage occurring in certain leukodystrophies.
7.3.1 Discussion
The concentration of NAA and NAAG rises considerably in two types of
leukodystrophy, Canavan Disease (CD) and Pelizaeus-Merzbacher-like Disease (PMLD).
I showed for the first time that NAAG, but not NAA evoked an inward current in mature
oligodendrocytes, by acting on NMDA receptors, although this current is small. The
response was partially of an indirect nature, as blocking neuronal action potential
significantly reduced the NAAG-evoked inward current. Additionally, there was a
substantial reduction in the current upon the block of GCP II, the peptidase enzyme that
cleaves NAAG to NAA and glutamate, suggesting that part of the response is caused by
glutamate and not directly by NAAG. In comparison, the granule cell response to NAAG
(which was significantly larger than the one observed in oligodendrocytes, despite the
granule cells being smaller in membrane area) was not affected either by inhibition of
action potentials or block of GCP II.
NAAG and NAA did not block the NMDA-induced current in oligodendrocytes,
while NAA exerted a small blocking effect on the granule cell response to NMDA. This
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block implies that NAA could antagonise granule cell NMDA receptor activation under
pathological conditions, such as CD (where NAA levels rise to 0.4-0.9 mM (Burlina et
al., 1999), i.e. the concentration used in this study), and thus possibly affect the cell’s
excitability.
The pathologically-relevant concentration of NAAG, reported in Pelizeus-
Merzbacher-like disease (Wolf et al., 2004; Sartori et al., 2008), evoked a statistically
significant current in oligodendrocytes (and in granule cells) at a concentration of
200 µM, but only when no external magnesium was present. This result further suggests a
very low affinity of NAAG towards oligodendrocyte NMDA receptors and lowers the
possibility of this substance having direct pathological effects on oligodendrocytes.
7.3.2 Suggestions for further work
I tested the effect of NAA and NAAG early in development on mature
oligodendrocytes that had recently myelinated axons. This implicitly assumes a
hypothesis in which the loss of myelin observed in CD and PMLD is caused by a process
of demyelination, i.e. the loss of already formed myelin. However, it is also possible that
the leukodystrophies develop due to an inability of the oligodendrocyte precursors to
differentiate into mature oligodendrocyte and hence produce myelin. The fact that the
NMDA receptor-mediated currents in OPCs (in particular their weak Mg2+ block) seem
similar to those in mature cells (Karadottir et al., 2005) suggests that it is unlikely that
NAA and NAAG damage OPCs by acting on these receptors. However, OPCs could be
affected by NAA or NAAG via a different mechanism, affecting their survival or their
ability to develop into mature oligodendrocytes. This hypothesis should be tested, by
applying NAA and NAAG to OPCs in the white matter and recording their membrane
current and [Ca2+]i changes.
7.4 Oligodendroglial and neuronal intracellular calcium
concentration changes as a response to NAA and NAAG
Chapter 6 reports experiments testing whether NAA or NAAG evoke [Ca2+]i
elevations in oligodendrocytes or neurons.
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7.4.1 Discussion
The application of NAAG, but not NAA, in both white and grey matter, evoked a
significant increase in [Ca2+]i (as assessed by AM-loading calcium dye into many cells in
the tissue) suggesting an activation of NMDA receptors – a hypothesis that was
confirmed by blocking the [Ca2+]i rise with AP5. Application of a blocker of mGluR3,
another candidate receptor by which these compounds might act, did not have an effect
on the white matter response to NAAG, but reduced the response in the grey matter. This
effect could be attributed to the opening of non-specific cation channels upon mGluR3
activation (Guérineau et al., 1995).
Surprisingly, when single oligodendrocytes were patch-clamped, they did not
exhibit a [Ca2+]i change on NAAG application, either in the soma or in their processes
(where oligodendrocyte NMDA receptors were suggested to be preferentially expressed;
Salter and Fern, 2005; Micu et al., 2006). This result might be explained by the
oligodendrocyte NMDA receptors having a small Ca2+ permeablity due to the presence in
their structure of an NR3 subunit (Sasaki et al., 2002), or by the action of NAAG being
largely indirect and through activation of neuronal NMDA receptors (perhaps, for
example, inducing an extracellular [K+] rise which leads to an inward current in
oligodendrocytes that does not include a Ca2+ component). In comparison, single patch-
clamped granule cells still displayed a [Ca2+]i rise, like the bulk dye-loaded grey matter,
confirming a direct action of NAAG on neuronal NMDA receptors. In some cells there
was also a clear rise in [Ca2+]i when the pathologically relevant concentration of 200 µM
NAAG was applied, although this did not reach statistical significance when averaged
across all cells studied.
The cell death assay performed after applying NAA and NAAG for 6 hours
showed that these substances are unlikely to cause a substantial death of oligodendrocytes
and neurons, at least on this time scale.
7.4.2 Suggestions for further work
As explained in section 7.3.2, it would be desirable to test the possibility that
NAA and NAAG act on OPCs and inhibit their development in the leukodystrophies.
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Ca2+-imaging studies should accompany the suggested electrophysiological experiments
to more comprehensively describe the effect of NAA and NAAG on OPCs.
The white matter showed a [Ca2+]i increase upon NAAG application, but this
effect was not seen when single oligodendrocytes were studied. This implies that the
change in [Ca2+]i in the white matter is presumably occurring in another cell type within
structure (into which the AM ester of the calcium dye has passed), presumably astrocytes.
It would be interesting to test this hypothesis by applying NAAG to single patch-clamped
astrocytes.
Finally, the cell death assay was performed for only 6 hours, and will probably
mainly detect necrotic cell death. In contrast, the exposure of oligodendrocytes to highly
elevated levels of NAA and NAAG in children who have the leukodystrophies is constant
and lasts for a prolonged time. That implies that the experiments should be repeated on
cultured slices, which could be exposed to NAA and NAAG for a considerably longer
time than 6 hours, and (in addition to propidium iodide) caspase 3 labelling should be
employed in order to assess both apoptotic and necrotic death caused by these two
substances.
7.5 Conclusion
The experiments performed during my PhD and described in this thesis
investigated the response of mature oligodendrocytes to pathological stimuli.
I showed that, in white matter ischaemia, the main origin of the excessive
glutamate release occurring is the reversal of glutamate transporters (located, most
probably, on axons and oligodendrocytes: Li et al., 1999). Glutamate, acting on its
ionotropic and metabotropic receptors, induces an inward current in oligodendrocytes that
is a result of potassium channel closing. The direct cause of this phenomenon is not
known. The sodium influx occurring through AMPA/KA receptors was previously shown
to result in the closing of potassium channels in oligodendrocyte precursors (Knutson et
al., 1997) making plausible an explanation that sodium ions actively block the potassium
channels’ pore from its intracellular side. Another possibility is that an excessive
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activation of glutamate receptors could trigger changes in the phosphorylation state of
potassium channels. It has been shown previously that TASK and TREK channels are
inhibited by the activation of Gq protein-coupled receptors (Mathie, 2007) that would also
occur upon type I mGluR activation. Changes in the phosphorylation state of potassium
channels could also cause their internalization: KCNQ1 channels were shown to undergo
increased endocytosis upon Gq protein-coupled receptor activation (Kanda et al., 2011),
and Kv4.2 internalisation was reported to be an effect of the phosphorylation of these
channels following AMPA receptor activation (Hammond et al., 2008). Finally, the
action of glutamate on oligodendrocyte potassium channels might be of an indirect
nature, e.g. glutamate activating its receptors on astrocytes could cause a release of a
secondary agent, such as 20-HETE, that would trigger the closing of oligodendrocyte
potassium channels.
The closing of the potassium channels might eventually lead to oligodendrocyte
damage or death in ischaemia. A loss of the potassium spatial buffering capabilities of
oligodendrocytes will increase the rise of extracellular potassium concentration occurring
in ischaemia. The resulting water efflux from the oligodendrocytes might disrupt the
myelin and the attachment of the oligodendrocyte processes to the axons, possibly
causing rupture of the oligodendrocyte membrane and thus, ultimately, death of the soma.
The slow voltage repolarisation phase seen in current clamp experiments might occur due
to the opening of slow outwardly rectifying calcium-activated potassium channels, caused
by the opening of voltage-dependent calcium channels. Even a small calcium influx (that
could be later amplified by calcium-induced calcium release), especially into the very
compact intracellular space of the myelinating processes, could cause a detrimental effect
to the processes and thus to the integrity of the whole cell. For a summary of the various
contributions to the oligodendrocyte response to ischaemia, see Figure 7.1.
The ischaemia-induced response in oligodendrocytes differs substantially from
that observed in neurons: unlike in neurons, the inward current is not primarily due to the
opening of non-selective cation channels and, once triggered, it cannot be blocked by
ionotropic glutamate receptor blockers (an effect similar to the END effect observed in
neurons). These features make the oligodendrocyte response to ischaemia unique and are
described in this thesis for the first time.
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I also tested the hypothesis that high concentrations of NAA and NAAG can
cause myelin damage and oligodendrocyte loss by acting on oligodendrocyte NMDA
receptors in two types of leukodystrophy: Canavan Disease and Pelizaeus-Merzbacher-
like Disease. I discovered that, although oligodendrocytes respond with a small current to
NAAG (but not NAA), its effect on the cells is to a large extent secondary to an action of
NAAG (or glutamate derived from NAAG) on neurons.
Further work is needed to describe the oligodendrocyte response to ischaemia in
greater detail and to test the possibility of an action of NAA and NAAG on OPCs, with
the long term aim of developing therapeutic strategies to prevent oligodendrocyte
damage.
Glutamate transporter reversal
and glutamate release
White matter ischaemia
Oligodendrocyte
glutamate receptor activation
Na+ influx and active
block of K+ channels?
Change in the phosphorylation
state of K+ channels:
 Inactivation of K+ channels?
 Internalisation of K+ channels?
Astrocyte
ionotropic receptor activation?
Secondary
substance release?
Potassium channel closing
Loss of K+ buffering capabilities?
Ca2+ influx?
Cell death
Figure 7.1
The possible sequence of events underlying the oligodendrocytes’ response to
ischaemia. In white matter ischaemia, cell membrane depolarisation causes the
reversal of glutamate transporters and a release of glutamate which acts on
oligodendrocyte glutamate receptors. The activation of the receptors triggers the
irreversible closing of potassium channels, which may occur due to changes in the
phosphorylation state of potassium channels and/or the active block of the channels by
sodium ions. Alternatively, astrocytic glutamate receptor activation might lead to the
release of a secondary substance that acts on oligodendrocytes. Closing of potassium
channels may result in cell death as a result of a decrease of the oligodendrocytes’
abilities to buffer potassium or an activation of a voltage-gated calcium influx into the
cell, either of which could lead to process loss and damage to the soma.
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